var title_f22_0_22528="Contents: General medical issues in women";
var content_f22_0_22528=[" <script type=\"text/javascript\">",
"  $$.inlineInitCustomer(",
"	false);",
"	var quirksmode = document.compatMode == \"CSS1Compat\";",
"	if (quirksmode) {",
"		$(\"html\").addClass(\"ie-standards\");",
"	}",
" </script>",
" <div id=\"message-wrap\">",
"  <div id=\"message-bg\">",
"  </div>",
"  <iframe id=\"message-bk\">",
"  </iframe>",
"  <dl id=\"message-container\">",
"   <dt id=\"message-title\">",
"   </dt>",
"   <dd id=\"message-body\">",
"   </dd>",
"   <dd id=\"message-controls\">",
"   </dd>",
"  </dl>",
" </div>",
" <div id=\"topPanel\">",
"  <div id=\"header\">",
"   <div id=\"header_container\">",
"    <h2 id=\"logo\">",
"     <a href=\"./toc\">",
"      Wolters Kluwer Health UpToDate",
"     </a>",
"    </h2>",
"    <div id=\"header_right\">",
"     <div id=\"searchpanel\">",
"      <a href=\"/login\" id=\"loginbutton\">",
"       Log in",
"      </a>",
"      <div id=\"cmsSearchBox\">",
"       <div class=\"header-search\">",
"        <form action=\"./search\" id=\"cmssearch\" method=\"get\" name=\"SearchForm\">",
"         <div class=\"header-search-left\">",
"          <input autocomplete=\"off\" class=\"searchfield\" id=\"cmsTxtBox\" name=\"search\" placeholder=\"Search UpToDate\" type=\"text\"/>",
"         </div>",
"         <div class=\"header-search-right\">",
"          <input alt=\"Search\" id=\"cmsSearchSubmit\" src=\"/sites/all/themes/uptodate/images/search_button.png\" type=\"image\"/>",
"         </div>",
"         <div class=\"clear\">",
"         </div>",
"        </form>",
"       </div>",
"      </div>",
"      <div id=\"cms_lang_dropdown\">",
"       <form accept-charset=\"UTF-8\" action=\"/\" id=\"lang-dropdown-form\" method=\"post\">",
"        <div class=\"form-item form-type-select form-item-lang-dropdown-select\">",
"         <select class=\"lang-dropdown-select-element form-select\" id=\"edit-lang-dropdown-select\" name=\"lang_dropdown_select\" style=\"width:100px\">",
"          <option selected=\"selected\" value=\"en\">",
"           English",
"          </option>",
"          <option value=\"ja\">",
"           ���������������������������",
"          </option>",
"         </select>",
"        </div>",
"        <input name=\"lang_dropdown_type\" type=\"hidden\" value=\"language\">",
"         <input name=\"en\" type=\"hidden\" value=\"/\">",
"          <input name=\"ja\" type=\"hidden\" value=\"/ja\">",
"           <noscript>",
"            <div>",
"             <input class=\"form-submit\" id=\"edit-submit\" name=\"op\" type=\"submit\" value=\"Go\"/>",
"            </div>",
"           </noscript>",
"           <input name=\"form_build_id\" type=\"hidden\" value=\"form-on4lUWpxHun_wp6revUkjCG6rK2IBuCGME9Cw0HXeok\">",
"            <input name=\"form_id\" type=\"hidden\" value=\"lang_dropdown_form\">",
"            </input>",
"           </input>",
"          </input>",
"         </input>",
"        </input>",
"       </form>",
"      </div>",
"      <div class=\"clear\">",
"      </div>",
"     </div>",
"     <ul id=\"utility\">",
"      <li class=\"first\">",
"       <a href=\"/home/about-us\">",
"        About Us",
"       </a>",
"      </li>",
"      <li>",
"       <a href=\"/home/news-events\">",
"        News &amp; Events",
"       </a>",
"      </li>",
"      <li>",
"       <a href=\"/home/contact-us\">",
"        Contact Us",
"       </a>",
"      </li>",
"      <li class=\"last\">",
"       <a href=\"/help\">",
"        Help",
"       </a>",
"      </li>",
"     </ul>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"   </div>",
"   <div id=\"nav\">",
"    <ul>",
"     <li id=\"productTab\">",
"      <a href=\"/home/product\">",
"       Product",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"editoralTab\">",
"      <a href=\"/home/editorial\">",
"       Editorial",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"whyUptodateTab\">",
"      <a href=\"/home/why-uptodate\">",
"       Why UpToDate",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"supscriptionOptionsTab\">",
"      <a href=\"/home/subscription-options\">",
"       Subscription Options",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"/store\">",
"       Subscribe",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"wkhcsTab\">",
"      <a href=\"/home/wolters-kluwer-health-clinical-solutions\">",
"       Wolters Kluwer Health Clinical Solutions",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"    </ul>",
"    <div class=\"clear\">",
"    </div>",
"   </div>",
"   <div id=\"greyBar\">",
"    <div id=\"greyBarTitle\">",
"     <span class=\"emphasis\">",
"      <a href=\"UTD.htm?3/3/3134\">",
"       Contents",
"      </a>",
"     </span>",
"     <img src=\"./../images/space_arrows.myextg\">",
"      <a href=\"UTD.htm?1/34/1568\">",
"       Family Medicine and General Practice",
"      </a>",
"      <img src=\"./../images/space_arrows.myextg\">",
"       General medical issues in women",
"      </img>",
"     </img>",
"    </div>",
"    <div id=\"greyBarButtons\">",
"     <div id=\"printGB\">",
"      <a class=\"icontxt\" href=\"?view=print\">",
"       <img align=\"middle\" alt=\"Print this page\" border=\"0\" height=\"20\" src=\"./../images/icn_print.myextg\" width=\"24\"/>",
"      </a>",
"      <a class=\"icontxt\" href=\"?view=print\" title=\"Print this page\">",
"       Print",
"      </a>",
"     </div>",
"    </div>",
"   </div>",
"   <!-- menuMessage.jsp -->",
"   <!-- /menuMessage.jsp -->",
"  </div>",
"  <!-- header -->",
" </div>",
" <!-- topPanel -->",
" <div id=\"leftPanel\">",
"  <ul>",
"   <li>",
"    <a href=\"UTD.htm?3/45/3806\">",
"     Specialties",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?18/22/18798\">",
"     Patient Information",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?3/13/3294\">",
"     What's New",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?0/37/606\">",
"     Calculators",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?0/40/654\">",
"     Authors and Editors",
"    </a>",
"   </li>",
"  </ul>",
" </div>",
" <!-- leftPanel -->",
" <div id=\"rightPanel\">",
"  <noscript>",
"   <div id=\"javascriptDisabled\">",
"    It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"   </div>",
"  </noscript>",
"  <div id=\"printHeader\">",
"   <div id=\"printHeaderLogo\">",
"    <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"    </img>",
"   </div>",
"   <div id=\"printHeaderText\">",
"    Official reprint from UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"    <a href=\"file://www.uptodate.com\">",
"     www.uptodate.com",
"    </a>",
"    <br>",
"     &copy;2013 UpToDate",
"     <sup>",
"      &reg;",
"     </sup>",
"    </br>",
"   </div>",
"   <div id=\"printHeaderLinks\">",
"    <a href=\"#\" id=\"printHeaderPrint\" rel=\"\" title=\"Click here to print\">",
"     Print",
"    </a>",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"     Back",
"    </a>",
"   </div>",
"  </div>",
"  <div class=\"toctable\" border=\"0\" cellpadding=\"0\" cellspacing=\"0\" id=\"tocTable\" width=\"100%\">",
"   <trs>",
"    <tds>",
"     <h1>",
"      Contents:",
"			General medical issues in women",
"     </h1>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds valign=\"top\">",
"     <div class=\"toctable\" border=\"0\" cellpadding=\"0\" cellspacing=\"0\" width=\"100%\">",
"      <trs>",
"       <tds>",
"        <strong>",
"         Adolescents",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?18/35/19000\">",
"           Guidelines for adolescent preventive services",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Breast disease",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?24/15/24825\">",
"           Breast masses and other common breast problems",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?8/33/8728\">",
"           Breast pain",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?3/23/3449\">",
"           Nipple discharge",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?10/52/11081\">",
"           Overview of benign breast disease",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?40/49/41754\">",
"           Screening for breast cancer",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Cardiovascular disease",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?40/9/41113\">",
"           Clinical features and diagnosis of coronary heart disease in women",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?27/35/28217\">",
"           Coronary heart disease and myocardial infarction in young men and women",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?27/57/28570\">",
"           Determinants and management of cardiovascular risk in women",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?10/63/11258\">",
"           Management of coronary heart disease in women",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?32/29/33241\">",
"           Screening guidelines for dyslipidemia",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Endocrine disorders",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?32/42/33449\">",
"           Clinical manifestations and diagnosis of Turner syndrome (gonadal dysgenesis)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?38/52/39751\">",
"           Clinical manifestations and diagnosis of premenstrual syndrome and premenstrual dysphoric disorder",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?16/6/16490\">",
"           Clinical manifestations of polycystic ovary syndrome in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?38/36/39495\">",
"           Diagnosis of polycystic ovary syndrome in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?28/16/28935\">",
"           Epidemiology and pathogenesis of premenstrual syndrome and premenstrual dysphoric disorder",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?2/2/2089\">",
"           Etiology, diagnosis, and treatment of primary amenorrhea",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?33/56/34697\">",
"           Etiology, diagnosis, and treatment of secondary amenorrhea",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?9/31/9721\">",
"           Evaluation of premenopausal women with hirsutism",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?13/63/14329\">",
"           Management of Turner syndrome (gonadal dysgenesis)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?23/28/24007\">",
"           Pathogenesis and causes of hirsutism",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?27/2/27685\">",
"           Physiology of the normal menstrual cycle",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?34/37/35416\">",
"           Treatment of hirsutism",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?3/10/3241\">",
"           Treatment of premenstrual syndrome and premenstrual dysphoric disorder",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Gastrointestinal disease",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?21/59/22455\">",
"           Clinical manifestations and diagnosis of irritable bowel syndrome",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?13/22/13673\">",
"           Etiology and evaluation of chronic constipation in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?29/57/30616\">",
"           Management of chronic constipation in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?12/25/12697\">",
"           Pathophysiology of irritable bowel syndrome",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?39/14/40169\">",
"           Treatment of irritable bowel syndrome",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         General hematology/oncology",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?5/3/5178\">",
"           Approach to the adult patient with a bleeding diathesis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?25/39/26234\">",
"           Causes and diagnosis of anemia due to iron deficiency",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?11/41/11930\">",
"           Evaluation of the patient with established venous thrombosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?24/62/25578\">",
"           Treatment of anemia due to iron deficiency",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?9/53/10072\">",
"           Women and lung cancer",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Gynecologic issues",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?24/1/24601\">",
"           Approach to the patient with an adnexal mass",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?24/15/24825\">",
"           Breast masses and other common breast problems",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?39/15/40185\">",
"           Cervical cytology: Interpretation of results",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?18/57/19352\">",
"           Differential diagnosis of the adnexal mass",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?30/11/30905\">",
"           Management of an adnexal mass",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?14/29/14810\">",
"           Overview of the treatment of endometriosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?18/48/19210\">",
"           Pathogenesis, clinical features, and diagnosis of endometriosis",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Hernia",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?30/37/31321\">",
"           Classification, clinical features and diagnosis of inguinal and femoral hernias in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?28/20/29000\">",
"           Overview of treatment for inguinal and femoral hernias",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Hypertension",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?35/29/36314\">",
"           Choice of therapy in primary (essential) hypertension: Recommendations",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?36/62/37859\">",
"           Effect of oral contraceptives and postmenopausal hormone therapy on blood pressure",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?2/63/3060\">",
"           Essential hypertension in women",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?4/4/4169\">",
"           Hypertension: Who should be treated?",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?32/40/33417\">",
"           What is goal blood pressure in the treatment of hypertension?",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Neurologic disease",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?20/44/21194\">",
"           Acute treatment of migraine in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?3/34/3624\">",
"           Headache syndromes other than migraine",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?26/4/26698\">",
"           Pathophysiology, clinical manifestations, and diagnosis of migraine in adults",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Obesity",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?8/9/8345\">",
"           Dietary therapy for obesity",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?33/4/33866\">",
"           Drug therapy of obesity",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?29/35/30266\">",
"           Health hazards associated with obesity in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?12/45/13016\">",
"           Overview of therapy for obesity in adults",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Osteoporosis",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?38/52/39754\">",
"           Overview of the management of osteoporosis in postmenopausal women",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?39/28/40393\">",
"           Screening for osteoporosis",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Other infectious diseases",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?14/29/14803\">",
"           Cellulitis following pelvic lymph node dissection",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?30/6/30825\">",
"           Clinical features and diagnosis of chronic fatigue syndrome",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?4/21/4440\">",
"           Treatment of chronic fatigue syndrome",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Psychiatric disease",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?25/33/26135\">",
"           Antidepressant medication in adults: Switching and discontinuing medication",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?5/18/5417\">",
"           Atypical antidepressants: Pharmacology, administration, and side effects",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?11/13/11481\">",
"           Clinical manifestations and diagnosis of depression",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?23/2/23593\">",
"           Eating disorders: Epidemiology, pathogenesis, clinical features, and course of illness",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?42/63/44023\">",
"           Eating disorders: Treatment",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?7/21/7512\">",
"           Factitious disorder and Munchausen syndrome",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?32/0/32776\">",
"           Generalized anxiety disorder: Epidemiology, pathogenesis, clinical manifestations, course, assessment, and diagnosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?39/8/40074\">",
"           Initial treatment of depression in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?7/25/7574\">",
"           Monoamine oxidase inhibitors (MAOIs) for treating depressed adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?5/0/5129\">",
"           Serotonin modulators: Pharmacology, administration, and side effects",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?5/28/5578\">",
"           Serotonin-norepinephrine reuptake inhibitors (SNRIs): Pharmacology, administration, and side effects",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?26/61/27609\">",
"           Treatment of resistant depression in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?35/20/36169\">",
"           Unipolar depression in adults and tricyclic and tetracyclic drugs: Pharmacology, administration, and side effects",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?36/38/37481\">",
"           Unipolar depression in adults: Epidemiology, pathogenesis, and neurobiology",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Rheumatic disease",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?7/55/8056\">",
"           Clinical manifestations and diagnosis of fibromyalgia in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?34/49/35608\">",
"           Differential diagnosis of fibromyalgia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?36/43/37562\">",
"           Epidemiology and pathogenesis of systemic lupus erythematosus",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?16/16/16646\">",
"           Menstrual function, menopause, and hormonal contraceptives in women with systemic lupus erythematosus",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?40/31/41464\">",
"           Overview of the clinical manifestations of systemic lupus erythematosus in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?40/38/41578\">",
"           Overview of the therapy and prognosis of systemic lupus erythematosus in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?30/19/31031\">",
"           Pathogenesis of fibromyalgia",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Screening for cancer",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?34/32/35337\">",
"           Cervical cancer screening tests: Techniques and test characteristics of cervical cytology and human papillomavirus testing",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?40/49/41754\">",
"           Screening for breast cancer",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?36/10/37034\">",
"           Screening for colorectal cancer: Strategies in patients at average risk",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?10/14/10474\">",
"           Screening for ovarian cancer",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Sexually transmitted diseases",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?12/15/12538\">",
"           Approach to the patient with genital ulcers",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?1/0/1032\">",
"           Clinical features and diagnosis of pelvic inflammatory disease",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?25/35/26166\">",
"           Diagnosis of gonococcal infections",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?38/44/39624\">",
"           Diagnostic testing for syphilis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?3/56/3976\">",
"           Disseminated gonococcal infection",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?9/10/9386\">",
"           Epidemiology, clinical manifestations, and diagnosis of genital herpes simplex virus infection",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?35/61/36823\">",
"           Epidemiology, clinical manifestations, and diagnosis of tuboovarian abscess",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?37/20/38217\">",
"           Epidemiology, pathogenesis, and clinical manifestations of Neisseria gonorrhoeae infection",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?41/46/42728\">",
"           Genital Chlamydia trachomatis infections in women",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?16/35/16954\">",
"           HIV and women",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?18/25/18837\">",
"           Laboratory monitoring of patients undergoing treatment for syphilis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?42/34/43560\">",
"           Management and complications of tuboovarian abscess",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?25/44/26312\">",
"           Neurosyphilis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?11/45/11992\">",
"           Pathogenesis of and risk factors for pelvic inflammatory disease",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?36/9/37017\">",
"           Pathogenesis, clinical manifestations, and treatment of early syphilis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?0/48/776\">",
"           Pathogenesis, clinical manifestations, and treatment of late syphilis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?11/55/12150\">",
"           Pathophysiology, transmission, and natural history of syphilis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?21/15/21751\">",
"           Prevention of genital herpes virus infections",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?8/13/8408\">",
"           Screening for Chlamydia trachomatis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?7/32/7690\">",
"           Treatment of genital herpes simplex virus infection",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?34/63/35832\">",
"           Treatment of pelvic inflammatory disease",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?25/53/26455\">",
"           Virology of human papillomavirus infections and the link to cancer",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Urinary tract infection",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?13/15/13561\">",
"           Acute uncomplicated cystitis and pyelonephritis in women",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?41/19/42295\">",
"           Approach to the adult with asymptomatic bacteriuria",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?5/24/5514\">",
"           Recurrent urinary tract infection in women",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?23/41/24214\">",
"           Urine sampling and culture in the diagnosis of urinary tract infection in adults",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Venous insufficiency/thromboembolism",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?5/57/6042\">",
"           Diagnosis of acute pulmonary embolism",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?11/41/11930\">",
"           Evaluation of the patient with established venous thrombosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?42/48/43786\">",
"           Overview of the causes of venous thrombosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?41/32/42503\">",
"           Treatment of acute pulmonary embolism",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?42/4/43082\">",
"           Treatment of lower extremity deep vein thrombosis",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Violence against women",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?20/7/20601\">",
"           Evaluation and management of adult sexual assault victims",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?6/15/6393\">",
"           Intimate partner violence: Diagnosis and screening",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?5/41/5784\">",
"           Intimate partner violence: Epidemiology and health consequences",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?13/54/14183\">",
"           Intimate partner violence: Intervention and patient management",
"          </a>",
"         </li>",
"        </ul>",
"       </tds>",
"      </trs>",
"     </div>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds>",
"     <img height=\"10\" src=\"./../images/spacer.myextg\" width=\"1\"/>",
"    </tds>",
"   </trs>",
"  </div>",
"  <div id=\"footer\">",
"   <div id=\"footerNav\">",
"    <ul>",
"     <li>",
"      <a href=\"file://www.wolterskluwerhealth.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Wolters Kluwer Health",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.factsandcomparisons.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Facts &amp; Comparisons&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.medispan.com\" rel=\"nofollow\" target=\"_blank\">",
"       Medi-Span&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.provationordersets.com\" rel=\"nofollow\" target=\"_blank\">",
"       ProVation&reg; Order Sets",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.provationmedical.com\" rel=\"nofollow\" target=\"_blank\">",
"       ProVation&reg; Medical",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://pharmacyonesource.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Pharmacy OneSource&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.medicom.com.cn/\" rel=\"nofollow\" target=\"_blank\">",
"       Medicom",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.lexi.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Lexicomp",
"      </a>",
"     </li>",
"     <li class=\"last\">",
"      <a href=\"/home/privacy-policy\">",
"       Privacy Policy",
"      </a>",
"     </li>",
"    </ul>",
"   </div>",
"   <div id=\"footerLogo\">",
"    <a href=\"./toc\">",
"     Wolters Kluwer Health | UpToDate",
"    </a>",
"   </div>",
"   <div id=\"supportFooter\">",
"    <span class=\"sfInfo\">",
"     &copy; 2013 UpToDate, Inc. All rights reserved.",
"    </span>",
"    <span class=\"sfInfo\">",
"     <span class=\"pipeSpace\">",
"      |",
"     </span>",
"     Release: 21.3 - C21.34",
"    </span>",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    <span class=\"sfInfo\">",
"     <a href=\"/home/terms-use\">",
"      Terms of Use",
"     </a>",
"    </span>",
"    <br/>",
"    <span class=\"sfInfo\">",
"     Licensed to:",
"     <span class=\"emphasis\">",
"      UpToDate Marketing Professional",
"     </span>",
"    </span>",
"    <span class=\"sfInfo\">",
"     <span class=\"pipeSpace\">",
"      |",
"     </span>",
"     Support Tag: [0505-95.154.198.148-AA6F1520E4-14]",
"     <br/>",
"    </span>",
"   </div>",
"  </div>",
" </div>",
" <!-- rightPanel -->",
"</body>"].join("\n");
var script_f22_0_22528=[""].join("\n");
var outline_f22_0_22528=null;
var title_f22_0_22529="Patient information: Maternal injuries from childbirth (The Basics)";
var content_f22_0_22529=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"9\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div>",
"   &nbsp;",
"  </div>",
"  <div id=\"basicsTopicMinWidth\">",
"   <div id=\"basicsTopicRight\">",
"    <div id=\"placeholder\">",
"     <div class=\"ieSpacer\">",
"     </div>",
"     <div id=\"basics-more\">",
"      <h4>",
"       <img src=\"file://www.uptodate.com/images/basics-more-title.png\"/>",
"      </h4>",
"      <dl>",
"       <dt class=\"basics\">",
"        The Basics",
"       </dt>",
"       <dd>",
"        <a href=\"UTD.htm?12/13/12499\">",
"         Patient information: Labor and delivery (childbirth) (The Basics)",
"        </a>",
"       </dd>",
"      </dl>",
"      <div id=\"tooltipper\">",
"      </div>",
"     </div>",
"    </div>",
"   </div>",
"   <div id=\"basicsTopicLeft\">",
"    <div id=\"topicTitle\">",
"     Patient information: Maternal injuries from childbirth (The Basics)",
"    </div>",
"    <span class=\"view\">",
"     View in",
"     <a class=\"lang\" href=\"./es-419/maternal-injuries-from-childbirth-the-basics?source=topic_page\">",
"      Spanish",
"     </a>",
"    </span>",
"    <a class=\"contributor contributor_credentials\" href=\"./authors-and-editors/patient-information\">",
"     Written by the doctors and editors at UpToDate",
"    </a>",
"    <div id=\"topicText\">",
"     <p class=\"headingAnchor\" id=\"H24442705\">",
"      <span class=\"h1\">",
"       What are maternal injuries from childbirth?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Maternal injuries from childbirth are tears in the skin and muscle around the &ldquo;perineum.&rdquo; The perineum is the area between the opening of the vagina and the anus. Some of these injuries are minor and tear only the skin. Others are more serious and can tear skin and muscle. In some cases, the tear goes from the vagina to the anus. These injuries are also called &ldquo;perineal injuries.&rdquo;",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H24442720\">",
"      <span class=\"h1\">",
"       What causes maternal injuries from childbirth?",
"      </span>",
"      &nbsp;&mdash;&nbsp;These injuries happen when the perineum does not have time to stretch during labor. The baby&rsquo;s head or shoulders tear the perineum during birth. The tears are more likely to happen if:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        The baby is very large",
"       </li>",
"       <li>",
"        The mother is giving birth for the first time",
"       </li>",
"       <li>",
"        The doctor or midwife helps pull the baby out with a device that holds onto the baby&rsquo;s head. This might be done if the baby gets partly stuck in the birth canal.",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      In the past, doctors and midwives sometimes cut the perineum to make the opening of the vagina larger. This is called an &ldquo;episiotomy.&rdquo; It was done to prevent maternal injuries during childbirth. But doctors and midwives now know that an episiotomy can make a woman MORE likely to have a tear near the perineum.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H24442736\">",
"      <span class=\"h1\">",
"       How are maternal injuries from childbirth treated?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Minor skin tears often need no treatment and heal on their own. If you have a tear that goes deeper, your doctor or midwife will use stitches to repair the tear. These stitches dissolve over time and do not need to be taken out.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H24442751\">",
"      <span class=\"h1\">",
"       What can I do to feel better while my injury heals?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Some people feel better if they:",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        Take &ldquo;sitz&rdquo; baths &ndash; This is a shallow, warm bath that helps clean and heal the vaginal area. Take them twice a day for 30 minutes each.",
"       </li>",
"       <li>",
"        Take medicines to relieve pain, such as",
"        <a class=\"drug drug_patient\" href=\"UTD.htm?19/35/20021?source=see_link\">",
"         acetaminophen",
"        </a>",
"        (sample brand name: Tylenol&reg;) or",
"        <a class=\"drug drug_patient\" href=\"UTD.htm?14/17/14614?source=see_link\">",
"         ibuprofen",
"        </a>",
"        (sample brand names: Advil&reg;, Motrin&reg;).",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      If you got stitches for a serious tear, your doctor or midwife might recommend foods or medicines to keep your bowel movements soft. This makes you less likely to strain to push out a bowel movement, which might reopen the tear.",
"     </p>",
"     <p>",
"      You shouldn&rsquo;t have sex until the tears heal. Sex can be painful and might reopen the tear.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H24442766\">",
"      <span class=\"h1\">",
"       Can maternal injuries from childbirth be prevented?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Sometimes. You are less likely to have a vaginal injury during childbirth if you control your pushing when you give birth. This helps the perineum to stretch slowly, making it less likely to tear.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H24442781\">",
"      <span class=\"h1\">",
"       More on this topic",
"      </span>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?12/13/12499?source=see_link\">",
"       Patient information: Labor and delivery (childbirth) (The Basics)",
"      </a>",
"     </p>",
"    </div>",
"    <div id=\"reviewProcess\">",
"     <span>",
"      All topics are updated as new evidence becomes available and our",
"      <a class=\"policy policy_editorialpolicy\" href=\"/home/editorial-policy\">",
"       peer review process",
"      </a>",
"      is complete.",
"     </span>",
"    </div>",
"    <div id=\"topicRetrievedDate\">",
"     <span class=\"emphasis\">",
"      This topic retrieved from UpToDate on:",
"     </span>",
"     Apr 20, 2013.",
"    </div>",
"    <div class=\"patTopicTool\" id=\"patTopicToolBottom\">",
"     <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"      Find",
"     </a>",
"     <a class=\"toolbutton printicon\" href=\"UTD.htm?22/0/22529?view=print\" title=\"Print This Topic\">",
"      Print",
"     </a>",
"     <a class=\"toolbutton emailicon etacLink\" href=\"#\" title=\"Email This Topic\">",
"      Email",
"     </a>",
"    </div>",
"    <div id=\"disclaimer\">",
"     The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions.",
"The use of UpToDate content is governed by the",
"     <a class=\"legal legal_termsofuse\" href=\"/home/terms-use\" target=\"_blank\">",
"      UpToDate Terms of Use",
"     </a>",
"     . &copy;2013 UpToDate, Inc. All rights reserved.",
"    </div>",
"    <div id=\"topicVersionRevision\">",
"     Topic 82904 Version 1.0",
"    </div>",
"   </div>",
"   <!--  basicsTopicLeft -->",
"  </div>",
"  <!-- basicsTopicMinWidth -->",
" </div>",
" <!-- topicContent -->",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-197.136.42.3-EB31556FB1-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f22_0_22529=[""].join("\n");
var outline_f22_0_22529=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H24442705\">",
"      What are maternal injuries from childbirth?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H24442720\">",
"      What causes maternal injuries from childbirth?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H24442736\">",
"      How are maternal injuries from childbirth treated?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H24442751\">",
"      What can I do to feel better while my injury heals?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H24442766\">",
"      Can maternal injuries from childbirth be prevented?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H24442781\">",
"      More on this topic",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?12/13/12499?source=related_link\">",
"      Patient information: Labor and delivery (childbirth) (The Basics)",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f22_0_22530="CT traumatic SDH";
var content_f22_0_22530=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=NEURO%2F68102&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=NEURO%2F68102&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    TBI subdural hematoma",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 380px; height: 424px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    CT scan showing a left acute subdural hematoma (SDH, arrow). Subdural hematomas are typically crescent-shape. In this case the SDH is causing significant mass effect and shift of midline structures to the right.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: J Claude Hemphill III, MD and Nicholas Phan, MD, FRCSC.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f22_0_22530=[""].join("\n");
var outline_f22_0_22530=null;
var title_f22_0_22531="Anti-GBM antibody disease: Recurrence after transplantation";
var content_f22_0_22531=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Anti-GBM antibody disease: Recurrence after transplantation",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?22/0/22531/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?22/0/22531/contributors\">",
"     Daniel C Brennan, MD, FACP",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?22/0/22531/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?22/0/22531/contributors\">",
"     Barbara Murphy, MB, BAO, BCh, FRCPI",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?22/0/22531/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?22/0/22531/contributors\">",
"     Alice M Sheridan, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?22/0/22531/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jun 2, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     OVERVIEW",
"    </span>",
"    &nbsp;&mdash;&nbsp;Anti-glomerular basement membrane (GBM) antibody disease may progress to end-stage renal failure, requiring either dialysis or renal transplantation. The incidence of recurrent linear IgG staining in the transplant may be as high as 50 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?22/0/22531/abstract/1\">",
"     1",
"    </a>",
"    ]. However, most patients remain asymptomatic [",
"    <a class=\"abstract\" href=\"UTD.htm?22/0/22531/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    There are only six reported cases of symptomatic recurrent anti-GBM disease in the literature [",
"    <a class=\"abstract\" href=\"UTD.htm?22/0/22531/abstract/2\">",
"     2",
"    </a>",
"    ]. A related phenomenon is the development of de novo anti-GBM disease in patients with hereditary nephritis (Alport&rsquo;s disease) leading to graft loss in up to 5 percent of recipients [",
"    <a class=\"abstract\" href=\"UTD.htm?22/0/22531/abstract/3\">",
"     3",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    This topic reviews recurrent anti-GBM disease after transplantation. The pathogenesis, diagnosis and treatment of anti-GBM disease are discussed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?4/19/4409?source=see_link\">",
"     \"Pathogenesis and diagnosis of anti-GBM antibody (Goodpasture's) disease\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?7/16/7432?source=see_link\">",
"     \"Treatment of anti-GBM antibody (Goodpasture's) disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    De novo anti-GBM disease following transplantation in patients with hereditary nephritis is also discussed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/33/36377?source=see_link&amp;anchor=H18#H18\">",
"     \"Clinical manifestations, diagnosis and treatment of hereditary nephritis (Alport syndrome)\", section on 'Anti-GBM antibody disease'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H39245169\">",
"    <span class=\"h1\">",
"     PATHOGENESIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The target glomerular basement antigen for both recurrent anti-GBM disease and anti-GBM disease following transplantation in patients with hereditary nephritis is the noncollagenous-1 (NC1) domain of the alpha 3 chain of collagen IV [",
"    <a class=\"abstract\" href=\"UTD.htm?22/0/22531/abstract/4-6\">",
"     4-6",
"    </a>",
"    ]. Collagen IV is a family of six alpha chains (&alpha;1 through &alpha;6) [",
"    <a class=\"abstract\" href=\"UTD.htm?22/0/22531/abstract/7\">",
"     7",
"    </a>",
"    ]. The &alpha;3NC1 antigen is specifically implicated in Goodpasture&rsquo;s disease. The &alpha;3NC1 monomer is assembled into the collagen IV network through the association of the &alpha;3, &alpha;4, and &alpha;5 chains to form a triple helical protomer and through the oligomerization of &alpha;345 protomers by means of end-to-end associations and intertwining of triple helixes.",
"   </p>",
"   <p>",
"    In one study an enzyme-linked immunosorbent assay was used to determine the specificity of autoantibodies [",
"    <a class=\"abstract\" href=\"UTD.htm?22/0/22531/abstract/8\">",
"     8",
"    </a>",
"    ]. In this study patients with anti-GBM disease had both autoantibodies to the &alpha;3NC1 monomer and antibodies to the &alpha;5NC1 monomer (and fewer to the &alpha;4NC1 monomer). High antibody titers at diagnosis of anti-GBM disease were associated with eventual loss of renal function.",
"   </p>",
"   <p>",
"    The &alpha;345 network is also a target for anti-GBM antibodies in post-transplantation glomerulonephritis among patients with hereditary nephritis. This anti-GBM syndrome is mediated by the deposition of antibodies to the &alpha;3NC1 and &alpha;5NC1 domains in response to the &ldquo;foreign&rdquo; &alpha;345 collagen network that is absent in the kidneys of patients with hereditary nephritis but present in the renal allograft [",
"    <a class=\"abstract\" href=\"UTD.htm?22/0/22531/abstract/9,10\">",
"     9,10",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Thus, the &alpha;345NC1 hexamer is targeted by antibodies that arise in both recurrent anti-GBM disease and in de novo anti-GBM disease among patients with hereditary nephritis, but these antibodies have different binding properties. In the study cited above, antibodies were found to bind to distinct epitopes in the &alpha;3NC1 monomer, but they did not bind to the native cross-linked &alpha;345NC1 hexamer in anti-GBM disease. In contrast, in patients with anti-GBM disease in patients with hereditary nephritis, alloantibodies bound to regions containing the binding epitopes in the intact hexamer [",
"    <a class=\"abstract\" href=\"UTD.htm?22/0/22531/abstract/8\">",
"     8",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The relatively low rate of significant recurrence of anti-GBM disease is thought to be due to delaying renal transplantation until circulating anti-GBM antibody levels have been undetectable for at least 12 months and there has been quiescent disease for at least six months post-treatment (without cytotoxic agents) [",
"    <a class=\"abstract\" href=\"UTD.htm?22/0/22531/abstract/11-14\">",
"     11-14",
"    </a>",
"    ]. The general lack of late recurrence reflects the usually self-limited nature of autoantibody formation in this disorder. In addition, the administration of maintenance immunosuppressive therapy may help suppress autoantibody production [",
"    <a class=\"abstract\" href=\"UTD.htm?22/0/22531/abstract/15\">",
"     15",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Those patients with clinically evident recurrence typically present with hematuria and proteinuria. Spontaneous resolution can occur, and graft loss due to recurrent anti-GBM antibody disease is rare [",
"    <a class=\"abstract\" href=\"UTD.htm?22/0/22531/abstract/1,16\">",
"     1,16",
"    </a>",
"    ]. Treatment may include pulse steroids,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?9/20/9546?source=see_link\">",
"     cyclophosphamide",
"    </a>",
"    , and plasma exchange, particularly among those with life-threatening pulmonary disease [",
"    <a class=\"abstract\" href=\"UTD.htm?22/0/22531/abstract/17\">",
"     17",
"    </a>",
"    ]. One study attempted salvage therapy with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?40/12/41161?source=see_link\">",
"     rituximab",
"    </a>",
"    but this was unsuccessful [",
"    <a class=\"abstract\" href=\"UTD.htm?22/0/22531/abstract/2\">",
"     2",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?7/16/7432?source=see_link\">",
"     \"Treatment of anti-GBM antibody (Goodpasture's) disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H762624647\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Although anti-glomerular basement membrane (GBM) antibody disease may progress to end-stage renal failure, the rate of clinically significant recurrence is low. The low rate of significant recurrence may be due to the practice of delaying transplantation until disease is quiescent. Maintenance immunosuppressive therapy may also prevent recurrence. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Overview'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Patients with clinically evident recurrence present with hematuria and proteinuria. Graft loss due to recurrent anti-GBM antibody disease is rare. Treatment may include pulse steroids,",
"      <a class=\"drug drug_general\" href=\"UTD.htm?9/20/9546?source=see_link\">",
"       cyclophosphamide",
"      </a>",
"      , and plasma exchange, particularly among those with life-threatening pulmonary disease. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Overview'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?7/16/7432?source=see_link\">",
"       \"Treatment of anti-GBM antibody (Goodpasture's) disease\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      De novo anti-GBM antibody disease may occur in some patients who have hereditary nephritis as the cause of end-stage renal failure. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?24/5/24663?source=see_link\">",
"       \"Genetics, pathogenesis, and pathology of hereditary nephritis (Alport syndrome)\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26819893\">",
"    <span class=\"h1\">",
"     ACKNOWLEDGMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;The editorial staff at UpToDate, Inc. would like to acknowledge Mohamed Sayegh, MD, who contributed to an earlier version of this topic review.",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/0/22531/abstract/1\">",
"      Kotanko P, Pusey CD, Levy JB. Recurrent glomerulonephritis following renal transplantation. Transplantation 1997; 63:1045.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/0/22531/abstract/2\">",
"      Sauter M, Schmid H, Anders HJ, et al. Loss of a renal graft due to recurrence of anti-GBM disease despite rituximab therapy. Clin Transplant 2009; 23:132.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/0/22531/abstract/3\">",
"      Kashtan CE. Renal transplantation in patients with Alport syndrome. Pediatr Transplant 2006; 10:651.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/0/22531/abstract/4\">",
"      Saus J, Wieslander J, Langeveld JP, et al. Identification of the Goodpasture antigen as the alpha 3(IV) chain of collagen IV. J Biol Chem 1988; 263:13374.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/0/22531/abstract/5\">",
"      Butkowski RJ, Langeveld JP, Wieslander J, et al. Localization of the Goodpasture epitope to a novel chain of basement membrane collagen. J Biol Chem 1987; 262:7874.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/0/22531/abstract/6\">",
"      Turner N, Mason PJ, Brown R, et al. Molecular cloning of the human Goodpasture antigen demonstrates it to be the alpha 3 chain of type IV collagen. J Clin Invest 1992; 89:592.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/0/22531/abstract/7\">",
"      Hudson BG, Tryggvason K, Sundaramoorthy M, Neilson EG. Alport's syndrome, Goodpasture's syndrome, and type IV collagen. N Engl J Med 2003; 348:2543.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/0/22531/abstract/8\">",
"      Pedchenko V, Bondar O, Fogo AB, et al. Molecular architecture of the Goodpasture autoantigen in anti-GBM nephritis. N Engl J Med 2010; 363:343.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/0/22531/abstract/9\">",
"      Hudson BG, Kalluri R, Gunwar S, et al. The pathogenesis of Alport syndrome involves type IV collagen molecules containing the alpha 3(IV) chain: evidence from anti-GBM nephritis after renal transplantation. Kidney Int 1992; 42:179.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/0/22531/abstract/10\">",
"      Kang JS, Kashtan CE, Turner AN, et al. The alloantigenic sites of alpha3alpha4alpha5(IV) collagen: pathogenic X-linked alport alloantibodies target two accessible conformational epitopes in the alpha5NC1 domain. J Biol Chem 2007; 282:10670.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/0/22531/abstract/11\">",
"      Denton MD, Singh AK. Recurrent and de novo glomerulonephritis in the renal allograft. Semin Nephrol 2000; 20:164.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/0/22531/abstract/12\">",
"      European best practice guidelines for renal transplantation (Part 2). Nephrol Dial Transplant 2002; 17(Suppl 4):16.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/0/22531/abstract/13\">",
"      Floege J. Recurrent glomerulonephritis following renal transplantation: an update. Nephrol Dial Transplant 2003; 18:1260.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/0/22531/abstract/14\">",
"      Knoll G, Cockfield S, Blydt-Hansen T, et al. Canadian Society of Transplantation consensus guidelines on eligibility for kidney transplantation. CMAJ 2005; 173:1181.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/0/22531/abstract/15\">",
"      Netzer KO, Merkel F, Weber M. Goodpasture syndrome and end-stage renal failure--to transplant or not to transplant? Nephrol Dial Transplant 1998; 13:1346.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/0/22531/abstract/16\">",
"      Cameron JS. Glomerulonephritis in renal transplants. Transplantation 1982; 34:237.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/0/22531/abstract/17\">",
"      KDIGO clinical practice guideline for the care of kidney transplant recipients. Am J Transplant 2009; 9:S36.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 7345 Version 6.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0505-194.187.108.93-69C8FD1B77-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f22_0_22531=[""].join("\n");
var outline_f22_0_22531=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H762624647\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      OVERVIEW",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H39245169\">",
"      PATHOGENESIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H762624647\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H26819893\">",
"      ACKNOWLEDGMENT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?35/33/36377?source=related_link\">",
"      Clinical manifestations, diagnosis and treatment of hereditary nephritis (Alport syndrome)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?24/5/24663?source=related_link\">",
"      Genetics, pathogenesis, and pathology of hereditary nephritis (Alport syndrome)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?4/19/4409?source=related_link\">",
"      Pathogenesis and diagnosis of anti-GBM antibody (Goodpasture's) disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?7/16/7432?source=related_link\">",
"      Treatment of anti-GBM antibody (Goodpasture's) disease",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f22_0_22532="Linear scleroderma face";
var content_f22_0_22532=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F83578&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F83578&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Linear scleroderma (morphea): Early manifestation",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 379px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f22_0_22532=[""].join("\n");
var outline_f22_0_22532=null;
var title_f22_0_22533="Proximal PA interrupt III";
var content_f22_0_22533=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F77417&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F77417&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Proximal interruption of the right pulmonary artery",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 360px; height: 528px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    An internal thoracic arteriogram displays the systemic vascular supply to the right lung.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Paul Stark, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f22_0_22533=[""].join("\n");
var outline_f22_0_22533=null;
var title_f22_0_22534="Xanthogranulomatous cholecystitis";
var content_f22_0_22534=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"0\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Xanthogranulomatous cholecystitis",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?22/0/22534/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?22/0/22534/contributors\">",
"     Shyam Varadarajulu, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?22/0/22534/contributors\">",
"     Salam F Zakko, MD, FACP",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?22/0/22534/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?22/0/22534/contributors\">",
"     Sanjiv Chopra, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?22/0/22534/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?22/0/22534/contributors\">",
"     Anne C Travis, MD, MSc, FACG",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?22/0/22534/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Nov 9, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Xanthogranulomatous cholecystitis is a rare inflammatory disease of the gallbladder characterized by a focal or diffuse destructive inflammatory process, with accumulation of lipid laden macrophages, fibrous tissue, and acute and chronic inflammatory cells [",
"    <a class=\"abstract\" href=\"UTD.htm?22/0/22534/abstract/1\">",
"     1",
"    </a>",
"    ]. In 1970, it was known by the descriptive term fibroxanthogranulomatous cholecystitis [",
"    <a class=\"abstract\" href=\"UTD.htm?22/0/22534/abstract/2\">",
"     2",
"    </a>",
"    ], but in 1981 the name xanthogranulomatous cholecystitis was proposed in a review of 40 cases from the Armed Forces Institute of Pathology [",
"    <a class=\"abstract\" href=\"UTD.htm?22/0/22534/abstract/3\">",
"     3",
"    </a>",
"    ]. Its importance lies in the fact that it is a benign condition that may be confused with carcinoma of the gallbladder, which is associated with a poor prognosis.",
"   </p>",
"   <p>",
"    Xanthogranulomatous cholecystitis was initially described as a variant of chronic cholecystitis. However, while the latter is usually regarded as a benign condition with questionable clinical significance, xanthogranulomatous cholecystitis is an active and destructive process that can lead to significant morbidity as the inflammatory process usually extends into the gallbladder wall and adjacent structures. Thus, it should be considered a distinct clinical entity.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     EPIDEMIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;The prevalence of xanthogranulomatous cholecystitis among patients with symptomatic gallbladder disease ranges from 0.7 percent in the United States to up to 10 percent in India and Japan [",
"    <a class=\"abstract\" href=\"UTD.htm?22/0/22534/abstract/4-8\">",
"     4-8",
"    </a>",
"    ]. The mean age at presentation varies in different studies from 44 to 63 years [",
"    <a class=\"abstract\" href=\"UTD.htm?22/0/22534/abstract/4,9\">",
"     4,9",
"    </a>",
"    ]. A study from India reported a 1:9 male to female ratio [",
"    <a class=\"abstract\" href=\"UTD.htm?22/0/22534/abstract/4\">",
"     4",
"    </a>",
"    ], while in other reports the male to female ratio ranged from 2:1 to 1:2 [",
"    <a class=\"abstract\" href=\"UTD.htm?22/0/22534/abstract/3,7,9\">",
"     3,7,9",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     PATHOGENESIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The pathogenesis of xanthogranulomatous cholecystitis is thought to be related to extravasation of bile into the gallbladder wall from rupture of Rokitansky-Aschoff sinuses or by mucosal ulceration [",
"    <a class=\"abstract\" href=\"UTD.htm?22/0/22534/abstract/3,10\">",
"     3,10",
"    </a>",
"    ]. This event incites an inflammatory reaction in the interstitial tissue, whereby fibroblasts and macrophages phagocytose the biliary lipids in bile, such as cholesterol and phospholipids leading to the formation of xanthoma cells.",
"   </p>",
"   <p>",
"    Gallstones may have an important role in the pathogenesis, since they appear to be present in all patients [",
"    <a class=\"abstract\" href=\"UTD.htm?22/0/22534/abstract/4,9,11\">",
"     4,9,11",
"    </a>",
"    ]. It has been suggested that xanthogranulomatous cholecystitis is analogous to xanthogranulomatous pyelonephritis, which results from obstruction and stasis due to renal calculi [",
"    <a class=\"abstract\" href=\"UTD.htm?22/0/22534/abstract/12\">",
"     12",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?16/26/16804?source=see_link\">",
"     \"Xanthogranulomatous pyelonephritis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     PATHOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;On gross examination, the gallbladder is thickened and the serosa is covered with dense fibrous adhesions (",
"    <a class=\"graphic graphic_picture graphicRef67995 \" href=\"UTD.htm?3/16/3332\">",
"     picture 1",
"    </a>",
"    ). The mucosal surface may be ulcerated and cross sections through the wall reveal xanthogranulomatous foci, which appear as yellow nodules or plaques. These yellowish foci may extend into adjacent structures, such as the liver, duodenum, transverse colon, and omentum [",
"    <a class=\"abstract\" href=\"UTD.htm?22/0/22534/abstract/4,9\">",
"     4,9",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Microscopically, the xanthogranulomatous foci are composed of abundant lipid laden macrophages, fibroblasts, and inflammatory cells (",
"    <a class=\"graphic graphic_picture graphicRef75696 \" href=\"UTD.htm?27/49/28440\">",
"     picture 2",
"    </a>",
"    ). The lipid laden macrophages are of two morphological types: rounded foamy macrophages and spindle-shaped cells with more granular cytoplasm and elongated nuclei. Other findings include the presence of cholesterol clefts, lipid droplets, hemosiderin deposits, and extravasated bile [",
"    <a class=\"abstract\" href=\"UTD.htm?22/0/22534/abstract/9\">",
"     9",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The relationship between xanthogranulomatous cholecystitis and gallbladder carcinoma is uncertain. Focal granulomatous changes were seen deep within the gallbladder wall in association with neoplastic invasion in a study of five patients, suggesting a possible relationship between both entities [",
"    <a class=\"abstract\" href=\"UTD.htm?22/0/22534/abstract/13\">",
"     13",
"    </a>",
"    ]. Another study found adenocarcinoma in nearly 10 percent of resected specimens of xanthogranulomatous cholecystitis [",
"    <a class=\"abstract\" href=\"UTD.htm?22/0/22534/abstract/9\">",
"     9",
"    </a>",
"    ], while in a larger study no such relationship was observed [",
"    <a class=\"abstract\" href=\"UTD.htm?22/0/22534/abstract/4\">",
"     4",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h1\">",
"     CLINICAL FEATURES",
"    </span>",
"    &nbsp;&mdash;&nbsp;A typical patient has a history suggestive of an episode of acute cholecystitis and occasionally may present with clinical and radiological features that mimic carcinoma of the gallbladder [",
"    <a class=\"abstract\" href=\"UTD.htm?22/0/22534/abstract/14\">",
"     14",
"    </a>",
"    ]. In a review of 13 cases from the United Kingdom, 11 patients (85 percent) experienced at least one episode of acute cholecystitis, which was the first presenting symptom in six patients [",
"    <a class=\"abstract\" href=\"UTD.htm?22/0/22534/abstract/9\">",
"     9",
"    </a>",
"    ]. One patient presented with acute pancreatitis and others had symptoms suggestive of biliary pain. In another series, obstructive jaundice was observed in 20 percent of patients [",
"    <a class=\"abstract\" href=\"UTD.htm?22/0/22534/abstract/15\">",
"     15",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Obstructive jaundice is caused by choledocholithiasis or compression of the common bile duct by the inflamed gallbladder (Mirizzi syndrome). In a study that compared patients with xanthogranulomatous cholecystitis with and without associated cancer, those with cancer were more likely to present with anorexia, weight loss, palpable mass, and jaundice [",
"    <a class=\"abstract\" href=\"UTD.htm?22/0/22534/abstract/16\">",
"     16",
"    </a>",
"    ]. Biliary strictures in association with xanthogranulomatous cholecystitis (xanthogranulomatous choledochitis) have also been described [",
"    <a class=\"abstract\" href=\"UTD.htm?22/0/22534/abstract/8\">",
"     8",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Physical examination is usually unremarkable except possibly for a positive Murphy's sign when acute cholecystitis is present. A right hypochondrial mass may be more common in xanthogranulomatous cholecystitis than in acute cholecystitis, mimicking carcinoma of the gallbladder [",
"    <a class=\"abstract\" href=\"UTD.htm?22/0/22534/abstract/15-17\">",
"     15-17",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h1\">",
"     COMPLICATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;There is a fairly high incidence of complications in xanthogranulomatous cholecystitis, amounting to more than 30 percent in one report [",
"    <a class=\"abstract\" href=\"UTD.htm?22/0/22534/abstract/15\">",
"     15",
"    </a>",
"    ]. Local complications in the gallbladder include perforation and the development of strictures. Prolonged cystic duct obstruction and gallbladder distension under pressure during the acute inflammatory phase can lead to extension of the xanthogranulomatous inflammation beyond the gallbladder with formation of hepatic abscesses and fistulas into adjacent structures, such as the liver, duodenum, stomach, colon, and skin [",
"    <a class=\"abstract\" href=\"UTD.htm?22/0/22534/abstract/9\">",
"     9",
"    </a>",
"    ]. A case of associated Mirizzi syndrome has been described [",
"    <a class=\"abstract\" href=\"UTD.htm?22/0/22534/abstract/15\">",
"     15",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?43/33/44565?source=see_link\">",
"     \"Mirizzi syndrome\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h1\">",
"     DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The diagnosis is usually made by histological examination of the resected gallbladder. The possibility of xanthogranulomatous cholecystitis should be considered in any patient presenting with a right upper quadrant mass",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    a biliary fistula. There are no consistent trends in biochemical or hematological findings that aid in the diagnosis. Imaging studies and fine needle aspiration cytology may be suggestive, but no reports on their utility exist. Confirmatory diagnosis is made only at surgery, sometimes requiring a frozen section.",
"   </p>",
"   <p>",
"    A major challenge in the management of patients with xanthogranulomatous cholecystitis is the distinction from gallbladder cancer. In a study that evaluated 4800 cholecystectomies performed over a five year period, 453 were diagnosed with xanthogranulomatous cholecystitis [",
"    <a class=\"abstract\" href=\"UTD.htm?22/0/22534/abstract/16\">",
"     16",
"    </a>",
"    ]. Of these 453 patients, 26 (6 percent) had associated gallbladder carcinoma. Both preoperative and perioperative fine needle aspiration cytology failed to reveal associated cancer in some patients.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Ultrasonography",
"    </span>",
"    &nbsp;&mdash;&nbsp;Ultrasonography often shows a thickened gallbladder wall (which may be focal or diffuse) with gallstones [",
"    <a class=\"abstract\" href=\"UTD.htm?22/0/22534/abstract/15,18,19\">",
"     15,18,19",
"    </a>",
"    ]. In a series of 26 patients, the most characteristic finding was the presence of hypoechoic nodules or bands in the gallbladder wall, which were present in 35 percent of patients [",
"    <a class=\"abstract\" href=\"UTD.htm?22/0/22534/abstract/19\">",
"     19",
"    </a>",
"    ]. Other findings on ultrasonography include a gallbladder mass, subhepatic fluid collection, obscure border between the gallbladder and liver, intramural hypoechoic nodules, and rarely, gas in the biliary tree in patients with a biliary fistula [",
"    <a class=\"abstract\" href=\"UTD.htm?22/0/22534/abstract/15\">",
"     15",
"    </a>",
"    ]. However, although the above findings are suggestive of the diagnosis, none is diagnostic, and it may not be possible to distinguish the gallbladder wall thickening of xanthogranulomatous cholecystitis from gallbladder carcinoma [",
"    <a class=\"abstract\" href=\"UTD.htm?22/0/22534/abstract/7,20\">",
"     7,20",
"    </a>",
"    ]. Furthermore, some of the findings, such as intramural hypoechoic nodules, can be seen in other conditions, including intramural abscesses, cholesterolosis, and adenomyomatosis [",
"    <a class=\"abstract\" href=\"UTD.htm?22/0/22534/abstract/21-23\">",
"     21-23",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/57/13209?source=see_link\">",
"     \"Gallbladder polyps and cholesterolosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Computerized tomography",
"    </span>",
"    &nbsp;&mdash;&nbsp;A retrospective review of the CT findings in 11 patients with xanthogranulomatous cholecystitis revealed intramural hypodense nodules in all patients, diffuse gallbladder wall thickening in 91 percent, and gallstones in 64 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?22/0/22534/abstract/20\">",
"     20",
"    </a>",
"    ]. The area occupied by these nodules in the thickened gallbladder was inversely proportional to the duration of symptoms, which may be due to the presence of active necrotic centers in newer xanthogranulomas (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef54177 \" href=\"UTD.htm?30/32/31232\">",
"     image 1",
"    </a>",
"    ). Extension of the inflammatory process into the liver was noted in 45 percent of patients; a similar observation was made in an earlier report [",
"    <a class=\"abstract\" href=\"UTD.htm?22/0/22534/abstract/6\">",
"     6",
"    </a>",
"    ]. The most specific CT finding in a review of 26 patients was a hypodense band in the gallbladder wall, which was seen in 33 percent of patients [",
"    <a class=\"abstract\" href=\"UTD.htm?22/0/22534/abstract/19\">",
"     19",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A study involving 18 patients correlated CT and MR findings with pathologic findings in xanthogranulomatous cholecystitis [",
"    <a class=\"abstract\" href=\"UTD.htm?22/0/22534/abstract/24\">",
"     24",
"    </a>",
"    ]. Low-attenuation areas in the wall of the gallbladder correlated with foam and inflammatory cells or necrosis",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    abscess in xanthogranulomatous cholecystitis. Areas of iso- to slightly high signal intensity on T2-weighted images, showing slight enhancement at early phase and strong enhancement at last phase on dynamic study, corresponded with areas of abundant xanthogranulomas. Areas with very high signal intensity on T2-weighted images without enhancement corresponded with necrosis",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    abscesses.",
"   </p>",
"   <p>",
"    The CT scan features of xanthogranulomatous cholecystitis and carcinoma of the gallbladder are similar. In one study, only the presence of intramural hypoattenuated nodules occupying an area greater than 60 percent of the thickened gallbladder had statistically significant specificity for the diagnosis of xanthogranulomatous cholecystitis [",
"    <a class=\"abstract\" href=\"UTD.htm?22/0/22534/abstract/20\">",
"     20",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In a retrospective study that compared the CT features of 18 patients with xanthogranulomatous cholecystitis and 17 patients with gallbladder cancer, five CT findings showed significant differences between both disease entities [",
"    <a class=\"abstract\" href=\"UTD.htm?22/0/22534/abstract/25\">",
"     25",
"    </a>",
"    ]. The five findings that were predictive of xanthogranulomatous cholecystitis were:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Diffuse gallbladder wall thickening: sensitivity 89 percent, specificity 65 percent",
"     </li>",
"     <li>",
"      Continuous mucosal line: sensitivity 67 percent, specificity 82 percent",
"     </li>",
"     <li>",
"      Intramural hypoattenuated nodules: sensitivity 61 percent, specificity 71 percent",
"     </li>",
"     <li>",
"      Absence of macroscopic hepatic invasion: sensitivity 72 percent, specificity 77 percent",
"     </li>",
"     <li>",
"      Absence of intrahepatic bile duct dilatation: sensitivity 67 percent, specificity 71 percent",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    When at least three of these five CT findings were observed, the sensitivity and specificity were 83 and 100 percent, respectively.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Cholecystography",
"    </span>",
"    &nbsp;&mdash;&nbsp;Oral and intravenous cholecystography are nonspecific and generally fail to delineate the gallbladder due to obstructing cystic duct stones in a majority of these patients [",
"    <a class=\"abstract\" href=\"UTD.htm?22/0/22534/abstract/26\">",
"     26",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Fine needle aspiration cytology",
"    </span>",
"    &nbsp;&mdash;&nbsp;Preoperative ultrasound-guided fine needle aspiration cytology is useful for the diagnosis of xanthogranulomatous cholecystitis since it can help to differentiate the disorder from gallbladder carcinoma, and thus assist in planning a surgical intervention. This was illustrated in a review of 17 patients with histologically proven xanthogranulomatous cholecystitis who underwent fine needle aspiration cytology [",
"    <a class=\"abstract\" href=\"UTD.htm?22/0/22534/abstract/27\">",
"     27",
"    </a>",
"    ]. The presence of histiocytes, foam cells, multinucleate giant cells, bile, and a mixed population of inflammatory cells in varying proportions on a background of pink, granular debris was felt to be characteristic of xanthogranulomatous cholecystitis. However, the nuclear pleomorphism in histiocytes seen in xanthogranulomatous cholecystitis can also be seen in malignancy. Furthermore, coexisting malignancy cannot always be excluded [",
"    <a class=\"abstract\" href=\"UTD.htm?22/0/22534/abstract/28\">",
"     28",
"    </a>",
"    ]. Fine needle aspiration biopsy can lead to fistula formation. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?3/30/3561?source=see_link\">",
"     \"Endoscopic ultrasound-guided fine-needle aspiration biopsy in the gastrointestinal tract\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     PET scanning",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although experience is limited, fluorodeoxyglucose positron emission tomography (PET) scanning has been found to be inaccurate in differentiating xanthogranulomatous cholecystitis from gallbladder cancer [",
"    <a class=\"abstract\" href=\"UTD.htm?22/0/22534/abstract/29\">",
"     29",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h1\">",
"     TREATMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;The only definitive treatment for xanthogranulomatous cholecystitis is surgery. The general principles for the management of acute cholecystitis should be followed in patients who present with acute cholecystitis. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/9/15511?source=see_link\">",
"     \"Treatment of acute cholecystitis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    During surgery, a markedly thick-walled gallbladder with extensive, dense, fibrous adhesions to neighboring structures should raise the suspicion for xanthogranulomatous cholecystitis. A frozen section or a fine needle aspirate is usually necessary to establish the diagnosis before the case is deemed to be an unresectable malignancy [",
"    <a class=\"abstract\" href=\"UTD.htm?22/0/22534/abstract/9,30\">",
"     9,30",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Because of the inflammatory and invasive nature of xanthogranulomatous cholecystitis, a complete resection of adjacent xanthogranulomatous tissue should be attempted, even if this includes resection into the hepatic bed [",
"    <a class=\"abstract\" href=\"UTD.htm?22/0/22534/abstract/15,31\">",
"     15,31",
"    </a>",
"    ]. A preoperative cholangiogram should always be performed, since adenocarcinoma of the bile duct in association with xanthogranulomatous cholecystitis has been described [",
"    <a class=\"abstract\" href=\"UTD.htm?22/0/22534/abstract/3\">",
"     3",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Open cholecystectomy is the preferred surgical technique in most patients due to dense fibrosis, extensive local inflammation, and concerns of possible coexistent malignancy [",
"    <a class=\"abstract\" href=\"UTD.htm?22/0/22534/abstract/32,33\">",
"     32,33",
"    </a>",
"    ]. In a study of 27 patients with xanthogranulomatous cholecystitis in whom laparoscopic cholecystectomy was attempted, 19 percent required conversion to the open method [",
"    <a class=\"abstract\" href=\"UTD.htm?22/0/22534/abstract/32\">",
"     32",
"    </a>",
"    ]. The presence of dense fibrosis and coexistent adenocarcinoma were the most common reasons that precluded a laparoscopic approach. An even higher rate of conversion to open surgery (80 percent) has been described by another group [",
"    <a class=\"abstract\" href=\"UTD.htm?22/0/22534/abstract/7,33\">",
"     7,33",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h1\">",
"     PROGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Morbidity following resection of xanthogranulomatous cholecystitis is largely related to postoperative complications. The postoperative morbidity rates were 30 and 32 percent in two series and were mainly related to wound infections, particularly in patients with fistulae [",
"    <a class=\"abstract\" href=\"UTD.htm?22/0/22534/abstract/9,15\">",
"     9,15",
"    </a>",
"    ]. Mortality is unusual. In one report it was due to toxic shock syndrome related to a sinus wound infection [",
"    <a class=\"abstract\" href=\"UTD.htm?22/0/22534/abstract/9\">",
"     9",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Xanthogranulomatous cholecystitis is a rare inflammatory disease of the gallbladder characterized by a focal or diffuse destructive inflammatory process, with accumulation of lipid laden macrophages, fibrous tissue, and acute and chronic inflammatory cells. The pathogenesis is thought to be related to extravasation of bile into the gallbladder wall from rupture of Rokitansky-Aschoff sinuses or by mucosal ulceration. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Pathogenesis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Patients often have a history suggestive of acute cholecystitis but occasionally present with clinical and radiological features that mimic carcinoma of the gallbladder. It may not be possible to distinguish xanthogranulomatous cholecystitis from gallbladder cancer based upon clinical, radiographic, or laboratory testing. However, patients with cancer are more likely to present with anorexia, weight loss, palpable mass, and jaundice. (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Clinical features'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H7\">",
"       'Diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Patients with xanthogranulomatous cholecystitis should undergo cholecystectomy to confirm the diagnosis, relieve symptoms and exclude gallbladder cancer. Open cholecystectomy is preferred in most patients due to dense fibrosis, extensive local inflammation, and concerns of possible coexistent malignancy. A complete resection of adjacent xanthogranulomatous tissue should be attempted, even if this includes resection into the hepatic bed. A preoperative cholangiogram should always be performed, to exclude adenocarcinoma of the bile duct. (See",
"      <a class=\"local\" href=\"#H13\">",
"       'Treatment'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     Jessurun J, Albores-Saavedra J. Gallbladder and Extrahepatic Biliary Ducts. In: Anderson's Pathology, Damjanov I, Linder J (Eds), CV Mosby, St. Louis 1996. p.1859.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/0/22534/abstract/2\">",
"      Christensen AH, Ishak KG. Benign tumors and pseudotumors of the gallbladder. Report of 180 cases. Arch Pathol 1970; 90:423.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/0/22534/abstract/3\">",
"      Goodman ZD, Ishak KG. Xanthogranulomatous cholecystitis. Am J Surg Pathol 1981; 5:653.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/0/22534/abstract/4\">",
"      Dixit VK, Prakash A, Gupta A, et al. Xanthogranulomatous cholecystitis. Dig Dis Sci 1998; 43:940.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/0/22534/abstract/5\">",
"      Reyes CV, Jablokow VR, Reid R. Xanthogranulomatous cholecystitis: report of seven cases. Am Surg 1981; 47:322.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/0/22534/abstract/6\">",
"      Hanada K, Nakata H, Nakayama T, et al. Radiologic findings in xanthogranulomatous cholecystitis. AJR Am J Roentgenol 1987; 148:727.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/0/22534/abstract/7\">",
"      Guzm&aacute;n-Valdivia G. Xanthogranulomatous cholecystitis: 15 years' experience. World J Surg 2004; 28:254.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/0/22534/abstract/8\">",
"      Krishna RP, Kumar A, Singh RK, et al. Xanthogranulomatous inflammatory strictures of extrahepatic biliary tract: presentation and surgical management. J Gastrointest Surg 2008; 12:836.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/0/22534/abstract/9\">",
"      Roberts KM, Parsons MA. Xanthogranulomatous cholecystitis: clinicopathological study of 13 cases. J Clin Pathol 1987; 40:412.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/0/22534/abstract/10\">",
"      Takahashi K, Oka K, Hakozaki H, Kojima M. Ceroid-like histiocytic granuloma of gall-bladder --a previously undescribed lesion--. Acta Pathol Jpn 1976; 26:25.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/0/22534/abstract/11\">",
"      Yoshida J, Chijiiwa K, Shimura H, et al. Xanthogranulomatous cholecystitis versus gallbladder cancer: clinical differentiating factors. Am Surg 1997; 63:367.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/0/22534/abstract/12\">",
"      Fligiel S, Lewin KJ. Xanthogranulomatous cholecystitis: case report and review of the literature. Arch Pathol Lab Med 1982; 106:302.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/0/22534/abstract/13\">",
"      Lopez JI, Elizalde JM, Calvo MA. Xanthogranulomatous cholecystitis associated with gallbladder adenocarcinoma. A clinicopathological study of 5 cases. Tumori 1991; 77:358.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/0/22534/abstract/14\">",
"      Srinivas GN, Sinha S, Ryley N, Houghton PW. Perfidious gallbladders - a diagnostic dilemma with xanthogranulomatous cholecystitis. Ann R Coll Surg Engl 2007; 89:168.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/0/22534/abstract/15\">",
"      Houston JP, Collins MC, Cameron I, et al. Xanthogranulomatous cholecystitis. Br J Surg 1994; 81:1030.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/0/22534/abstract/16\">",
"      Rao RV, Kumar A, Sikora SS, et al. Xanthogranulomatous cholecystitis: differentiation from associated gall bladder carcinoma. Trop Gastroenterol 2005; 26:31.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/0/22534/abstract/17\">",
"      D&uuml;ber C, St&ouml;rkel S, Wagner PK, M&uuml;ller J. Xanthogranulomatous cholecystitis mimicking carcinoma of the gallbladder: CT findings. J Comput Assist Tomogr 1984; 8:1195.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/0/22534/abstract/18\">",
"      Kim PN, Ha HK, Kim YH, et al. US findings of xanthogranulomatous cholecystitis. Clin Radiol 1998; 53:290.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/0/22534/abstract/19\">",
"      Parra JA, Acinas O, Bueno J, et al. Xanthogranulomatous cholecystitis: clinical, sonographic, and CT findings in 26 patients. AJR Am J Roentgenol 2000; 174:979.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/0/22534/abstract/20\">",
"      Chun KA, Ha HK, Yu ES, et al. Xanthogranulomatous cholecystitis: CT features with emphasis on differentiation from gallbladder carcinoma. Radiology 1997; 203:93.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/0/22534/abstract/21\">",
"      Graif M, Horovitz A, Itzchak Y, Strauss S. Hyperechoic foci in the gallbladder wall as a sign of microabscess formation or diverticula. Radiology 1984; 152:781.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/0/22534/abstract/22\">",
"      Raghavendra BN, Subramanyam BR, Balthazar EJ, et al. Sonography of adenomyomatosis of the gallbladder: radiologic-pathologic correlation. Radiology 1983; 146:747.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/0/22534/abstract/23\">",
"      JUTRAS JA. Hyperplastic cholecystoses; Hickey lecture, 1960. Am J Roentgenol Radium Ther Nucl Med 1960; 83:795.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/0/22534/abstract/24\">",
"      Shuto R, Kiyosue H, Komatsu E, et al. CT and MR imaging findings of xanthogranulomatous cholecystitis: correlation with pathologic findings. Eur Radiol 2004; 14:440.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/0/22534/abstract/25\">",
"      Goshima S, Chang S, Wang JH, et al. Xanthogranulomatous cholecystitis: diagnostic performance of CT to differentiate from gallbladder cancer. Eur J Radiol 2010; 74:e79.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/0/22534/abstract/26\">",
"      Cossi AF, Scholz FJ, Aretz HT, Larsen CR. Computed tomography of xanthogranulomatous cholecystitis. Gastrointest Radiol 1987; 12:154.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/0/22534/abstract/27\">",
"      Shukla S, Krishnani N, Jain M, et al. Xanthogranulomatous cholecystitis. Fine needle aspiration cytology in 17 cases. Acta Cytol 1997; 41:413.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/0/22534/abstract/28\">",
"      Krishnani N, Dhingra S, Kapoor S, Pandey R. Cytopathologic diagnosis of xanthogranulomatous cholecystitis and coexistent lesions. A prospective study of 31 cases. Acta Cytol 2007; 51:37.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/0/22534/abstract/29\">",
"      Makino I, Yamaguchi T, Sato N, et al. Xanthogranulomatous cholecystitis mimicking gallbladder carcinoma with a false-positive result on fluorodeoxyglucose PET. World J Gastroenterol 2009; 15:3691.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/0/22534/abstract/30\">",
"      Hales MS, Miller TR. Diagnosis of xanthogranulomatous cholecystitis by fine needle aspiration biopsy. A case report. Acta Cytol 1987; 31:493.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/0/22534/abstract/31\">",
"      Reed A, Ryan C, Schwartz SI. Xanthogranulomatous cholecystitis. J Am Coll Surg 1994; 179:249.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/0/22534/abstract/32\">",
"      Kwon AH, Matsui Y, Uemura Y. Surgical procedures and histopathologic findings for patients with xanthogranulomatous cholecystitis. J Am Coll Surg 2004; 199:204.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/0/22534/abstract/33\">",
"      Guzm&aacute;n-Valdivia G. Xanthogranulomatous cholecystitis in laparoscopic surgery. J Gastrointest Surg 2005; 9:494.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 635 Version 2.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0603-61.234.146.186-69ABC6F150-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f22_0_22534=[""].join("\n");
var outline_f22_0_22534=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H15\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      EPIDEMIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      PATHOGENESIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      PATHOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      CLINICAL FEATURES",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      COMPLICATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Ultrasonography",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Computerized tomography",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Cholecystography",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Fine needle aspiration cytology",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      PET scanning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      TREATMENT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      PROGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"GAST/635\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"GAST/635|DiagnosticImage\">",
"      <a href=\"#\" title=\"DIAGNOSTIC IMAGES\">",
"       DIAGNOSTIC IMAGES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?30/32/31232\" title=\"diagnostic image 1\">",
"      Xanthogranulomatous chol CT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"GAST/635|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?3/16/3332\" title=\"picture 1\">",
"      Xanthrogranulomatous chol gross",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?27/49/28440\" title=\"picture 2\">",
"      Xanthrogranulomatous chol Light",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?3/30/3561?source=related_link\">",
"      Endoscopic ultrasound-guided fine-needle aspiration biopsy in the gastrointestinal tract",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?12/57/13209?source=related_link\">",
"      Gallbladder polyps and cholesterolosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?43/33/44565?source=related_link\">",
"      Mirizzi syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?15/9/15511?source=related_link\">",
"      Treatment of acute cholecystitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?16/26/16804?source=related_link\">",
"      Xanthogranulomatous pyelonephritis",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f22_0_22535="Thyroid hormone suppressive therapy for thyroid nodules and benign goiter";
var content_f22_0_22535=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Thyroid hormone suppressive therapy for thyroid nodules and benign goiter",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?22/0/22535/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?22/0/22535/contributors\">",
"     Douglas S Ross, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?22/0/22535/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?22/0/22535/contributors\">",
"     David S Cooper, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?22/0/22535/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?22/0/22535/contributors\">",
"     Jean E Mulder, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?22/0/22535/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Oct 2, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The efficacy of thyroid hormone suppressive therapy in euthyroid patients with solitary benign thyroid nodules or sporadic nontoxic multinodular goiters is controversial. Most studies have shown that few thyroid nodules regress in patients taking thyroid hormone. However, suppressive therapy does appear to interfere with goitrogenesis in many patients, and recent speculation suggests that it could reduce the risk of thyroid oncogenesis, as well. The American Thyroid Association does not recommend suppression therapy of benign thyroid nodules in iodine sufficient populations [",
"    <a class=\"abstract\" href=\"UTD.htm?22/0/22535/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    This topic will review potential benefits and risks of thyroid hormone suppressive therapy and suggest therapeutic approaches to patients with goiter. The overall approach to the evaluation and treatment of patients with goiter and with thyroid nodules is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/27/32185?source=see_link\">",
"     \"Diagnostic approach to and treatment of goiter in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/53/28506?source=see_link\">",
"     \"Diagnostic approach to and treatment of thyroid nodules\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     PATHOPHYSIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Suppression of thyrotropin (TSH) secretion in normal subjects by the administration of thyroid hormone results in thyroid atrophy [",
"    <a class=\"abstract\" href=\"UTD.htm?22/0/22535/abstract/2\">",
"     2",
"    </a>",
"    ]. Although the pathogenesis of thyroid nodules and sporadic nontoxic multinodular goiters is poorly understood, TSH is presumed to be necessary if not sufficient and, therefore, suppression of TSH secretion might be expected to result in a decrease in nodule or goiter size or at least prevent further enlargement.",
"   </p>",
"   <p>",
"    The importance of TSH in goiter formation varies with the cause of the goiter. For example, in patients with iodine deficiency or chronic autoimmune (Hashimoto's) thyroiditis, an increase in TSH secretion is the predominant cause of goiter. In contrast, most patients with thyroid nodules or sporadic nontoxic multinodular goiters have normal serum TSH concentrations. In them, particularly those with nontoxic multinodular goiters, the thyroid enlargement is probably caused by several growth factors (including TSH) that act over time on thyroid follicular cells that have different synthetic and growth potentials. The result is diffuse and later multinodular thyroid enlargement; some nodules eventually become autonomous [",
"    <a class=\"abstract\" href=\"UTD.htm?22/0/22535/abstract/3\">",
"     3",
"    </a>",
"    ], and others may undergo cystic degeneration.",
"   </p>",
"   <p>",
"    Because thyroid hormone is presumed to reduce goiter size by reducing TSH secretion, suppressive therapy would be expected to be",
"    <strong>",
"     ineffective",
"    </strong>",
"    in patients in whom serum TSH concentrations were already subnormal due to autonomous thyroid hormone production.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h1\">",
"     NONTOXIC GOITER",
"    </span>",
"    &nbsp;&mdash;&nbsp;Thyroid hormone suppressive therapy is effective in reducing goiter volume and preventing the development of new nodules in some patients, particularly in patients from regions of the world with borderline or low iodine intake [",
"    <a class=\"abstract\" href=\"UTD.htm?22/0/22535/abstract/4-6\">",
"     4-6",
"    </a>",
"    ]. In the absence of a history of childhood head and neck irradiation, we presently do not routinely treat euthyroid goitrous patients from areas of iodine sufficiency with T4. However, in iodine-deficient patients, or selected younger patients who are concerned about growth of their goiter, a trial of T4 aiming either for minimal TSH suppression or a low normal TSH is a reasonable intervention pending further studies, especially those that assess the efficacy of suppressing serum TSH into the low normal range. The American Thyroid Association does not recommend suppression therapy of benign thyroid nodules in iodine sufficient populations [",
"    <a class=\"abstract\" href=\"UTD.htm?22/0/22535/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <br/>",
"    The evaluation and management of nontoxic goiter is reviewed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/27/32185?source=see_link\">",
"     \"Diagnostic approach to and treatment of goiter in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1785826\">",
"    <span class=\"h2\">",
"     Efficacy",
"    </span>",
"    &nbsp;&mdash;&nbsp;In randomized control trials, thyroid hormone (T4) suppression can interfere with the process of goitrogenesis (goiter growth and new nodule formation). Only some goiters respond, while others grow despite T4 treatment [",
"    <a class=\"abstract\" href=\"UTD.htm?22/0/22535/abstract/4,7\">",
"     4,7",
"    </a>",
"    ]. Treatment must be continued or goitrogenesis resumes [",
"    <a class=\"abstract\" href=\"UTD.htm?22/0/22535/abstract/4\">",
"     4",
"    </a>",
"    ]. As examples:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In a double-blind trial, 78 patients with nontoxic goiter (average thyroid volume 53 mL) were randomly assigned to L-thyroxine (T4) or placebo for nine months and then followed for an additional nine months [",
"      <a class=\"abstract\" href=\"UTD.htm?22/0/22535/abstract/4\">",
"       4",
"      </a>",
"      ]. Thyroid volume, as assessed by ultrasonography, decreased in a greater proportion of patients in the T4 group (58 versus 5 percent) (",
"      <a class=\"graphic graphic_figure graphicRef54294 \" href=\"UTD.htm?34/46/35565\">",
"       figure 1",
"      </a>",
"      ). In the responders, the mean decrease in thyroid volume was 25 percent. Over half the patients in the T4 group developed thyrotoxic symptoms during the trial, and goiter growth resumed in this group after therapy was discontinued.",
"     </li>",
"     <li>",
"      In another trial from an iodine deficient region of Italy, 71 premenopausal women with benign nontoxic multinodular thyroid disease (mean thyroid volume 15 mL) were randomly assigned T4 (2",
"      <span class=\"nowrap\">",
"       mcg/kg)",
"      </span>",
"      or no treatment [",
"      <a class=\"abstract\" href=\"UTD.htm?22/0/22535/abstract/5\">",
"       5",
"      </a>",
"      ]. Compared with baseline values, treatment with T4 for one year significantly reduced mean thyroid volume (15.6 to 10.6 mL), mean dominant nodule volume (1.8 to 0.8 mL), and the number of nodules greater than 5 mm (0.8 to 0.4). In contrast, those parameters significantly increased from baseline in controls (14.8 to 20.0 mL, 1.2 to 2.5 mL, and 0.7 to 1.5, respectively).",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1785833\">",
"    <span class=\"h2\">",
"     Dosing",
"    </span>",
"    &nbsp;&mdash;&nbsp;T4 suppressive therapy was previously commonly used for goiter, but its use has declined due to concerns regarding the long-term side effects from the induction of subclinical hyperthyroidism, such as reduced bone density and increased risk of atrial fibrillation. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/22/23913?source=see_link\">",
"     \"Subclinical hyperthyroidism\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    It is possible that the benefits of T4 therapy do not require suppression to subnormal serum TSH concentrations. In one trial, 49 patients from Istanbul (a city with reported adequate iodine intake) with solitary thyroid nodules were randomly assigned to receive high-dose (serum TSH &lt;0.01",
"    <span class=\"nowrap\">",
"     mU/L)",
"    </span>",
"    or low-dose (serum TSH 0.4 to 0.6",
"    <span class=\"nowrap\">",
"     mU/L)",
"    </span>",
"    T4 therapy [",
"    <a class=\"abstract\" href=\"UTD.htm?22/0/22535/abstract/8\">",
"     8",
"    </a>",
"    ]. High and low dose T4 therapy were equally effective in reducing nodule volume (36 and 45 percent reduction in nodule size in the high and low-dose groups, respectively).",
"   </p>",
"   <p>",
"    In another trial of T4 therapy, 1024 patients with mild to moderate iodine deficiency and one or more thyroid nodules were randomly assigned to T4 (goal TSH 0.2 to 0.8",
"    <span class=\"nowrap\">",
"     mU/L),",
"    </span>",
"    iodine (150 mcg, ie the amount of iodine present in most multivitamins in the United States), T4 plus iodine, or placebo [",
"    <a class=\"abstract\" href=\"UTD.htm?22/0/22535/abstract/6\">",
"     6",
"    </a>",
"    ]. After one year, mean thyroid nodule volume decreased in all groups (-12.1, -9.0, -21.6, and -5.2 percent, respectively). Treatment with T4 plus iodine was significantly superior to placebo, T4, and iodine alone. Individual changes in thyroid nodule volume were variable. Decreases of more than 50 percent were seen in 7.6, 9.5, 11.3, and 8.5 percent of the nodules in the T4, iodine, T4 plus iodine, and placebo groups, respectively [",
"    <a class=\"abstract\" href=\"UTD.htm?22/0/22535/abstract/6\">",
"     6",
"    </a>",
"    ]. Thus, maintaining TSH in the lower end of or just below the normal range (rather than below 0.01",
"    <span class=\"nowrap\">",
"     mU/L)",
"    </span>",
"    appears to be efficacious. It is possible that this strategy will mitigate the adverse effects of T4 suppressive therapy. This concept requires further study.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1785840\">",
"    <span class=\"h2\">",
"     Special populations",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h3\">",
"     Irradiated patients",
"    </span>",
"    &nbsp;&mdash;&nbsp;External radiation exposure during childhood (therapeutic radiation as part of cancer therapy, radiation for nonmalignant conditions, exposure from nuclear power plants [Chernobyl, Fukushima]) increases thyroid tumorigenesis. There are few data to determine the efficacy of thyroid hormone suppressive therapy in reducing nodular thyroid growth in this population [",
"    <a class=\"abstract\" href=\"UTD.htm?22/0/22535/abstract/9,10\">",
"     9,10",
"    </a>",
"    ]. In a nonrandomized study of 632 adults who were treated prior to age 16 with conventional radiation for nonmalignant conditions and who subsequently had benign thyroid nodules removed surgically, patients who were treated with thyroid hormone had a lower incidence of recurrent nodules than those who were not (14 versus 34 percent, RR 0.69, 95% CI 0.47-1.01) [",
"    <a class=\"abstract\" href=\"UTD.htm?22/0/22535/abstract/11\">",
"     11",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/49/1818?source=see_link\">",
"     \"Radiation-induced thyroid cancer\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    External radiation exposure for malignancy during childhood also increases the risk of hypothyroidism [",
"    <a class=\"abstract\" href=\"UTD.htm?22/0/22535/abstract/12,13\">",
"     12,13",
"    </a>",
"    ]. All patients with hypothyroidism require treatment with thyroxine (T4). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?42/53/43865?source=see_link\">",
"     \"Treatment of hypothyroidism\"",
"    </a>",
"    .) However, whether irradiated euthyroid patients with one or more thyroid nodules or multinodular goiter benefit from T4 suppressive therapy is uncertain. In the absence of contraindications (such as atrial arrhythmia, ischemic heart disease, or osteoporosis), some UpToDate experts treat euthyroid patients with benign thyroid nodules and a history of external radiation exposure in childhood, aiming for a low normal or minimally subnormal serum TSH concentration. Other experts, however, would not treat such euthyroid patients, unless the serum TSH was in the upper part of the normal range (ie, &gt;3.0",
"    <span class=\"nowrap\">",
"     mU/L).",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1785743\">",
"    <span class=\"h3\">",
"     Suppressive therapy after surgery for nontoxic goiter",
"    </span>",
"    &nbsp;&mdash;&nbsp;The apparent efficacy of thyroid hormone therapy for suppression of nontoxic goiter led to its use to prevent goiter recurrence after partial thyroidectomy [",
"    <a class=\"abstract\" href=\"UTD.htm?22/0/22535/abstract/14-16\">",
"     14-16",
"    </a>",
"    ]. Two randomized trials showed a trend toward fewer recurrences with T4 therapy (15 versus 22 percent and 21 versus 35 percent) that were not statistically significant [",
"    <a class=\"abstract\" href=\"UTD.htm?22/0/22535/abstract/17,18\">",
"     17,18",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h3\">",
"     Hashimoto's thyroiditis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Thyroid hormone is particularly efficacious in reducing goiter size when thyroid enlargement is due to an elevated serum TSH concentration in patients with hypothyroidism due to Hashimoto's thyroiditis. However, even euthyroid goitrous patients with Hashimoto's thyroiditis may respond to suppressive therapy with thyroxine [",
"    <a class=\"abstract\" href=\"UTD.htm?22/0/22535/abstract/19\">",
"     19",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11800002\">",
"    <span class=\"h2\">",
"     Oncogenesis in goiter",
"    </span>",
"    &nbsp;&mdash;&nbsp;A potential benefit of T4 suppressive therapy is a reduction in the risk of thyroid cancer. The risk of thyroid cancer in patients with thyroid nodules increases with increasing serum TSH concentrations [",
"    <a class=\"abstract\" href=\"UTD.htm?22/0/22535/abstract/20\">",
"     20",
"    </a>",
"    ]. In a retrospective analysis of patients with nodular goiter, the prevalence of papillary thyroid cancer was significantly reduced in 7859 patients with nodular goiter taking T4 compared with 20,055 patients not taking T4 (3.2 versus 5.1 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?22/0/22535/abstract/21\">",
"     21",
"    </a>",
"    ]. These data suggest that suppressive therapy might reduce oncogenesis in goiter [",
"    <a class=\"abstract\" href=\"UTD.htm?22/0/22535/abstract/21\">",
"     21",
"    </a>",
"    ]. This hypothesis is still speculative and additional data are required. The use of T4 suppression therapy to reduce tumor growth and recurrence in patients with differentiated thyroid cancer is reviewed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?43/17/44313?source=see_link\">",
"     \"Overview of the management of differentiated thyroid cancer\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h1\">",
"     SOLITARY NODULES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Data on the impact of thyroid hormone suppressive therapy for solitary nodules are conflicting, as illustrated by the results of several randomized trials [",
"    <a class=\"abstract\" href=\"UTD.htm?22/0/22535/abstract/7,8,22-31\">",
"     7,8,22-31",
"    </a>",
"    ] and the following meta-analyses:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A meta-analysis of six trials (346 patients) showed that patients randomly assigned to suppressive thyroid hormone therapy for longer than six months were more likely to have a reduction in nodule volume by more than 50 percent, but this was not statistically significant (RR 1.9, 95% CI 0.95-3.81) [",
"      <a class=\"abstract\" href=\"UTD.htm?22/0/22535/abstract/32\">",
"       32",
"      </a>",
"      ]. The meta-analysis was limited by heterogeneity in the study results.",
"     </li>",
"     <li>",
"      A meta-analysis of nine trials (609 patients) concluded that thyroid hormone suppression was more likely than placebo or no treatment to reduce nodule volume &gt;50 percent (response rate 22 versus 10 percent, RR 1.88, 95% CI 1.18-3.01) [",
"      <a class=\"abstract\" href=\"UTD.htm?22/0/22535/abstract/33\">",
"       33",
"      </a>",
"      ]. However, long-term treatment appeared to be less effective, and regrowth was likely after cessation of thyroid hormone.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The trials included in the meta-analyses enrolled patients with solitary thyroid nodules and ultrasonographic evaluation of nodule volume. Appropriate suppression of TSH was documented by measurement of serum TSH or by TRH stimulation test. In one of the trials in the meta-analysis, 49 patients with solitary thyroid nodules were randomly assigned to receive high-dose (serum TSH &lt;0.01",
"    <span class=\"nowrap\">",
"     mU/L)",
"    </span>",
"    or low-dose (serum TSH 0.4 to 0.6",
"    <span class=\"nowrap\">",
"     mU/L)",
"    </span>",
"    T4 therapy [",
"    <a class=\"abstract\" href=\"UTD.htm?22/0/22535/abstract/8\">",
"     8",
"    </a>",
"    ]. High and low dose T4 therapy were equally effective in reducing nodule volume (36 and 45 percent reduction in nodule size in the high and low-dose groups, respectively).",
"   </p>",
"   <p>",
"    The majority of the trials in the meta-analyses were of relatively short duration (6 to 18 months) [",
"    <a class=\"abstract\" href=\"UTD.htm?22/0/22535/abstract/31-33\">",
"     31-33",
"    </a>",
"    ]. In one of the trials with longer follow-up, a five-year trial from an iodine-sufficient area of Italy, in which 83 patients were randomly assigned to receive T4 or no treatment, nodule volume (measured by ultrasonography) decreased in only a small subset of T4-treated patients (those with complete TSH suppression) [",
"    <a class=\"abstract\" href=\"UTD.htm?22/0/22535/abstract/30\">",
"     30",
"    </a>",
"    ]. After five years, however, fewer patients receiving T4 suppressive therapy developed new sonographically detected nodules (7.5 versus 28.5 percent).",
"   </p>",
"   <p>",
"    In another of the trials included in the meta-analyses, the characteristics of patients with nodules more likely to respond to suppressive therapy were [",
"    <a class=\"abstract\" href=\"UTD.htm?22/0/22535/abstract/29\">",
"     29",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Abundant colloid on biopsy",
"     </li>",
"     <li>",
"      Degenerative changes if the nodules were small (&lt;2.4 mL in volume or &lt;1.7 cm in diameter)",
"     </li>",
"     <li>",
"      Absence of hyperplastic or fibrotic changes",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Thus, thyroid hormone suppressive therapy is effective in reducing nodule volume and preventing the development of new nodules in some patients, particularly those patients from regions of the world with borderline or low iodine intake. In iodine sufficient regions, only 17 to 25 percent of patients with a solitary nodule will have a decrease in nodule size (more than 50 percent) as a result of T4 treatment [",
"    <a class=\"abstract\" href=\"UTD.htm?22/0/22535/abstract/7,31,32,34\">",
"     7,31,32,34",
"    </a>",
"    ]. Furthermore, in some patients solitary nodules regress spontaneously.",
"   </p>",
"   <p>",
"    In view of the small percentage of thyroid nodules that regress after T4 treatment, the modest responses, and the potential adverse risks (atrial arrhythmias and reduced bone density) of thyroid hormone suppressive therapy, we do not suggest the routine use of thyroid hormone suppressive therapy for solitary palpable thyroid nodules in areas of iodine sufficiency. This is consistent with American Thyroid Association guidelines [",
"    <a class=\"abstract\" href=\"UTD.htm?22/0/22535/abstract/1\">",
"     1",
"    </a>",
"    ]. However, in iodine deficient regions, a trial of T4 aiming for low normal or minimally subnormal TSH concentrations appears to be a reasonable intervention pending further studies that assess the efficacy of suppressing serum TSH into the low normal range.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14735925\">",
"    <span class=\"h1\">",
"     SUGGESTED APPROACH",
"    </span>",
"    &nbsp;&mdash;&nbsp;Uncertainty and controversy remains regarding the efficacy, risks, and benefits of thyroid hormone suppressive therapy for thyroid nodules and benign goiter. Because T4-suppressive therapy results (by definition) in subclinical hyperthyroidism, treated patients are at increased risk for atrial fibrillation, other cardiac abnormalities, or reduced bone density. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/22/23913?source=see_link\">",
"     \"Subclinical hyperthyroidism\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/11/17593?source=see_link\">",
"     \"Bone disease with hyperthyroidism and thyroid hormone therapy\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The use of T4-suppression has therefore dramatically declined. Since only 17 to 25 percent of nodules regress, and the degree of regression is modest, we do not recommend T4 suppression for solitary or dominant thyroid nodules. We do not routinely use T4 suppression for patients with nodular goiter. However, in select patients (history of external radiation exposure during childhood, iodine-deficient region, and younger patients with growing diffuse or nodular goiter who are concerned about growth of their goiter), a trial of T4 aiming either for minimal TSH suppression or a low normal TSH is a reasonable intervention pending further studies, especially those that assess the efficacy of suppressing serum TSH into the low normal range, which would mitigate the adverse effects of treatment.",
"   </p>",
"   <p>",
"    Speculation that suppressive therapy may reduce the risk of oncogenesis as well as goitrogenesis may result in reconsideration of T4 suppression for more patients with goiter, especially if efficacy can be demonstrated when TSH is suppressed into the low normal range. Suppressive therapy is not useful if the TSH is already subnormal.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topics (see",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?23/4/23618?source=see_link\">",
"       \"Patient information: Thyroid nodules (The Basics)\"",
"      </a>",
"      and",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?22/9/22674?source=see_link\">",
"       \"Patient information: Hyperthyroidism (overactive thyroid) (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Beyond the Basics topics (see",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?18/16/18691?source=see_link\">",
"       \"Patient information: Thyroid nodules (Beyond the Basics)\"",
"      </a>",
"      and",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?3/6/3172?source=see_link\">",
"       \"Patient information: Hyperthyroidism (overactive thyroid) (Beyond the Basics)\"",
"      </a>",
"      and",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?23/15/23794?source=see_link\">",
"       \"Patient information: Antithyroid drugs (Beyond the Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14736348\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      T4 suppression interferes with goitrogenesis (goiter growth and new nodule formation). Only some goiters respond, while others grow despite T4 treatment. Treatment must be continued or goitrogenesis resumes. (See",
"      <a class=\"local\" href=\"#H6\">",
"       'Nontoxic goiter'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      T4 suppression may also interfere with oncogenesis in nodular goiter. (See",
"      <a class=\"local\" href=\"#H11800002\">",
"       'Oncogenesis in goiter'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      In iodine sufficient regions, 17 to 25 percent of patients with a solitary (or dominant) thyroid nodule will have a modest decrease in nodule size (&gt;50 percent) as a result of T4 suppression therapy. In some patients, solitary nodules regress spontaneously. (See",
"      <a class=\"local\" href=\"#H10\">",
"       'Solitary nodules'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Because T4-suppressive therapy results (by definition) in subclinical hyperthyroidism, treated patients are at increased risk for atrial fibrillation, other cardiac abnormalities,",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      reduced bone density. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?23/22/23913?source=see_link\">",
"       \"Subclinical hyperthyroidism\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?17/11/17593?source=see_link\">",
"       \"Bone disease with hyperthyroidism and thyroid hormone therapy\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      For most euthyroid patients with diffuse or nodular goiter, we suggest not routinely treating with T4 suppression therapy (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). However, in select patients (iodine-deficient, history of childhood neck radiation, younger patients with growing diffuse or nodular goiter who are concerned about growth of their goiter), a trial of T4 aiming either for minimal TSH suppression or a low normal TSH is a reasonable intervention. Suppressive therapy is not useful if the TSH is already subnormal. (See",
"      <a class=\"local\" href=\"#H14735925\">",
"       'Suggested approach'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      For euthyroid patients with solitary nodules living in iodine sufficient regions of the world, we suggest not treating with T4 suppressive therapy (",
"      <a class=\"grade\" href=\"._grade_5?title=Grade 2B\">",
"       Grade 2B",
"      </a>",
"      ). However, in iodine-deficient regions, a trial of T4 aiming for low normal or minimally subnormal TSH concentrations is a reasonable alternative. (See",
"      <a class=\"local\" href=\"#H10\">",
"       'Solitary nodules'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H14735925\">",
"       'Suggested approach'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The use of thyroid hormone suppressive therapy for prevention of recurrence in patients with differentiated thyroid cancer is reviewed separately. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?43/17/44313?source=see_link&amp;anchor=H8#H8\">",
"       \"Overview of the management of differentiated thyroid cancer\", section on 'Thyroid hormone suppression'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/0/22535/abstract/1\">",
"      American Thyroid Association (ATA) Guidelines Taskforce on Thyroid Nodules and Differentiated Thyroid Cancer, Cooper DS, Doherty GM, et al. Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 2009; 19:1167.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/0/22535/abstract/2\">",
"      Rienhoff, WF Jr. Microscopic changes induced in thyroid gland by oral administration of desiccated thyroid. Arch Surg 1940; 41:487.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/0/22535/abstract/3\">",
"      Studer H, Peter HJ, Gerber H. Natural heterogeneity of thyroid cells: the basis for understanding thyroid function and nodular goiter growth. Endocr Rev 1989; 10:125.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/0/22535/abstract/4\">",
"      Berghout A, Wiersinga WM, Drexhage HA, et al. Comparison of placebo with L-thyroxine alone or with carbimazole for treatment of sporadic non-toxic goitre. Lancet 1990; 336:193.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/0/22535/abstract/5\">",
"      Cesareo R, Iozzino M, Isgr&ograve; MA, et al. Short term effects of levothyroxine treatment in thyroid multinodular disease. Endocr J 2010; 57:803.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/0/22535/abstract/6\">",
"      Grussendorf M, Reiners C, Paschke R, et al. Reduction of thyroid nodule volume by levothyroxine and iodine alone and in combination: a randomized, placebo-controlled trial. J Clin Endocrinol Metab 2011; 96:2786.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/0/22535/abstract/7\">",
"      W&eacute;meau JL, Caron P, Schvartz C, et al. Effects of thyroid-stimulating hormone suppression with levothyroxine in reducing the volume of solitary thyroid nodules and improving extranodular nonpalpable changes: a randomized, double-blind, placebo-controlled trial by the French Thyroid Research Group. J Clin Endocrinol Metab 2002; 87:4928.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/0/22535/abstract/8\">",
"      Koc M, Ersoz HO, Akpinar I, et al. Effect of low- and high-dose levothyroxine on thyroid nodule volume: a crossover placebo-controlled trial. Clin Endocrinol (Oxf) 2002; 57:621.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/0/22535/abstract/9\">",
"      Murphy ED, Scanlon EF, Garces RM, et al. Thyroid hormone administration in irradiated patients. J Surg Oncol 1986; 31:214.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/0/22535/abstract/10\">",
"      DeGroot LJ. Radiation and thyroid disease. Baillieres Clin Endocrinol Metab 1988; 2:777.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/0/22535/abstract/11\">",
"      Subbiah S, Collins BJ, Schneider AB. Factors related to the recurrence of thyroid nodules after surgery for benign radiation-related nodules. Thyroid 2007; 17:41.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/0/22535/abstract/12\">",
"      Chow EJ, Friedman DL, Stovall M, et al. Risk of thyroid dysfunction and subsequent thyroid cancer among survivors of acute lymphoblastic leukemia: a report from the Childhood Cancer Survivor Study. Pediatr Blood Cancer 2009; 53:432.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/0/22535/abstract/13\">",
"      Sklar C, Whitton J, Mertens A, et al. Abnormalities of the thyroid in survivors of Hodgkin's disease: data from the Childhood Cancer Survivor Study. J Clin Endocrinol Metab 2000; 85:3227.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/0/22535/abstract/14\">",
"      BERGFELT G, RISHOLM L. POSTOPERATIVE THYROID HORMONE THERAPY IN NONTOXIC GOITRE. Acta Chir Scand 1963; 126:531.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/0/22535/abstract/15\">",
"      Anderson PE, Hurley PR, Rosswick P. Conservative treatment and long term prophylactic thyroxine in the prevention of recurrence of multinodular goiter. Surg Gynecol Obstet 1990; 171:309.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/0/22535/abstract/16\">",
"      Bellantone R, Lombardi CP, Boscherini M, et al. Predictive factors for recurrence after thyroid lobectomy for unilateral non-toxic goiter in an endemic area: results of a multivariate analysis. Surgery 2004; 136:1247.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/0/22535/abstract/17\">",
"      Bistrup C, Nielsen JD, Gregersen G, Franch P. Preventive effect of levothyroxine in patients operated for non-toxic goitre: a randomized trial of one hundred patients with nine years follow-up. Clin Endocrinol (Oxf) 1994; 40:323.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/0/22535/abstract/18\">",
"      Heged&uuml;s L, Nygaard B, Hansen JM. Is routine thyroxine treatment to hinder postoperative recurrence of nontoxic goiter justified? J Clin Endocrinol Metab 1999; 84:756.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/0/22535/abstract/19\">",
"      Svensson J, Ericsson UB, Nilsson P, et al. Levothyroxine treatment reduces thyroid size in children and adolescents with chronic autoimmune thyroiditis. J Clin Endocrinol Metab 2006; 91:1729.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/0/22535/abstract/20\">",
"      Fiore E, Vitti P. Serum TSH and risk of papillary thyroid cancer in nodular thyroid disease. J Clin Endocrinol Metab 2012; 97:1134.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/0/22535/abstract/21\">",
"      Fiore E, Rago T, Provenzale MA, et al. L-thyroxine-treated patients with nodular goiter have lower serum TSH and lower frequency of papillary thyroid cancer: results of a cross-sectional study on 27 914 patients. Endocr Relat Cancer 2010; 17:231.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/0/22535/abstract/22\">",
"      Gharib H, James EM, Charboneau JW, et al. Suppressive therapy with levothyroxine for solitary thyroid nodules. A double-blind controlled clinical study. N Engl J Med 1987; 317:70.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/0/22535/abstract/23\">",
"      Mainini E, Martinelli I, Morandi G, et al. Levothyroxine suppressive therapy for solitary thyroid nodule. J Endocrinol Invest 1995; 18:796.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/0/22535/abstract/24\">",
"      Lima N, Knobel M, Cavaliere H, et al. Levothyroxine suppressive therapy is partially effective in treating patients with benign, solid thyroid nodules and multinodular goiters. Thyroid 1997; 7:691.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/0/22535/abstract/25\">",
"      Cheung PS, Lee JM, Boey JH. Thyroxine suppressive therapy of benign solitary thyroid nodules: a prospective randomized study. World J Surg 1989; 13:818.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/0/22535/abstract/26\">",
"      Reverter JL, Lucas A, Salinas I, et al. Suppressive therapy with levothyroxine for solitary thyroid nodules. Clin Endocrinol (Oxf) 1992; 36:25.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/0/22535/abstract/27\">",
"      Larijani B, Pajouhi M, Bastanhagh MH, et al. Evaluation of suppressive therapy for cold thyroid nodules with levothyroxine: double-blind placebo-controlled clinical trial. Endocr Pract 1999; 5:251.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/0/22535/abstract/28\">",
"      La Rosa GL, Lupo L, Giuffrida D, et al. Levothyroxine and potassium iodide are both effective in treating benign solitary solid cold nodules of the thyroid. Ann Intern Med 1995; 122:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/0/22535/abstract/29\">",
"      La Rosa GL, Ippolito AM, Lupo L, et al. Cold thyroid nodule reduction with L-thyroxine can be predicted by initial nodule volume and cytological characteristics. J Clin Endocrinol Metab 1996; 81:4385.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/0/22535/abstract/30\">",
"      Papini E, Petrucci L, Guglielmi R, et al. Long-term changes in nodular goiter: a 5-year prospective randomized trial of levothyroxine suppressive therapy for benign cold thyroid nodules. J Clin Endocrinol Metab 1998; 83:780.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/0/22535/abstract/31\">",
"      Zelmanovitz F, Genro S, Gross JL. Suppressive therapy with levothyroxine for solitary thyroid nodules: a double-blind controlled clinical study and cumulative meta-analyses. J Clin Endocrinol Metab 1998; 83:3881.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/0/22535/abstract/32\">",
"      Castro MR, Caraballo PJ, Morris JC. Effectiveness of thyroid hormone suppressive therapy in benign solitary thyroid nodules: a meta-analysis. J Clin Endocrinol Metab 2002; 87:4154.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/0/22535/abstract/33\">",
"      Sdano MT, Falciglia M, Welge JA, Steward DL. Efficacy of thyroid hormone suppression for benign thyroid nodules: meta-analysis of randomized trials. Otolaryngol Head Neck Surg 2005; 133:391.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/0/22535/abstract/34\">",
"      Gharib H, Mazzaferri EL. Thyroxine suppressive therapy in patients with nodular thyroid disease. Ann Intern Med 1998; 128:386.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 7887 Version 6.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1003-200.167.4.114-B6D75EF485-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f22_0_22535=[""].join("\n");
var outline_f22_0_22535=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H14736348\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      PATHOPHYSIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      NONTOXIC GOITER",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H1785826\">",
"      Efficacy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H1785833\">",
"      Dosing",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H1785840\">",
"      Special populations",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      - Irradiated patients",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H1785743\">",
"      - Suppressive therapy after surgery for nontoxic goiter",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      - Hashimoto's thyroiditis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11800002\">",
"      Oncogenesis in goiter",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      SOLITARY NODULES",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H14735925\">",
"      SUGGESTED APPROACH",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H14736348\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"ENDO/7887\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ENDO/7887|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?34/46/35565\" title=\"figure 1\">",
"      T4 suppression of goiter",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?17/11/17593?source=related_link\">",
"      Bone disease with hyperthyroidism and thyroid hormone therapy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?31/27/32185?source=related_link\">",
"      Diagnostic approach to and treatment of goiter in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/53/28506?source=related_link\">",
"      Diagnostic approach to and treatment of thyroid nodules",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?43/17/44313?source=related_link\">",
"      Overview of the management of differentiated thyroid cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?23/15/23794?source=related_link\">",
"      Patient information: Antithyroid drugs (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?3/6/3172?source=related_link\">",
"      Patient information: Hyperthyroidism (overactive thyroid) (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?22/9/22674?source=related_link\">",
"      Patient information: Hyperthyroidism (overactive thyroid) (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?18/16/18691?source=related_link\">",
"      Patient information: Thyroid nodules (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?23/4/23618?source=related_link\">",
"      Patient information: Thyroid nodules (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?1/49/1818?source=related_link\">",
"      Radiation-induced thyroid cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?23/22/23913?source=related_link\">",
"      Subclinical hyperthyroidism",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?42/53/43865?source=related_link\">",
"      Treatment of hypothyroidism",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f22_0_22536="Essential thrombocythemia";
var content_f22_0_22536=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=HEME%2F61742&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=HEME%2F61742&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic2\" style=\"width: 1040px;\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Increased platelets on peripheral smear in essential thrombocythemia",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 360px; height: 239px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Peripheral smear from a patient with essential thrombocythemia shows an increased platelet number and clumps of large, abnormal platelets.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Carola von Kapff, SH (ASCP).",
"    </div>",
"   </div>",
"  </div>",
"  <div class=\"figure\" style=\"width: 450px\">",
"   <div class=\"ttl\">",
"    Normal peripheral blood smear",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 393px; height: 257px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    High power view of a normal peripheral blood smear. Several platelets (black arrows) and a normal lymphocyte (blue arrow) can also be seen. The red cells are of relatively uniform size and shape. The diameter of the normal red cell should approximate that of the nucleus of the small lymphocyte; central pallor (red arrow) should equal one-third of its diameter.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Carola von Kapff, SH (ASCP).",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f22_0_22536=[""].join("\n");
var outline_f22_0_22536=null;
var title_f22_0_22537="Palmar hand anatomy";
var content_f22_0_22537=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PC%2F52608%7EPC%2F50552&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PC%2F52608%7EPC%2F50552&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Palmar hand anatomy",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 409px; height: 440px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAG4AZkDASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwD6pooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiivBvH37Q1v4d8Q6lo2naDLeXFjM0DzS3ASNmHXAAJ60Ae80V8hXn7QvjXVrqO202LS9M81wiskJlZc98ucfpXbaZ8VfEkOp28l9cRXVruVZIfJVdw4BIIGQe/p7VhVxEKTSl1PTwGU4jHxlKja0e/5I+h6KRGDIrDoRmlrc8wKKKwfHOv8A/CM+F77VRCJnhUBIycAsxCjPtk0EzmqcXOWyN6ivG/hZ8T9U8Q+JRpWsw2zCdGaKSFChQqM4IycjFeyUk7mOGxMMTDnp7BRRRTOgKKKpQarp89/LZQXttJeRffgWUF1+o60m0ilGUrtLYu0UUUyQooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAK5r4h3F9b+GCdJuzZ3s17ZWyThQ2wS3UUbHB4PDmulqO4t4bmMR3MMcqB1kCyKGAZWDK2D3DAEHsQDQB5jJ4w12xv72/wBRtJYEazhWDTZAB5UjXCQGRj1I3uxznBRVPGa1T4j16YjTZbWCxv3S6lFzPGQrxRLCcrGshKsTMBgucbGbkYFdrPZWlw8jT2sErSRmFy8YYtGeqHPVfbpVJfDehraLaro2mi1WTzVhFqmwPjG4LjGccZoA4jRPFWof2baW8czTalNb2KwrJF55ld7YyPgbkAPykks4H8i8ePNUm0k38NpZxLb6Ymo3Mcm5i582RGjQg4H+rJDfNj0PWu3m0DR57fyJ9J0+SD5P3b2yFfkG1OCMfKOB6DpT00fTEgeFNOslheLyWjEChTHknYRj7uWY46cn1oAp+J9Tu9P/ALLisFgM99eC1DzAlYwY3bdgEE42dMjPqK5EeOtZuNsOn6Ulzd29s1xcIg+WYrPLDtQlxsBMLHcd2NygjvXos1vDO0TTRRyNE/mRl1BKNgjcM9DgkZ9zVC60DRruOKO70nT544mZ41ltkYIzHLEAjgk8n1NAHOyeKdThe/vZrWyXR7LUfsUriRjKE3KplIwAApYE8ngE+1Z83jfWbnyF0jSknkmtZNQiTG7zoPMZYhksu0soVi3zBdyjBrvGsLNre5t2tLdoLnd58ZjBWXcMNuGMNkcHPWodQ0XS9Shhi1HTbK7ih4iSeBZAnGPlBHHHpQBnXPi3T7aZoZrbWjIuN3k6NdzJ07OkRVvqCRUX/CaaX/z6+IP/AAQX/wD8ZrpQAoAAwB0AooA5r/hNNL/59fEH/ggv/wD4zR/wmml/8+viD/wQX/8A8ZrpaKAOa/4TTS/+fXxB/wCCC/8A/jNH/CaaX/z6+IP/AAQX/wD8ZrpaKAOZfxtpSIzNba+FAySdBvhj/wAg18Fa7fHU9d1O/Ykm6upZsn/acmvv3x9f/wBl+B9fvs4MFjM4PuEOK/POMYjUHrgZoGjW8LrnXLZ2SRkizI2xGcgAdcAE9cV6dot7bza1p8bxXrK1xGGCWUzsRuGcKFJP0Fcf4AltLOx1W5uZUWaUx20Sk/MRku5A6n7qj8a9Y+Flq1/470fywSsbmc5GMBVJ5/SvLxdpVlFrsfbZG5UcuqVIyS+J+ei9fI95HjTSwP8Aj08Qf+CC+/8AjNH/AAmml/8APr4g/wDBBf8A/wAZrpaK9Q+IOa/4TTS/+fXxB/4IL/8A+M1xHxl8Vafe+AL6CC31lHd4sGbR7uFeHB5Z4go/OvXK8w/aD1GK28FR2TczXlwoUey/MT/IfjSZy46Sjh5uW1meV/AwB/iNpzAceVKeRg/cr6jr5i+A67viNan0t5j+lfTtKJw5H/uz9X+gUUUVR7Bn+INQXStDv79yALeFpB7kDgfnivn34RWs2ofEGym3tuhElxK46ngg5+pavTfjpqf2PwetojYkvpljx/sj5j/IVifs+6biDVdUccuy20Z9h8zfqR+VcFb95iIw7an1WXL6plNbEPeei/L9X9x7BRRRXefKnOeP/F1h4I8NTa1qqTSW8bpHshALszHAABI+v4VzfhL4z+DPE+oW2n2N/NDf3LBIre4t2Rnb0BwR+teb/tha3ts/D+hRtzJI97Kvso2p+rN+VcR+yvof9p/Es38i5h0u1ebJHG9/kX9Cx/Cgdj7GooooEFFFFABRWFc680N7r1uLcEaZZx3Qbd/rCwkOOnH+r6+9ZWn+NPMldLmzkeSWeG3tYbYbnkd7QXBBLEAYAfk4HAzQB2VFcrfeOtKstMsNRuFnSyu1DCVjGnl84IZWcMSD1CBjxWrpeu22p6je2drFdZs3aKWV4SsW8YyoY8MeR0oA1aK5i78a6XZ6reafeCWGa2gluOWjbekYyxCqxYccjcFz2zUCeOLY6l5Uun31vYLYNfveTx+WI41JyWQ/MBgZz156UAddRXIQ/EDSJUIEd4bjzI4hbxxiWRvMV2Q4jLDB8p+pBG07gK1bPxLYXc1tBGJ1uJ7iW28l48PG0YJYsOwwBz33r60AbVFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUVHc3ENrA81zLHDCgyzyMFVR7k0ASUVyx8b6ZcsU0KG912QcZ02HfFn/rsxWL/x+jf4v1I/JHpmhQHvIWvJyPoNiIfxcUAdTXO33jPQrW5a1ivPt96vW10+NrqUf7yxg7fq2BUH/CFWV2d3iC91DXG7peTYg/78xhYyPqpPvXRWVnbWFstvY20Ntbp92KFAir9AOKAPIfjnr+tS/CzXW/sJtO0+VFheW9uVEzBnUfLFHuHOf4mBA7dq+OzX2X+1O7L8JbgLnDXlup+m7P8AQV8l+GdKfVNRAI/0eHDzE+meF+pqZSUE5PobUKMq9SNKG7djsvCdh9i0eIuoE0v7xuOQD0H5Yr374A6KQmoa1Kv3v9GhJ9By5/PA/CvGwCSAoz6AV9LfCNlb4e6RsUDCuDgdTvavKwv72u5y9T7nPf8AYctjQpbO0f1/Gx2FFFFeufABXzn+0JqTXfi+CxTJisbcFsdmc5/ltr6Mr5f8dN/aF34y1UncP7UhtIz7KH/+IFTI8jOZP2HIuv6K5Y+AK7viEh/u2kp/9Br6Yr5u/Z6XPjuZv7tk/wD6EtfSNOIZIv8AZvmwoopCQoJPAHNM9c8C+P1+l94jt9NcLJDaW+XRhkFnOen0C12/w++HnhqLwdph1Hw3o1xdyxCWSSexidvm5AyVzwCK8i1CU+KPH0zFwI7292hicBYw2M59Aor6ftWha3jNsyNBtAQocrjtgiuDCtzqTqdD6nPIxwuEw+Et71rv+vVs5/8A4QHwd/0Kfh//AMFsP/xNH/CA+Dv+hT8P/wDgth/+JrpaqavfRaXpV7f3BxDawvO59lUk/wAq7z5Y+HvjnJpp+J+r22iWNpY2NkVtVitYViQsq/McKAM5J59q9k/Zg8DaPqHgi71fXtI0/UHu7tlg+2WyS7I0G35dwOMnd09K+ZdRvJtRv7u+ny1xdTPO/qWZicfrX398N9DHhvwHoWk4w9taoJB/tkbn/wDHiaBsT/hAfB3/AEKfh/8A8FsP/wATR/wgPg7/AKFPw/8A+C2H/wCJrpaKBHNf8ID4O/6FPw//AOC2H/4mr+j+GtC0Wd5tG0XTNPmddjSWtrHEzLnOCVAyMgcVrUUAYOs+GodSurqdb++sjd24trpbYxgTRjdgHcjFSN7jKlTz14GEj8KafFqkN9E06PDdLdpGGGwMtq1sFxjO3YxPXOQOccVv0UAcbcfD7TpbZoI77UYI5LX7FN5bREyxb3cAlkOMGRvu4zxnOBjpNK0yHTftfkNI32q4e5feQcM2MgYA44q9RQByD+ArBzOrX2ofZ5BdbYAYwsZuQ3mEHZuJ+Y4LFsfTitHUfC9lqEyvcSXHlGyfT54QV2XEDDBV8jI78qVPNb1FAHOWnhSGB7RptRvro2s6XEXmiFcFUdADsjUsMSHJOTkDnrl2m+Hlt/GWr69IIw91HHDCqMThQq73IPAZisanGflhTnsOhooAKKKKACiiigAooooAKwPHOq3GjeHjd2bBZjdWkG4wtNtWW4jjYhF5Y7XOAOpxW/VbULG21G3WC8j8yJJopwu4jDxyLIh49GRT6HHORQByGn+L7s+HxeOltdyy30tta5EkDXCJnLeUFkkDgqylduflzwOla98c3F/o0N3oNpsTFjJPLcOFaITyqNgTadx2k55GMjGT06a68LaRc3Uly1vLHPJN55kguZYTv2bCw2MMZXAOPvYGc4FQDwZoKx28aWciRwJFGqJcyqrLE26PeA2H2nkFs0AY2peOjplhdXBt0uzBPeCSJWZZRFBIVJVFV931bavqRmt3w3qkuoX/AIiEzg29pfJFB8oG2M2lvLz6/NIx59fam3ng3Q7wSia0lHnecJfKuZY/MErbpFbaw3KTk4PAycAVp2Wl2dkbv7NAF+1yCScFiwdhGkYPJP8ABGgwPT1JoA5BPiGgjvC2nNMYo4ZoDayFkuEkmEQ2u6IpOWHKll5+9T5fGl/YXOttqulJFa2ItkjWObfIZZiqqhxwcuwGR0HY1r2/gzQrddqWkzKEjiUSXU0gRI3Doq7nO1QyggDA4x0q5feHNLvrm6nurZne6iWKYea4VwpypKg43A9GxuHGCKAMOx8aT3d1aWcOi3D3k0k0bASbIwIxExdWkVSy4lA+7ncCMcZrQ0PxRFq9/DZw20iXAile6UsD9maOXy9jepZg+PUIT6VdsdA0+yuIbiJbmSeHzBHJcXUs7AOFDDLsTg7F+mOMZNN0TQ4dL1HWb8FHutTuBNK6x7MKqBETqc4AznuWY8ZxQBnyaf4o1GRhd6xaaVbEnEemwebNj/rrKCv5R/jT7XwTocc6XF7bSapdqdwn1OVrplPqoclU/wCAgV0lFACKoVQqgAAYAHaloooAKKKKAPD/ANrfUBb/AA8sbIHDXl+nHqqKzH9dteF+CrUW+iJJgh7hvMb6DIH6fzr0b9sW/MmpeGNMU/djmuCPclVH8jXIWcItrKCEcCONV/IVwZhO0FHufVcKYdTrzrNfCvxf/ATPRfhj4dN9ba1rNwmbeztJkhyOGlKHJ/Afqa9Q+CxJ+HenZ7GQf+Pms7w5CuifBWWSX5WkspZmz6yA4/mK2PhDbtb/AA90gOMF0aTH1Y4/SjDU1CUV5X++ws4xTxNKtJ7Koor5KX/D/M7Giiiu8+WEdgqsx6AZr5YvyW+GNzct96815nJ9dsZ/+Kr6f1Ntmm3bekLn9DXy5qTbfhJoq/8APTVLh/rhQKmR4mbvRej/AER0n7OabvF2oP8A3bP+brX0RXgH7NqZ1/WX9LZF/N//AK1e/wBOOxvkythV8wrnvH+p/wBkeDtVu1bEghMcf++3yj9TXQ15P8f9T8rSdN0xG+a4lMzj/ZQcfqf0rKvPkpuR9JleH+s4unT6X19Fqzwi8bZBgE88fhX038HdOk034eaVHKW3zKZ8H+EOSQB+GK+aVtHv9VsbGP79zIka/wDAmxX2LaQJa2sNvCMRxII1HoAMCssHDlprzObOcQ8Znded9KaUF8tX+NyWvLP2ldb/ALH+FOoxI+2bUHSzTnnDHLf+Og/nXqdfOP7Y90RY+F7QE4aaaUj1woA/9CrrMDxD4UaJ/wAJF8R/D+msm6J7pZZRj/lnH87f+g4/Gvv2vlL9kTQ/tXirWNbkTKWNutvGfR5Dk/8Ajq/rX1bQNhRRRQIKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKjuZ4bW3knuZUhgjUu8jsFVQOpJPQUAfI/7Q8/9q/HG3swcpZ28EZHp1kP6EVDBC11cxQRjLzOsYHuTj+tY+r6nB4l+LfiTWbSUT2bSt5Eo6MgARSPYha7r4aWi3njjSxJgRQObmQnoAgLfzArycY+esoH3nDy+rZfUxD839y/zuemfEPfqeo6D4F01yqMEe7Zf4YkHA/IE/lXYJ4Tgso1GhXt5pbKMBYpPMiP1jfI/LFct8Jom1nV9e8V3IJe7nMFvn+GNfT/x0fga9NrtowU71H129Oh85mFeeGccLB/Cve85PV372217HneqP4ptdSCazrqWGnSMEhu7K0Rowx4Al3klMnv09xXdabDcW9jDFe3Ru7hFw8/lhN59do4FS3VvDd20tvcxrLDKpR0YZDA9QawvC8stlc3Wg3cjSSWYD20jnJlt24XJ7lSCp+gPetIx5Jb7nLVq/WKWiScd7JK62vtf1V/PobWoqX0+6UdWiYfoa+U9WlH/AArfw/Dnlb+7yPwT/Gvoz4jeKIPCnhq4vJMNcyAxW0RP33I/kOpr5n1UkeENBU9XmupD/wB9IP6Vcj5DOakb8q3S/No9L/Zqizda9L6JEv6sa91rxf8AZqjxp+uy46zRL+St/jXtFNbHflKthIfP82FfOXxl1E6l46nhiO5LRFtkH+11b9Tj8K+iLudLW1muJTiOJC7H2AzXy/4eJ1zxrHdXXzK873sxP91cyH+WK4sc7qNNdWfccNQjTlVxc9oR/wCD+SDwbZX8/wAVLWHSrW0unsCW2XNw0KZjXH3ljc9favoD7Z4x/wCgF4f/APB1N/8AIleUfs7wNe+Jtb1WUZYRAZ9Gkcsf5V75XZBWVkfEZdN1oSry3nJt/NnNfbPGP/QC8P8A/g6m/wDkSvmv9qq/1S48RaDbazZ2NpLDaySItpdvcKQzgZJaKPB+Xpg/Wvrmvjz9qF5dV+L0OnQAtKtpb20aj+87Mf8A2YVR6KPTf2ctM8RaL8OYbjTtI0iePU5mu/NudSkgkKnCqCi27gDC8fN37V6j9s8Y/wDQC8P/APg6m/8AkStXw9pkei6Dp2mQACOzt0gXH+yoGf0rQoEc19s8Y/8AQC8P/wDg6m/+RKPtnjH/AKAXh/8A8HU3/wAiV0tFAHNfbPGP/QC8P/8Ag6m/+RK1NGm1eVZf7asbC0YEeWLS8e4DDvndFHjt6/hWjRQByWo6rdW+peLUNx5cVlpkNzBuwBGSJ8t+aDrxxWJpXiDWF1BLRZEkub6+t7UNdBmWDOmmdmCAjPzRn5cj7x5FdzqOjaZqUsUuo6dZXcsX+reeBZCnOeCRxyBUxsLM3IuDaW5uBJ5wl8sbt+wpuzjO7YSueuCR0oA4C98fX8ei299bW0M00Fot3f2yxEhUMjJuEjOoUExyYGHbjpXU+HdU1DVNR1UTQ2sVhaXMlrGUdjI7LjkjGAOT61buPDuiXIhFzo+nTCFSsYktUbYCckDI4BPXFaEFvDB5nkRRxeY5kfYoXcx6scdSfWgDg77xvf6eLm9ubS3lsI5r+BYYg3nE2ySOG3E4+YREbccEg57U5PFXiBbaMS6Za+dcXFtFbzSExROJd+eAzk7dgO7gNuHAwa7VdPs0dGW0t1ZJHmUiNQVd87mHHBO45PU5NVrPQNHsc/YtJ0+3y6ynyrZEy652twOoycHtk0AcxP4zu7O8uNPurOJ9SsjNPcxwscG1SESCVM8klnRMHvu9OdHwZreq6vvbU7FYYHgjuIJkAVX3ZygG9i20bTv4Dbugxz0QtbcXjXYgiF00YiabYN5QEkKW64BJOPc1X03R9M0x5X03TrOzebHmNbwLGXxnGcAZ6n8zQBeooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAoorkviN4+0bwFpBvNXl3TyAi3tIzmWdvQDsPVjwKANrxLr2meGtHn1TW7uO0soRlnc9T2UDqSewFfHPxg+Lmp+Pbh7K08yx8Oo3yW2fnnx/FKR+i9B7mud+IHjjXfiHrqT6kzsu/baWEALJFnoFXqzHuep/SvWfhJ8ALu4urbVvHUYgs1w6aXnLyHt5pH3R/sjn1x0oHseceCNNuLPTWubqB4hd4khLjG+MZAYexOcV658MbQm08VagODbaXJGrejMD/RaofFG4S48daksSqkNuUto0UYChFAwB2Gc12/wz0eW5+F3iM24JuL7zY0A/i2pgD8ya8dfvMRJ+v4H6DJrCZTTg9L8v4tN/qdl8H0VPh5pOxdu5XY+53nmuzriPg5qEF74EsIYSBLaZgmTurAk/qDXb16dC3s427HxeZqSxlXm35n+YVz3iy3lhS31qyQtd6cS7IvWWE/6xPyGR7qK6Gg81co8ysctKo6U1L+muq+Z5Dq+iah4m8R6r4g1qNf7D02zdtMjDBlnzGWEnH5/XA7V4zrTY8P+G0z/wAu80n/AH1M3+FfQNl4Win13VNJudT1aOyh2T21rDcmOMRPnK4HOAwYdemK8m+OqxReOVtrdFjht7OKNUUYC/eP9azi3LVo8PP8vpYWHtKc+bm7rvZrX00t0PQv2cItvhbUpf795t/JF/xr1qvNf2fovL+H4b/nrdyt/If0r0eaWOCJpJpEjjUZZnOAB7mtVsdmXRthqa8jj/i9qX9m+BL7YcSXO22X/gR5/wDHQa8Z8GwG28MeLtYIwLewNpGfRpTg/pj866r4yeMNM1rT4NM0mY3PlXHmSzoP3eQpG0N3PPasCa7tbf4H3MEE0Ru7jUFE6KfnAzkZHphK89yVTEqz0SPsMUqmX8PVZSi1Kd/uf/Dfidn+zjZ+V4Y1K7I5nutg+iKP6sa9brxH9nfxGqrd+HbkhXybm2zxuzjev8j+de3V6C2Pi8rlGWFhy9PzCvl+/sRr37XoikG6O0kjnYf9coFI/wDHiK+oK+c/BJD/ALWnicuPmFvKFz/uxf0pnon0ZRRRQIKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAoorxj49fFyPwfayaJ4flSTxFMnzOPmFmh/iP+2ew/E+4Bq/GH4vaZ4Dgaxs/Lv/ABDIuUtgflhB6NKR0HoOp9utfKMEPij4n+MW2mbVNZujlnY4SJM9+yIP85NT+AfBWu/EbxFJDZGR8v5l7qE+WWPPUsf4mPYdT7CvtH4e+BtG8CaKthosHztgz3L8yzt/eY/yHQUD2OZ+Enwi0jwHAl3OE1DX2X95eOvEfqsQP3R79T+lenUVleItcg0Oy8+WG4upmZY4ra1j8yWRmOAAOwz3OAO5oEeR/EfwGT4q+0Wmp2Ub6pKzR2szHzWkxlgij7w4J7YrsfA2oR6Bpvh3Qp9L1K0e+adUkulRTvUbyWVWO3cC2B2xzXS+HtFksg11qtyNQ1WR3Y3TxKpiRjnyo+pVBgcZOSMnrUPiuZ7e98PTLfpaRnUVikRlJ+0B0cCMYBwc4OeOlYwoQhJzitWehiczxGJoxoVHeMf+GVzjLqIeC/irazQfu9J14FJEHCrNnr+ZB/4Ea9Urh/jDpLal4NmngB+1WDi6iI6jb97H4ZP4V0HhHV013w3p+ooQTNEC+Ozjhh+YNTT9ycodN1+prjH9Yw1PE9V7svls/u0+RsUUUV0HlHHeL7CRvE+h3ltdy2U8gltFnTkBiN6BlPDKdrDHvxg189/FGe9n8d6qdTMJuo2WNvJzswFGMZ5/Ovq66tYLpYxcRLII5FlTcPusDkEe4r5H+IVwLnxxr0wOQbyQA+wOP6VlyWbfc8viLE8+FpUn0f8An/me/fCm1u0+E1imnSxw3sscrxSSruVWLtgkd6kh+HzalIs/i/WLzWHHP2cN5UAP+6Otbfw6t/svgTQoiMEWkZP1Iz/WuipypxnbmPWy/E1cLh4wpO2i1sr7d918jw346RWuntoWm2EEVvbxxySCOJQoGSo7fSuV8YeGrTSPCHhvVVMgn1CPEyMcrnG4MPTjtWz8ergy+MY4Qc+TaKMehJY1ofGxYf8AhXnhX7LIksKFUV0IKn91jg/hXDGnGrWnfofR5tmNbLMnozptNu7aeqkr6pp7p31OUWYXOlaZq3h5Db694fiUTRrz58CniUeuM4Yeh9BXvvgbxVZeLdDivrNgsoAWeDPzRP3B9vQ9xWD8PfDGlTaXoPiEwH+0Dp6RMwb5WBXBJXoTjjNWdC+Hmn6D4wl1vSrme3hkRlayX/V5P9O4HY120lOKtLU+Urxpe3jXwUeWE0nKP8r/ALvkdtXzTqpbwp+1raXU5222rqqqx6ESR7P/AENB+dfS1fPX7XOkSpp3h/xLZZS4sbgwNIOqhvmQ/gy/rWpuj6Forn/AHiKLxZ4N0nWoSP8ASoFaRR/DIOHX8GBroKBBRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUV5h8bPila+ANK+zWZjuPEN0h+zwHkRDp5j+w7DufxoAp/HX4sQ+B7A6ZpDRzeI7lMop5W1Q/8tHHr6L369K+c/hj8Pda+J3iCaeWaZLDzS9/qUvzFmPJVc/ec/kO/YU74ZeB9X+Kni+4nvridrQSedqWoOcsSedin++e3oPwr7V0DR7DQNIttM0i2jtrK3XZHGg6e59Se570D2IPCnhzS/CuiQaVodqttZwjoOWdu7Me7Hua16qanqFtptq9xduVRVZgqqWd8AkhVHLHAPABNc8LXUPFcYfUlex8PXVqVfTZEKXUjMf8Alo6t8gwB8q8nccntQIm1PWrzULi90rwwn+nxxK5v7iFmtItxHAII3vtO7avHqRV/R9AtNNvLnUNpm1W7VFubtyS0m0YAAJOxep2jgEmtGytLexs4bWyhjgtoUEccUa7VRRwAB2FTE4HPSgArn/Gyy/2XazQRWUjwX1tKfteAqr5qhmBJADAE4PrVu98RaTZXtvZT38H224VmhtkbdJIADkqo5PQ/jxXG+N9Wv9X8HyXUegTDRlzNeRXxaG5ZI3Vl8tFyQSRuyxGAvIoFKSinJ7I9EmjSaJ4pVDRupVlPQg9RXmfw4Mvhnxfq/hCdy9sM3dmx/unGR+RH4g13XhbXLXxHoVrqliT5U65Kk5KN3U+4NcRpWdT+N+qTrwmnWSw/UnH+J/Kuet8UJLe56mWzVWhWi9YOPN801yv8bfM9MoooroPMGu6ojOxwqjJNfFeoyteajdS9WnmdvxZj/jX1/wCL7wWHhXV7onHlWsjD67TivkrwtaG+8SaTagZM11EmPqwqZHzuePmnTpr+tj7B0mAW2lWcAGPKhRPyUCrdFBOOT0qj6FKysfNvj0HWvind2yk4kuo7QEdQAFU4/M1jeObLV/C1u/hXUR5unLc/a7KcjqMEHb9c8jsfrVjTrW98S+OJxpk3k3s9xNcRSk42lSWHPboK6jxx4l/4SLwBfadrdutt4j0uaNnR1wXG4KWX8DyB9elebhZrmk31Z7vGeWzq4Km6b1ow1XWztq1293foenfCaXzfh1oTekG38iR/Sutr5u+H/iDxb4Y8PpqNnZtqfhzzGWSIHcYSD8xGOU9e4r3bwp4n0vxTpwvNJuBIBxJE3Dxn0Ydv5V6KZ8ngMXCrTjB6SSWj6+a7m3XGfGTQv+Ei+Gev2CqGmFs08P8Avx/OMfXbj8a7OkdQ6MrDKsMEe1M9A+fP2Ptaa48Pa5o8j5W1nS5iU9lkBz/48ufxr6Er5V/ZyP8AYHxt8SaEeFZLiBR/1zlyv/jua+qqBsKKKKBBRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFcp8SvG+neAvDUuq6j+8lJ8u2tlOGnkxwo9u5PYUAZfxh+JFj8PtB8w7LjWLkFbO0z94/wB9vRB39egr5F8OaN4g+Kfjoxec9xqF4/nXd3IMrDH3Y+gHRV+go2+Jviv47kdI2vNWvGycZEVtGOnP8KL+vuTX1l4E8L6J8J/DdrYrKs+q6jMsTTFSHu7gg4QYBIUYPsBknvQPY6vwX4Y03wf4dtdH0eLZbwjlj96Vz952Pck03UPEGNQh07SLaS/upTIrTRANBalRz5rZ4OSBtHzHPSq1lpOr6kbC98Q372s8W5nsNOlIt2yflDsRufA4PQE84ra0fSrDRdPjsdKtIbS0j+7FEuBnufcnuTyaBGXo/hwJcWep6/JFqevwRtGLvytixBiSVjTJCjnGfvEDk1pa7q9poelzX+oO6wR4GI0LuzE4CqoBJJJAAHrU2pX0Gn2j3Fy4VRhVBYAux4VVyeWJwAO5NYXhzTLi6u4/EWuQS2+rzW/lCzM/mR2ibidoA43kbdx55GAcCgBZG8R6sbxLbyNFs2jQ2tyy+dcFjgktEwCrxkYJJzWD8QNOi0fw1qOrXd5e6hd/ZBZiO4nbyHLYUsYlwuT1PFeh15Z8f77yvD+n2QPNxcbyPZB/iwrGvPkpuSO/K6CxGLp02rpvX0WrD4D39xeaVewTQ2629myxQNHEqFVOWKcDpnn8a9RdVdGRwGVhggjIIrgfgfY/ZPBCTsuGu53lz6gHaP8A0GvQKWHv7KPNuVm/s/rtRU0kk7WXlo/xPG54r/4T+IJ7u1glu/B18+6SOPk2rHv7fyIwOoFX/hXqFtq3jrxdqFnJ5lvcGN4mIwSvPY16nIiSRskiq6MMFWGQR7ivDT4PTU/ifr1hp99No0lvGtxbPaDaFyFyMDHHPalV0lD1/RnLl1KdChiVS1XLdLt78b2fY90qpqeo2el2j3Wo3UNtbp1eVgorxXxf/wAJJ4Sttuo/EEs7D91bpBunk/Dt9Sa8n1y41O5uFfW7m5muSM7biQs6j3B+79K25j57E5v7D3eR382v0uejfFL4pf29bTaPoKlNNf5Zrhxhph6KOy+/U+1cp8J/K/4WLofncr5xx/vbTj9cVi3+ky2OnadNOGFzfKZYoe4izhWP+8c49h713usaMPB3jfwMm0K4igaY+snmHf8A+hY+gpHjc9avWVer9lr8XofR9RXaGS1mRSQWRgCPpUtFWfaJ2dz50+CrCP4gW6OMsYZVGfXGf6GvT/il4Ig8SabJe2sYXVrdCUYD/XKP4G/oe1eV/D8/YfiraxnjF1PD+jivpAjIwelefg4KdJwl3PquIa9ShjYVqb1cV6bvR915Hj/7P2q2iaXfaM86i5M7TxRN1ZCoBx64I5FaPi/wDc2GoN4j8ByfYtVT5pbROIrgdSAOgJ9Oh9jXn3hPwtNqXiDxPZ6dcPa6zpdyZrOQNgcOwKn0z8vP9K9a8AeNDrLSaTrUf2PxBa/LLCw2+Zjqyj+Y/HpW8JuL9nU+T7/8E+YeDw+Y4RYnCx5Uviit4O+6/u9u2zLHw98aW/i2xlV4jaaranZdWjcFD0yM84z+XSuuryX4lWsvg/xZYeNtMT9w7C21GJRwyn+L8R+oWvVraeO5t4p4HDxSoHRh3BGQa6EcGGqybdKp8UfxXRnyxz4f/a7/ALiXd3+Ymh/xr6rr5U/aFH9h/Hfw5rA4Drazk/7kpU/pX1WORTOxhRRRQIKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAr4w/aO1241/4rz6bLIUs9NMdnCvUKWwXfHqSfyUV9nk4GT0r4F8R3R8T/Fu9nh+b7drISPHdfNCj9BQNH2h8O/Auj+BNEWw0eLMj4a4upB+8nb1Y+noOgqxMWl+IFvHLcWhhh05pYrZlBmEhk2tIDjhdvy8Hv0roq5vxSj2Goabrtvb2ji1Zob2aZtrRWjDLspzj5WVGI5yAcUCOkoqO3niuYI57eRJYZFDo6HKsp5BB7is7xFq66TYO0Yim1CVWWztGlVGuZQpIRcken5UAZcVt/wkHie5mv47K40zSZkFjtfey3IU+Y7gHAK7gACMjk+ldTWV4Y0xdJ0aGDyIobiQme5WIkqZ3O6QgkkkFicZ7YrVoAK+f/jrqsd54phtIJA62MG1wDnDsckfXG2vUviV4sTwtoTPEQ2o3GY7ZDzz3Yj0H88CvGdZ8Ly6dF4c/tIu2savcmScOclELLgH/aOST+VcGNnzR9nH5n1XDmGVOosVV0vdR89NX6Jfie++ELH+zfC2lWeMGK2QN/vYyf1JrXrP1fV9O0KxNxql5DaW6jAaRsZ9gOpPsK4dvGGv+KSYvA+lGG0JwdV1Bdkf1ROrf54rtSUUkfJYnFx9o3LWT1stWd1rGr6fo1m11qt5DaQL/HK2M+w9T7CvDte8STX3jhdZ8MPLYRahD9givryErEz/AN5f/HeT09K6+88M6B4aiGvePtUk1i/H3Wujld392KLv/npTf7P1v4iW0h1C0j0bw6Iz9jgkjBuGfHySH+6B6dwcc9azrRclputSsBjeTEezr6QmnFpaySkrXvsrb/I4G205pNfl03wzKdb8SMc3mt3BLRWvqY855H985P8AdqTwn4PsvEnio2VozXGi6Y++/wBQk63k3cA9lznA9Mk8kVYt77WNP0eXwFpmlLa67cXBhmuYhgPERy5PXp/F02+9dx4qitfhz8KJ7LTiBPIn2dZOjSSvwz/lk+2BRTkprmR5GMyp4KtKnX1jHW62a3Vu9929+h5/4ejXxz8ZmuVQHTrSTzVUD5RFFhUGPQnH51vftFRm31Dw3qA42O65+hVq1f2eND+x+HLrVpVxLfSbIyR/yzTj9Tn8hSftH2vmeE9PuAP9Vd7f++kb/Cr6HN7F/wBnzqS+KXvfierW8gmgjkHR1DfmKkrI8IXP2zwro9xnPmWkTf8AjorWJABJOAOpNWe/CXNFPufN8x/sr4xkkZCarnj0ds/+zV9I180R3EevfFeO4R1ENxqYZWY4G1W4/MKPzr6XrhwX27bXPqOJE17BS+Ll1/r7zx3w9nS/2gtats4W9gZx75VX/oa7Dx74Lj8QrHf6dJ9i1y2+aC5XjcR0ViP0PauN8SOtt+0LobqRmaBVbHqVkA/kK9krqlBTTjI+QyjEVMLUnKk7OMn9z6eh5voOpyeOfC+t+HNeiWHWbdDBOuMZP8Lgf7wH+TUvwP1aS+8Hf2fdE/a9Kma0kB6hRyv9R/wGqPjUf8Ir8RtH8RxjbZX/APol5jpnoCfwwf8AgNReHv8AinfjbrGnj5bXWYBdxDsXHJx+O+ooyesZbr+kducUoUq9HGUVaFRWt2fVfJrTyZ55+2RZFJvDGooPmKzwE+42sP619DeGL3+0vDWk3uc/abSKbP8AvID/AFryD9rqy8/4e6fdgZNtqCZPoHVl/niu1+BN99v+EnhqUtuZLXyT9UYr/StyDvaKKKBBRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAcp8VPEA8MfD7XNU3BZYrdkh56yN8qfqRXyJ+z7ov8AbXxY0SNyDHZs17Jk9dg4/wDHiK9J/a48W+bead4TtX+SHF5eYP8AEciNT+GW/EVw37MzMvxi0vb3t7gH6bKB9D7WpGUMpVgCpGCCMgilooEc7H4Ut7S4ibSr6/02zjhaFbG1dVtxnd8wQqcMC2QR6Cp9H8NWGmtbzN519fQK6pe3r+dOAxywDnoD6DArbooAKqarqFtpWnXF9fSCO3gQu7H09B79qi1rWdO0O0Nzq15Dawj+KRsE+wHUn2FeMeJ9ev8A4o61BofhdHi0yL97LNOCoYj+JgOw7DqT6VFSTitNx0p0vaKNRu27SV3b0/V2XdkuiXNvr/iCfxp4xuIrTSLZ9tnFM3DFegA/i29Tjqx9qoeLvEE/jTx7oI8Owy2uzAtri8jKq53Z8wL/AHeP0rvNA+G+heH4I77X7galPbJxNesBDCB/dQnAH1zXDa5r0mv/ABYsZ/Biw30sEXlQNLlIsgNk/QZz744rmdJwgk9W2rnZLMpYnEOdSTpQjGSjGOsrW0Wztfq1/wCBLc72z8C6RpjNrPjHUDq96nzNc6g4EMffCoeAPbmo7nx/catI1j4B0mXU5F+T7ZIvlWsX4n7304p9j8O21G6S/wDHGpS63djlbfJS2j9gg6/jXe21vDawJDbRRwwoMKkahVA9gK67Hh06M7WiuRffJ+r/AOHOK8OeBAmorrXiy7/tnXOqs4/c2/tGnTj1rS+IfiQ+HNCL2qedql04t7KEcl5W4Bx6Dr/+uunZgqlmICgZJPAFea+E1PjXxrc+KJwW0nTi1rpaHo7fxy/4f/Wo2KqRVGKpUvil/Tb/AK3MLxBoeo+DLTw54kkuJ7+9spCNRkdixYSHJAP90ZKj6isT41a4PFGv6Jo2jyCaEoki7ejSS4C/kuPzNe9anb213p9zBfIr2skbLKrdCuOa+bvAt/pOjeIn1y50u6utIhuGit7w5Jgb+EkDgnaa5pfup3+y/wAGepXwyzPB08BSklVjsnvKC1aX95PW3VH0ZoWmxaPo9lp1uP3VtEsQ98Dr+PWuN+Ott9o+HN6wGTBLFL/4+B/7NW9B418Nz2D3kesWnkou5svhh/wE85/CuA+IHxI0HV/Dt/pFlHd3DXMZQS7NiqeoPPJ5HpWk69OK1kEsnxeJpSoUqTva21raeZ2HwhuftXw50Rs5KRGI/wDAWK/0rlviv8QYIrSfRNDnElzIClxcIcrEvdQe7Hp7V5fpWta9Jo0PhzSZrhrbcx8m2Q73LHJBI5xz04qbRtAnh8c6Zo2pwoJTcR+dDkMAp+Yg446da4quLc1y01o9Ln0+T8PrBQjUxzXPGN+VO+y3ff8ALzLEHgzUl8FSeJVDxCKRXijA+YxDrL+BwR7ZNe8fD/xCviXwzbXhI+0qPKuFHaQdfz4P41vy28Utq9vJGpgdDGUxwVIxj8q8F0/UZ/hf4s1rT5g72M0LNDgZ3HBMTf8Asp/+tWkaf1WSts9H6nPXxn9sYeq5q06d5R/w9V8t/MzPEGqSXPxnt9W/5dI9UjtI3HQ+WVVsf99Z/GvpKvnTxnos2ifDPwnfTIwvRdtdTkjB3y/Pz/3yBX0NazLcW0M6fckQOPoRmu2J8HlvNGdRS3dpfec/8RdEGv8AhC/s1XM4TzofZ15H58j8a8l1XWjNpPgbxZkm5026+w3h74GOv1XP517/AF8/+LtK/s2+8X+HduLe8h/tSyHo6HcQPw3j8Kxqe5UUu+n+R9DUg8Vltagvih78fl8X6P5HZftH2Yvvg7rbLhvIEVwpH+zIv9DWT+ylei5+FgtyctaXs0WPQEhh/wChVs3U3/CU/AO8YndJLpEit/vohH81rz/9je9L6L4ksieI7iKYf8CQg/8AoNdBxU5qcFJdT6LooooKCiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAqpq+oW+k6Vd6heuEtrWJppGPZVGT/KrdeF/tX+Kv7M8H23h+3kxc6tJmUA8iBCCfzbaPzoA+XvFOt3HiXxHqWs3hPnXs7TYP8ACD91fwXA/CvSP2WoDL8W4JAMiGyncn0zhf615HX11+yt4QGj+DpfEF1Hi91c5jJHK26n5R/wI5b8qCme30UUUEkN5cwWdrLc3cqQwRKWeRzgKB3Jrz1vF+v+K5Hh8DaesNjuKnV74YT3MadW/wA8Vyvjrxjpev8AihtN1C5m/wCEc05/3sNuCz38wP3eP4Aff+mM/wAVfE++u7ZNL8PWjaTbBfLCR480gdhjhB9OfesJ14xfLu+yKo4Gvi4Ou37Ogt5vS/p89NE23sSeNtNsNHIt5r2XxJ4vuyIzLMd62wP91Oisegz068Vu+GNY0jwPpo0nSYn13xPP808NiN4D9lL9Aq9PzrwG88T6Zp18guvO1Fw+ZobWbYAP4gZcHLdegP1r6g+D2veD9d0Fm8Fwx23k7Vubdk2zRsRxvPfocHJBqadOTl7Se/TyNKteMaH1TL48tNu8pNe9N9NOiXTmd/Ir2fgzU/E9ymofEC53xA7odIt3Igi/3yPvH/Oe1ZNjbwQfHkQWkMcMFvZ7UjjUKqjy+wH1r12vJtI/efHzVD/ctj/6An+NFdaw9UdeS0IUliJLf2ctevQ9ZopsjeXGzkMQoJwoyT9K811Dxf4p1O0uLjRdGXRtMhVnk1DV/lIUdSIxz2966LnkVa8aW/4F/wCKep3M0Vl4W0dyNU1lvLZh/wAsYB99z+GR+ddfoemW2i6RaadYpst7aMRoPXHc+5PNeffBvSr29S48W6/M9zqN8PKt3kGCsAPUDtk9vQe9en0LuZYa9S9eStfbyX/B3OJ+MWtf2L4C1B0YrPdAWseDzl+v/ju6vMY/EM/hPwfp3hnSIFbU7qMXF27Rh9rS8qir3bbt69OK3/jBJ/b/AI78NeGVbMIb7RcAdlJ5P4IrH8ay/hdF/wAJD8T77VpFBig8ydR2GTtQfgP5Vy4mcrqEXqz1shoU6uKr42srwoxSS6OT1Dw78IdT1BVuNauE09G+by1UPL+PYfrXXad8ItCs0Ml7NdXzqCQrtsQ/gvP616XSMMqR6iqhhKUelzuxGf46u37/ACrstPx3/E8q+AN693pOrpLHApt7rYhjiVSFIzgkdRx3rn/Dn/Ez+O11N1WK4ncf8BXaKt/s93qx6h4msG+8JROPoGZT/SqvwXX7b8QdXvDziOV8/wC9IKzrJc1OK7/kY8M1p1MBiMRUk3Llau9Xq2j3WvJPjlBZXr2UEBk/tuCGS5VUXOYF+/k9sdR9DXrdebeDIk8S+NvFWuzASWif8Sq2yOCij5yPqf5101YKpFwfU8+hjqmCxNKpS3v+HX8NPmYPiHUW8ZfA+5uZTuvbBkM3qWQjLfipz+dd/wDDHUP7T8BaLcFssLcRN9U+X+leZ/DG2Kal4u8JXH3ZoZI1B9VJTP5MPyre/Z4vWfwxf6bLxLY3RG09gwz/ADDVnh5ucE3uPOsPHB5u1D4Zxuvz/U9WrzT41acyWWna/bpmbT5dsvHWJ+CD7Z4/GvS6pazp8OraTd2FyMxXETRt7ZHX8OtaVYc8HE3wOIWHrxqS1XXzT0a+48v+Bc6ah4N1rRScrDM6KD/zzkU4/UNXnH7IEht/E/iiwbg/Z42x7pIyn+ddR8FpJdF+IWo6RdArJNC8bL/00jb/AAz+dct+z/jTPj74q08cBlvIwP8AdnBH6UUZ88FI5Pqrwcp4V68jaXmt4v5xaZ9S0UUVoAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFfC3x38THxR8TdVuI332lm32K3wcjahIYj6tuP5V9vawLg6Teiy/4+vIfyf8Af2nb+uK/OI79zebnzMndnrnv+tA0aHh3SZde8QabpFv/AK2+uEtx7bjgn8Bk1+h+m2UOm6da2VogS3tolijX0VRgfyr43/Zh0saj8WLWZ13JYW0tzz/eICL/AOhGvtGgGY+o+IbKwu3tpY7151AISG0kk3Z9CFwfzrzL4meKtY1C0m06wtpbCB5I7YAuPPmmflY/lPyYHzEZz0BxmvT/ABPqUmm6YWtVD307i3tYz/FK3Az7Dkn2BritL0qC68a29oCJbPw3CZpp3/5a3svJZj6gc+2R6VjJOUuW+hvUqRo4fmhG05e6m3e3eS9Fte+voYHjK40z4e+G9P0nSra2k8SSQ7TdeWpkjB+9JnrkknH/ANauX+G3w9/4WBpMuoareXVto7yNGDA22W9wcN85+7GDkcfeOSTjFcZ4juNR8R+K1soZ/P1jXrk28Mw6RQkkNIB2AQcegya+ttB0q10PRbLS9PjEdpaQrDGo9FGPzopxu+cwaThCO8Vbl8l0fq1qu0Wtm5Hxf8e/Alt4E8YxW+lRPHpF5brLbhmLbWX5XXJ684P/AAKu/wD2OJcat4oi9YYH/VhXon7Tnhf+3/hzLfwR7rzSH+1pgcmPpIPy5/4DXlX7IE4TxtrkGf8AW6erD32yf/XrYOh9Y15P4c+b47a8eu23P8o69Yryjwr83xx8RkdoT/7Trnr7w9T1sr/h4j/A/wA0er15z8RppPEeu6d4LsXZUnxdak6H/VwKeF+rH+ld/f3UVjY3F3cNthgjaRz6ADJrhvhFZSXNhfeJ79T9v1uZpgT1SEHCKPbHP5Vu+x89iP3jVFdd/Rf57HeW0EdtbxQQIscMShEQDhQBgCpKKx/F+qronhjU9RY4NvAzr/vY4/XFM6JSUItvZHh7akL3xf478QswP2O3e1ts9i5ESkfgD+ddn8ANOEOg6hflebicRKf9lB/ix/KvI9Vs7jw/GtlIW3ahZW95cZ67iWbH6/pX0Z8N9P8A7M8EaRARhzCJX/3n+Y/zrjXv4j0X5npZanh8i5paSqzbfon/AJo6Wiiiuw88+WfAeuJ4e+IV1LM4S3ma4t5CegySVP8A30B+dd3+z1FuvdZnI5EUSfmWP9K57wfoGma1H46k1O382SwkkngcMVKsPM9Oo4HHtXW/s8L/AKHrbnqZIh/463+Ncc9a8PmdHDUJ08mxUns3G336noHj3WRoHhDVNRziSOEiL3dvlUfmRUHw30U6D4M0yzkH78x+dOe5kf5mz+ePwrA+IxOt+LPDHhhOYnmN/dj/AKZx9Afqc/pXotdfU82H7yvKXSOn6v8AQ8W1D/iQfHiCdspBfFeT0PmLt/8AQhVf4e6jDpPxo8Q6XbsrWt9LIAc8B1JfH6uK2Pj5priy0zWrfKy2svlMw6gHlT+DD9a5fT9HbQfCnhnxVLIk12+ri5uJVOf3cvykE/hz7k1y0vcqTh53+89PiDnrUMJjIL4U1J9uXS3q07/I+gaKAcjI6UV1nMeMeJX07SfjrpdxvZTMqtMB8oV2BQHPcHjNee+BD9g/ay1aEnAlurxf++k3iu3+MGkteeOnaHInXRzcxkdcxuSf0zXluiak037Sujamw2m/nhc+5eHY3/jwNc9P3akod9f8zslN4rCxxEt4twfyScb/AC0+R9iUUUV0HGFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABXwh8b/D/APwjfxP1uzjTZbTyfa4AOmyT5sD6NuH4V9318t/th2Eceu+HNQXAlmglgb1IVgR/6EaBopfsgJnxvrrY5XT1H5yCvqXVNTs9KtxPqFwkERO0FuSx9AByT7Cvl79j3/kcfEH/AF4J/wCjK+i/F+oahp1nJPbGyt7WOMu1zcEu4bsqRjGWPGMnv0qZy5Vc2oU/a1FDv52/z/JnPXPiNJrnVPEV5bSw6focZitYpl2vLO4GTt7HBVQOvzGsDxDdv4S+HqWNzME13WzJc30ueYw3zSt+C4Qe9SWe26e3t9Vm/wCJXoJOo6zcN0nvT8wj99pOSPXArwv4x+NpNZmvpWdheXoCRwD/AJdrYfdB/wBpvT6nuKyjdR83/X4HPiXDFYpxj/Dhpp2W9n3k9F83sj0z9nrw7Jrfie88cXMBi06GM2Olow5YdHkHt1X8/SvoasHwDp40rwRoNiqhfIsYUIAxg7Bn9a3q2S5VZFzm5ycmV9RhS50+6glQPHJEyMpGQQQQRXx3+y/eJYfF5LYkKtzbXFuo91IYD8lNfZbDKkeoxXwL4Cvv7G+K+j3RO1YdWCt/umQqf0Y0xI++68o8JcfHDxLn/nif/ader15P4Y4+OfiHPeA/yjrnr/FD1PWyz+HiP8D/ADRt/GO7lPhy20W0JF3rVylmoHXYTlz+XH412un2kVhYW9pbrthgjWNB7AYFcHJ/xPvjLGn3rXQLPcfTz5en4hf5V6JW6PnqHv1J1Pkvl/wbhXnnxedr+LQvDkR+fVr5BIP+mSfM39Pyrv7hHkt5UikMcjKQrgZ2nHBryL4fNquu/EJpfEGWufD1q1oXI+/K7H5/qVz+lS5a8ppiqfNQ0a1ajbrZ3bf3J/gYfxat49S+JVjptqvzmKC2YD3Y4H4A171DGsMSRoMIihVHoBXz/o1/FqnxtS6m+eOS+kWP/gKME/8AQRX0HXPhfec6nd/kfR5y1RhQwi+xG79ZasKKK5vV/Eb6V4s0rTLq3VbHUEZY7rd0mHRCPcfzrplJR1Z49KjOs3GCu7N/dqzy34bLul+JMZ6lZf8A2pXD+Etc1Dw1qllqsEsy6atwkd1GrfI4IPBHc7ckfSu5+Gxxe/Ekn+7L/OSsTwfpkWp/Dbxkkq5MKQzxnuroGIP8xXJP+ND5iy6m58OYhxdnGSa9VI9K+Hbr4g8Y+JfFAO+2LjT7J+xjTliPqcGvRq4v4OxQx/DjRjAgUPGzv7sXOTXaV2LY4sIrUYye71+/U5n4kxWc3gnVY9QnjgiMXyySHADjlf1wK8p8K3UWufCXX/D8kq/bbdHuLeMn5iow+R9CD+ddx8ejj4dXPvPF/wChV49oljLaXWrS27st5pMIuU/20DKHU+xV648RL2dSM16H0GVw/tGhictm7K0ZJ+bvH7tj6L8FakNX8JaRf5y09sjN/vYw36g1tV5v8Cb4T+EJ7Ik5sbqSMA9kb5l/ma9IrsTurnhYeTlTi5b9fXqedeMolX4p+E2kGY7u2urVvcFen6186X0J0rx74L1E/KYdUFrIT2KSrj9Gr6P+KJ+y634L1I8JBqgiY+gkXH9K+f8A48Wps5tchQbXt9XW5iI/hEiMf57awnpUi/Vfh/wD0Mt96hi6XZxl+Sf5n2DRWN4M1Qa14R0bUwc/a7OKYn3Kgn9c1s10HKFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABXy/+2M+dW8MJnpDO36rX1BXyh+2BciTxnoVsDkxWLOR6bpP/ALGgaL/7IsMVoPFutXTrHBBHFE0jdABuc/0rrPEt9qXigW2qssjC4naPQtLA/wBaVBzcSD0A5HvgdOud+zpp+mQ/BjXbzXUDafc3cjTKSRuRFUAce4NdX4FmuNY8W6d4huIhZ2c9pNDZWmcrDbx7Bn6lifwFYVVzSSex10qsqdNqjpUldc3aKV5W83tfpddzg/EvjKCw8GR6XaQJHpEas16s43XM0obJ35GFZn9Mn3FeGeHbW48W+PNMtpsNPqN9GHx0Clhn8Ao/IV6J+0XrmmahruNHCeXdOJndOBIEG0Pj3bPPfaD3qz+yh4dOp+PLnWZUzbaVAQpI486TKj8l3H8RToxduaW48V7KFqdBWiknb1W1+ttrvrfa9j67RQiBVGFAwAOwpaKK2OIK/OnW3Nl4q1CROGg1CRh7bZSf6V+i1fnh49h8rxn4jh/u39wv/kRqBo/QiwuBd2FtcL0mjWQfiAa8p0idLT43+IJpjtjS0Z2J7AKhP8q7f4Y3v9ofDvw3dE5MlhDk+4QD+leOfEW8msfiH4ghtFJudQgWzjx6yKg/kDXPiN4ep6OBqKlRxM30py/NHpPwbhkudH1HX7lSLjWbyS55/wCeYJVR+hr0CqOhafHpOi2OnwgCO2hSIe+BjNXq3R4+Hp+zpxi9/wBeo2R1jjZ3OFUEk+grwjwJ4hvNPvtX1K5kH2XWLe71FQVGd8bELz16AjFet+PL3+zvBmtXWcGO0kwfcjA/U14l44sX0rwf4KRCUd7B0fHcPtYj/wAeNYYmThDmXQ9HKKEMVmUKE1pyy+/o/wAGZPw/t5f+Et8O3rE7X1Dyvq2wsf519Q14J4bsvsdp8OpD9661Wec/TbtH6LXvdLCR5aSQ81r+2zPES7SS+6KQVg+NPDy+JNEa0WUQXUbrNbz4z5cinIP9K3qK6JRUlZnPRqzozVSDs1qeA/Dp3ii+JDTyLJKsMgdwMbm/eZOPc1e+EVv5/gfxghGfMiKf+Qm/xridO/tCBvFmr2B3W3nSWd0n+xKWw34ED869P+BFv5vhPWAektwU/wDIYH9a4m74iK7JnflVK3DtSd788vu956fr8zY+Bc3nfDfTgf8Alm8if+Pk/wBa7+vMv2fZP+KJuID1gvZVPt0Nem12rY8LAu+Hg/JHnvx4Qt8Obwj+GaI/+PCvK9Nu42v/ABbeAjyv7LkHPcsI1H617P8AFu0N58O9bjUZZIfNH/AWDfyBrwfw9YNrPibTLGN9kV+sPm84DIACw9/uVxYy/u27n0PDbgsdXU3a9NP5RlqeofDCFtF8a6jpb5UXel2l6FP94IFb9TXq9eeeJQNM+LXhS8A2xXlvNYsR6gblH54r0OuyKsrHg0p806l/5m/v1/U4f40WrXHw/v5ov9bZvHdIfQowP8s14r+0BCL17y+iX5L7TIL5cd9pBP6A19IeJrIaj4d1OzIz59tIgHuVOP1rwDW4Rq/grwZLId3nWs+mSZ7EZVRWOI0Sl2aPRyn/AH2dL/n5Tkvmtf8AI9E/Zv1D7f8ACDRQTlrYy2x/4DI2P0Ir02vCP2Qbxn8DatYP9601A5HpuRf6qa93roOUKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACvkL4xabffED9oGbQtH2GaOOK13ufljCrvdj7Dd/Svra/u4bCxuLy5bZBbxtLI3oqjJP5CvjP4SfEKw0j4u3/iTxGWS31Tzw8wUt5JkcMCQOcYG3igaPqfwr4E0nQfA1t4XZDe2MYPmGbrK5bcWOOnJ4HbivPPjB4t0fw7o/wBm0zagt4GsU8p8F1OMxJ7fKNzfgO+Mr4y/HXTodKXTfA93HfXlxhpbxCwjgQHOARgljjt0FfNWtavd6zdCe9ZSVGFRBtVB7ColFy0NIcq96T26dH6vt3VtdiHVL+bUr6S7uTmR8AKo4UDhVA9AOK+3PgT4OPg34fWVtcx7NRu/9Lu/UOwGF/4CuB9c18+fs3fD1vFPiZdc1GEnRtKkDLuHE845VfcLwT+Ar7Gq0raESk5O73CiiigkK+AfivF5PxO8VR44GpTH82z/AFr7+r4R+Otubb4ueJ0IxuuRJ/30in+tA0fUfwC1BB8FNCubh9sVtbyK7HsqOwP6CvP/AAR5vjH4uJqFyCY43e9YHkKq8Rr+Hy1T8E601j+zdZ2sbYmu7ye1UDrt8ws36cfjXdfArSBZ6h4jnYfvIpI7PPoyrucfmR+Vc0nz1lHotfmddaKpYBd6s0v+3Ye8/vaSPXaKKK6TjOD+NkrDwHPaxn95ezw2yj13OP8ACuR+Pvk21r4ftI1HmxJJg+igKAPzFdT8Uf8AS9b8F6Z2n1QTMPaNc/1rifi2/wDanxN03Ttw2RiGI88De+T+mK5MY/3bXeyPT4YhzZpKo9oL9H/mdDrVn/Z918LrTGDFPtP18sZ/WvVq8++IgC+L/AIHAF+4H/fAr0GumKsrHjRm6lerN9Xf8EFIwJUheGxxS0ydvLhkf+6pP6VRszwLw1ZvZfCjxpeSurNdXZiGO+1wCfzY13PwGj2+C5X/AL95IfyCj+lcbE/l/ASV/wDn6v3P1zMf/ia774KReX8P7Q/89JZX/wDHz/hXHviF6HqZfFU+Hlb7U/0uZHwM/cjxVZnjyNTfj8x/SvUq8t+Fn+j+PvHtp0/0tZQPqX/xFepV1rY+fwGlBLtdfiyhr9uLvQtRtyM+dbSR4+qkV8z+Ebg2WpeEb8nAE3lsfpIVP6NX1FcukdtK8pxGqFmPoAOa+VwgHgXTryMjMep3CoemRtRh+o/WubF/w79j2cka/tanTf24zi/uT/Q9r+MgNrp+haunD6dqkMhPorHB/pXoIIIBByDXCeNJoPFXwk1G5smEiS2nnpjqHTDEfUFSK6XwhfDUvC2k3oOfOtY3P12jP610Jp6o8rkdLFTpyVnZferp/oa9fPUkXlfC5pVHz6Vr8nH91d2MfqK+ha8RktgfCnxNsMf8e+pNOo9ASG/pWeIV6b9DtwE/Z5lhp+dvvsY37Mzix8cfEDSVOEW4WZB7b3H8iK+h6+Vv2d9Rb/hd+upIcG7s5OPUoyH+Wa+qa0i+ZJhWh7OpKHZtfcFFFFUZBRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFAHjn7Ufig6H8Pf7MgZlutZkNuCO0S4aQ5+mB/wKvjn6V+iHi7wzpXi3RJtK121W5tJOR2ZG7Mp6hh6183eJf2adZgunbw3q9pd2hPypeAxyKPQkAg/Xj6UDR4BXa/C34e6p8QdcFrZK0GmwsDeXpX5Yl/uj1c9h+J4r1fwf8As03TXKS+LtWhW2U5NtYZLP7F2A2/gD+FfRnh/RNO8PaVBpui2kVnZQjCRRjA+p9SfU80Bcb4a0PT/Deh2mk6RAILK2TYijqfUk9yTyTWnRRQIKKKKACvij9phQvxi1bAHzQW7H/v2B/Svtevi39qAbfi9fn1tLc/+OmgaOi+EcJ1ay8EaO4zClxPdOD0IMpb+SD869w+C/73w9qd4fvXeqXMpPr82P6V5B8C9Eg1prcTvNEtlYLNHJC+10cMMEH869h+Bw/4t5ZuerzTOfxc1y4e7lKT6v8ALQ7s65YVMLQT+GDbXm7P8b/gd9RRRXUcB57r3+mfGXw3bnlbOxnuSPQsdo/kK8b8Z6zaX3jHV5jJL/aEs7PZbSNuyEgHd35A4x6GvYtTvxaeOvFGpE4/s3RY0B9GZncfyFfJtzqJ/wCFg2TM2VidYT/wIHd/6FXHiI+0koeTf6I9bh+r9UhVxX804x+V/e/CNj6n8T3y6nq3w0vl6XFyZPxMYJr0+vC9FuTPp/wxDHmDUZoCfpnH6Yr3SuilLmipdzya1H2GNxFJdJW/BBVTWJPK0i+k/uQO35Kat1jeNJfI8Ia1L022cp/8cNaEVHaDZ4vq0v2b4E+Gbfvczl/r8zt/UV6B8ENSju/BUdqoCy2UrROPUE7gfxB/SvK/iRcNZ/CzwpChw0WlS3I9iVVQfzarn7OXiVri6s1nky17bNazZ7zQ9GPuUI/OuFXVb2nTRf18z6DC8ksnpYS3vcvOvk2rfcm/kdv4P/0f43eL4Ogmt45gP++P/iq9Sry2A/Zv2hLgDgXWmD8cY/8Aia9SrtR8tgtIzXaT/O5X1BPMsLlP70TD8wa+VvEeoHTfhx4eeyVEmhgurokqGBkMm3cQeDwvevq+QbkYeoIr438YMx8FmL/nhazL9P35/wAawxGqS7tfmerlnu472i3VOo/wX+Z2nwO8d2sWj3Gm67ceVZX8TgOUZljlAw2cA7Qw559K9S+BerW194Et7SG6hnlsZZYCI5Ax2hyVPHbBFfLPwe1eTTfEUG1sCKeO4X2wwDfmDX0j4P8ADmi3fjHxlpuq6XZ3EkV4t3A8kQLosi5+V+o7dDRR92Th2/UrNX7Sph8Y96icX6rr87JnrNeULb58V/EvTyOLmzjuFH/bMg/rXXjwgLXnRtd1zTvRPtX2pPptnD4HsMe2K4OS38Sad8WrqBJtN1Se/wBIx++VrQMqtjGV8wbvfAHsK2mrqx585ezq0qnaS/U8c+D1x9h+P+mEnAuVkjPvuhJ/mtfY9fDmj3r6P8YPDl7eQSReTdxK6RgysRuKnaF5Y4PQDJ9K+w7Lxn4dvJxbpq1tDdHpb3RNvMf+2cgVv0qKH8OPoepmiSxlW38zf3u50FFAIIBByD0IorU4AooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAK+Mv2pxj4tXB9bGA/+hV9m18b/ALVq4+KhPrp8J/V6Bo9A/Z3Ih0/VJTwE0tT/ADNeo/BWPZ8NdHyPvq7fm7V498I7n7F4J8T3A+8mjqB9SCP617r8OLX7H4D0KH0tI2/76G7+tc2F+D5v8zszzXM0u0I/io/5HR0UUV0nEeIeOr8xWnjufdg3WoW2ng+0cYZv0Jr5USVrvXklBO6W6Ugj3fivfPiZfFfClzPuP+l6lqF19dpESn9DXidpp/2O58KXLjAvnEvPos+z+lc9P3qkn6L9Ttg/Z5dQivtOc/vdl+TPofw4dul+DGP/ACz8Run5ha+g6+etLOzwxoEn/PLxUOfrtr6Fp4b+FEyzL/kaYn/EvyCuX+KMvk/DzxA3/To6/mMf1rqK4n4zyeX8NdZ9XVEH4yKK2exwYl2ozfk/yPFfjTIsHhaCFjj7NoFrEB/tSSL/AEWuI+FNxf8AhrXp7bULae0ubKW31HypVKsEyFY49Cjg/hXefEi2XVfHmjaGeY7q/wBOtXH+wkYdh/Ouk+OemRWvxB8PakqhRqWn3mmykDqyp5kef1/Kubl5qc/V/h/wx9BTmqOIw8XsowT9JLX/ANKZ0mvEW/x48OTg/Lc2Lpn14f8A+tXqdeAQWstj4m+HF+19Pc292qiNJuTDkAMobqVy3Gele/1vTlzK54EaSoYivRTvaX6IK+Rdd0i3u7K7E8Eby+VqEcbleVZGZhg19dV8y6pFtjkOOF1jUbc/RlB/rWeIdop9mvzO/LkpY2MH9qNRf+S3/Q8k0jR1h0fwxqbK4XU/tkRKsVy0ZUryD719E6HoVsPiPYC31DWIItV0SO5Ei6jM7l1IyCzsxIx2OQO1eUx2wk+AXgrUVHOna3LA/sJCwP67a9P8O6rby6n8ObiKdGuLfztNuUB+ZCV+XI9DxzSbtWt3X6lYqPNlsaqWsKiv6SSWvkenf8IxeJ/x7+K/EEPp81vLx6fvIW/xrhfEml6xp/xQ8LOviKeWa5gnt0uLi0hJXAzgqiqDnP8AhivX689+KP8Ao+v+Cb7tFqgiJ9nH/wBat2eXi3anzdmvzR8u/EOC80X4g20k9xFJPbagQsixFACsoOSNx474zX1vd2vie7tzDe2vhjUoG6pKJUVh64Icfh+tfMf7SVsbXxdfSDgrdeYP+BIrV9d6FN9p0TT5zz5tvG/5qDWWH+C3Zv8AM9vNV/tHMvtRi/vijgD4V1G2Jex8M2Omv1B0XxBPbr75jEKIfoQRQZfH+n82dvfXiD/lneCznyPQMskB/E5/GvTaK2PNPObXxv4st5Qms/D7VAnTzbG4hmP4pu4/BiPeun0XxRb6rcpb/wBna1ZTspbbeabNGox1Bk2lAf8AgXPbNb9FAHF+PEuLjXPDtrbwvcCU3G6EXb2ytiMYJdOeD7VkrqHibS7TUYJtThuG0e1tY5W+zby7ugEkpYnJC8vjGTt5PNdh4p8R2Xh3T57i63yTJBLOkEaM7OEGSflB2ryAWPAyM0xfFGnqs32hnjeOdbcRopmd2MKS8IgLcLIM8cAZ6c0Aci/iqdJbeB/ENumlSai9qust5I8yMWvm8MR5ZIkyu4LjjGMg1Th8YeIJbjT1uZ7Gwc21tKi3TrAt7vYhyFZSxyAMKhBUsM5yBXT6v4n0BZ9OvrgSXKRfZbi0ngy/F15kSPtBzjarckd+MkVsy+IdPS5Nt5kouCrGNXgkRZCELlVcrtLbQTgEkAHjg0AU/Bl3qOow395qF3HJD9uu7aCFIdnlpDcyxAlsncSEHp9OpPHweNbxY7m4Ooi82RX5ura2jjLWQilKRP7E9w5weowFNd/Za1DP4bs9YmjljhuLeKfy0RpXXzACFAUEscsBwKzrDXfDel2dlb2t5HBHdyTNBC2/e7iX96NrfMGDvyp5GegA4AOLs/EF9f3+mLcXkF39i1uRIriGZZQ6HS7iTDMiIrEMT0UDgDnGTIfEWvx6PLetqu9otFttZ2fZ4wC7l90XT/V4Uf7Wf4u1dhYeNtFvNFtNTEs8UNypZI3t3MgCgFiVUE7VDDLfdGRk1Pe+LdGtpJ4UvYJrmFVd4Y3GQrbSpJ6AEMCDnntQBx154yvo/EtxDaXcbQbryBrWd4/NiaGJ2VxGqblUmPgu53KwIUZBrufCr302g2lxql1Hc3NxGsxaOHylXcoO0DJ4HPU0yTxPo0U9xFLfxx/Z1kaR3Vlj/d/6wByNrFf4gCSO+KvaZqFvqVuZrUy7AxQiWF4mUjsVcAjqO1AFuiiigAooooAKKKKACiiigAooooAKKKKACiiigAr48/ayU/8AC0YeOumxY/77kr7Dr5C/aqx/wtiwz0+wQZ/7+vQNanQ+DYGtfht4y7iOyt4c+5avovw2nl+HdLQfw2sQ/wDHBXguilB8IfGhDKZGmjBGeQMrg4/Ovf8ARRjR7AekEf8A6CK5sJ/DT/rc7M7/AORtUXaMV+BcqG9mFtZzzN92ONnP0AzU1c98Q7o2XgbXZgcMLSRV+rDaP1NdJ59SXJBy7I+Z/iuzQeAdBRvvyacZ2+sszNXJfEO1bTPC3wzmA2t/ZbS/j55f/wBmrsv2iV+x2VjZAY+zadaw49wCaZ+0jpv9neF/hzGF2+VppgP1VI81hQ3l6/5HpYqPs6GGp9qa/Ns6vS5d/wAObK47r4jgk/NRX0ZXzVozf8Wjkf8A556xbP8AotfStLDfw0ZZrpmuI/7d/IK4D43n/ihmiHWa7t4//IgP9K7+vP8A4yHfpWg2w6z6xbLj8TW72PLxr/cT9DzeOIX37Q+lRYysF9dzf9+4Ng/VqtftV3xsZ/BEoOAl7K5+m1VP6Mar+AT9r/aFuJDz5VvfSj6tKi/0qh+2S+B4UX0Ny36R1lRV6frf8z28wfJinb7PL+CSNbV5x/wiXw1vVP8Ax73vlE+nzj/4mvf6+Z/tP2j4K6XOT+8stXRsdwGUn+tfSsD+ZDG/95Qf0ooO8F6Hn4yPJmeJXdp/fcfXzn4gj2Wett/zw8Tv+Tx//Wr6Mr5/8Ux/6L46AH+o1y3m/wC+lx/WpxP8NnRlrtmeG85NfemjlPBkH9o/sx+K7ZV3S6bqElyvtsaOT+QatrTI7VfAuk6/HGovtN1mMNKvBMTENg+vJpf2c4F1Lwj8RdFYA+ZPIoU/7cbL/Ss3R4NRPhDVfD1jEXgWIahLcSDgxQKQce7OuPwNFT+JB+pVWTjlmKh25fvu1b+ux9RDmuB+MNl9s0nRR5zwbdVgHmr1QtuUN+BIrstGuFu9HsbhPuywI4/FQa5v4srjwPeTgZNrJDcj/gEqk/oDW72PLxNp0JPyv+p83/tCzSahvu7lAl35ca3CDosqF4nx7ZXP0Ir6j8Bzef4I8Py/3rCA/wDkNa+ffi/oAmvNdjabztsC3Ej7cZeZnYYHbHFe5fCOXz/hh4WkznOnQ/8AoArnw8tZx8z3cwpyVHD1JbuEU/VL/Jo62iiiuk8sKKKKAOZ8VeGp9Zlnls7+O0e4sJdOm8y3MwMb91wy4YHPPIOenSsm/wDDd/pGonVtHM15evcmTy0hjKqhtYIWBDzR9TbqwYHjdjaRk13lFAHAaX4EuYNG06N9QjivrbTtKteITJGslm7vk/MpZWMhGPlIxnPOBYk8DTTeIIdTudRt5XiuZbkO1mTNiSCSLy/MMhxGDJkKFHCgHJ+au3ooA5u68NSSeENO0SG/8trNIEMrREpMIwAVdAwJVscru/McGt4Y8HDQ76zuRdQsLdL5PKgtvJj/ANJmil+UbjtC+VgDnO7tjnraKAOCPgB/smmRNfWc76dFJaw/abFnjaBthAdRKCXBQfMCAQSNvQjRbwcp0vVrJLuONb825HlwbViEUcaYC7uh8v1GM45xXWUUAcPD4Cjgnu/LfTJYJmuHQXWnmWRTNuLKzeYAy5dhjaCV4z1J3vCeiy6FYT2816115k5lUYcJCCqjYgd3YL8pbBY8scYGANqigAooooAKKKKACiiigAooooAKKKKACiiigAooooAK+Q/2rwB8UtPPrp8X/o16+vK+RP2sht+J+nN66dH/AOjXoZUd0dFpdhYXHwz8S3vmsmp2xAKJJjfExTG9e4znHoa+jdFOdGsD6wR/+givnzQ9Jsr34VeJb94v9OtGPlyqxB2lUJU46jvg96998Mv5nhvSXH8VpE35oK5cGrU0d2fyTzepq37q36avby1NKuN+K5MvhiGwX72oX1ta49Q0gJ/QV2VcZ40/0nxd4Nseo+1y3bD2jjOP1YV0s8fFa0nHvp97seD/ALSCfbvHC2Scma4tLcAe4H+Nbv7YkKx6F4VK4HlzTIB7bF/wrO8axjWvjxo0CYZDrcYP0iTJ/wDQat/tlT/uvC0Gf4riT9EFY4fZvzf5nt5rpUhDtCK/8lv+pmaTcXq/C6+iSzElgbq2d7gPhoXG3AK9wRxkd6+pLdt8Ebf3lB/Svm/QBv8Ag34s7lJbZ/1SvonS236ZZt/ehQ/+OipwqtTRz5xJPNatlb3YfPctV598Uf3mt+CLfs+ro5H+6P8A69eg15749PnfELwJb9cXE0p/BB/hXQzysZ/Ct3a/NHmXw1l8n9oi7hbhpLO7X8RMDVf9spT/AMUq3bF0M+/7urOmxNZftNWdwBiKee9ts++zfitf9rzSxc+BdM1ID57K9CE/7MikH9QtZ0PgR7WZ/wC9Sfez+9JnMNoUM/wt1fV7aSVDb3UcYVG/dyxgIBkeoLEg19G+HZvtPh/TJv8AnpbRt+aivGfC8K3P7PGsIgBK73P4bD/IV6l8NZ/tPgHQZM5/0RF/IY/pU4dJQXmcmaTbzWpF9Ipfczpa+fPGeqWFlffEmxvbhYJpZ7SaISAhWIGThsYz+NfQdeM69Du174nQY/1lhby4+imqrK8GvJkYeXJjcNJdJr9TkP2V7lP+Ez8bWqsGSQRzKQcg/M4z+orsfDkCxXek2sg2+YdQ0O5H+1uaRP0J/OvKfgPpthqXxe1mx1CEtFJZu8eyRomRgyHKspBHBPQ1v+JbfUPC3jPWhY3+pLZWWowXYMji4AZowyljJlySC4zu5xzmsanwxn6foe1h1+9r4Z9eb8OZdfW/yPcPhbcNceANG3nMkUXkP7FCUP8AKrPxGi87wHr6YzmylI/BSa4H4S33i2PQr2JLLSbsw3kjSQSyvayKZMScYV1x8/A4+tdP4l8RXI8Papb6r4b1m18y1lXzYo0uouVPOYmZgPqorq6HzFL38Mku1vwPGvifq4t49WZ8lrqxspAf9lYc/wAyK9i+BEvm/CDwq3pZqv5Ej+lfNXjLUV8Q6bHbtPAt3FZW8YAO0uEUFflPOcEA+4r6H/Zyk8z4OeH89UWVPpiVhXNh1aU773PoMfV9rhsNKO3Ivvsk18rI9KooorqPKCiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAr5D/a44+JGnn/AKhif+jHr68r5F/a6/5KLpv/AGDF/wDRj0AjsfhrKb34W+MkAyjWaTD6+W2f/Qa9r8Ay+d4J0J/Wyi/RQK8R+BjrP8PvE8GQS+lg4+kcgr2L4Vv5nw70Bv8Ap1UflkVz4bSCXr+Z1Zy3LNHN/ahF/gv8zqq858Uasln8YvC0EmNj2s0eT/C0hwD+JTH416NXkvjixudU8Xa9Jp8Rl1DTbCzntlHXeszPgfUZrdnk41yUFy73X4a/oeceBh/aX7RGnu3KxC9ufxJYA/yqP9siT/ideG488LbTt+bL/hVv4HRm7+NdzcEf6nSnf6F5B/jWd+2R/wAjH4ePb7FL/wChiscN/Cie/nDvjai7afckjW8K3Vv/AMK28YaZLIqXkltHcRxHjcqAbsfTivoLwxJ53hvSpM53WsR/8cFeF+GdHstV8J+MxPAHe0hE9u4OCjCJuhHb1HQ17N8PZfO8DaDJ62cX/oIqcLfk18/zMc65P7Sbju4Rv9y2+86GvPvEYEnxi8JIekdpcyD67SK9Brz/AFrn40+HB6adcH9a6GeTivhj/ij+Z5vq93DB8YdGyf8ASH8UOq/7ht2Vv1YV3/7RVl9u+D3iAYy0MaTj/gLqf5ZrxTxBcTTfHzw64RvIbXmZG7M3mKCB9Bj86+kPiTZjUPh94jtSM+Zp84H1CEj+VZ0PgXz/ADPYzPTEtdlH8Io8O+HOpalZeAtTsWtGu9MmsEkmWMZlh82L5ZAP4k459Otd18HfC3h7VPANhcXGlWpuleRHlQFGYhz1K4PQiuR+Ds72D6VdX8oW01HSJIm3dEWFR/RT+ddz+z1Nv8F3Uag+XHfSbD6ghTWWGej9WZ54uTH0tFeUNbdWrLX0aZ1X/CE6Qv8AqJdYtyOnk6xdoPbgS4P4g15rf+GseOvGNpBq2rxr/Y6y5Nx5jSfL91i4Ykfr717hXl97NFD8ZNUtpXCvf6J5UQP8bA5x9cA/lXRPVHnVJ8lSlL+8v1PCPg1aXjfGyO3stRltZ3tJG+0eWjkjYDgqRgjgeh966z4wXOt+HfiLFaNqcF3/AG3p6rNI9ngYikJUlVcZI9RjjjHes74Hwf8AF942x93TJW/9BWum/aQheH4geDryMfMbe5jX6gqw/nXOnfD3fb9D6Jx5M3cF1nb5NnXeFLjxGnjPXlsptCvDewW1/u2ywxyAqUyvLkdBnOa6fWLvxYuk3qz6LoskZgkDPDqsgbG087WgA/8AHq5nRr+y0jx54UgRwBf6GISexYsXXPuSHrsfiPrC6L4P1CbaXnljaCGNerOyn+QyT7A10Rd1dnzcpQpe1j0i5f5nz1psF9NBFJqugSXMd/osghUSRHCRKoVwHYdNm71weK6L4LxWR8ISFdI8SxXEN7PH9p0udkUfNuCsiSYYgN3UjpzVXxXrAtPBPhG9DrFJFptxaTDuqjCNx7gfrXVfso3LXXw/1WV+raxM2PTMUR/rXPSv7WR7U1COV4Zp6tXt99/PXTqbg1rUbDm11vXyo6JrHhmedcf78EcePqxP40D4mTWRxqdnYzIP4re5eCQ+3l3CRgH23mvTaK6jzTzuw+Mngq5dY7jVkspScYmwyg+hkjLR/wDj1dppGt6VrMZk0jUrK+QDJa2nWQD/AL5Jqzc2dtdDF1bwzAjGJEDcenNZyeF9AS7iuk0PS1uonEkcwtIw6MOjBsZB96AMTV/GUmn+I59P8i0eKGa1h2G4K3EpmIGY0x823OSM9AemKt2/jSxu442srLU7h5mZYY1t9hlCZ3su8gFVxyc85AGcitaDS7Sy1TUNVLETXKoZWkI2oEXHBxwMdcmsyHwxZfYNOi07ULu3ksQ5guoGjaTbJywO5CpU8H7vYGgBp8baWfLeFLqa2aK3ne4SLCQxzkiNnyQeSOcAlepwMmoH+IOhI1+Wlk8q0guLjzBtYSrBnzdoDbsjBxuA3dRkc1Xg8EQx6rLH9rli0cWtnCllGynzRAzn96WQtjJX7rDPOfe1J4HsW0/UtPW9vo9OvoZ4Gtk8rEYmDBtrGPfxuYgFiB6YAAANabXba30C41i5hu4LSBGkdZYGSTavfYeeeoB5qhceL7S3tLuaazu45bWZYZ4JWhjZNy71cs0gTaR33deOoIFrxTYt4h8I6jZabcQlr22aOGbdlORwcgHj8DVF/Blu9yl4+paidTW4+0fbT5JkJ8vywu3y9gAXphQc5OeTkArw+ObSS6kkjR5tNksrC5tWiQmSV7qWdFXBPH+qT0xk5q7YeL7O8uYoBZ38LSPNCpljUDzot2+LhjlgFY5HynHDGobPwPptolssc943kRWUSlnU5FrLJJGT8vUmRt3qAMY6mS88GaZeWrW1xJdNC813OwEgXJuFkWQZAyBiRsY5HHJoArwePtIlgnbZdedDPHbPbxKs8m+QHYB5TMOdp75GOcV1cEnnQRybHTeobY4wy5HQjsa5q18GWkN0tzNf39zOslvIGk8pQPJ37AFSNQB+8OcD06V1FABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAV8j/ALXKlviJpQH3m00D/wAiNX1xXyT+11lPiHpD9hpwP5SNQNHafC2zfS5fszqixaloUghCjHCZX8zgn8a9P+Db7/hrof8AsxMv5O1ee+Fb6G+tfh1cWhDzGO6s5VXrs2Zz+oP413PwQbd8N9NH91pV/wDHzXLhXo1/Wtmd+exSx1OSVrwkvlGXKvwSO8rgbeVYvF3j66Y4WC0txn0xCzV31eT63MyL8TXQ4aR7a3H1aNV/9mreo+WLZ50Ie0xNCn3kvyZxv7O1qw+Imu3R5U6XCo9syHI/8dqr+2Tp+bbw1qAB4ae2b8QrD+RruvhIsD/EHxw1oE8m3NvbrtHHHmZ/lVD9rOy+0fC+O4A+a1v4nz6Bgyf+zCpoK1NI9DNJKWMqSXV3+/W3yOU8Da39g8D+J5QN9zd2ltDEmMlmkUr0+hJ/CvZ/hLIJfhzoRHOLfb+RI/pXhHgGeys9c0uXV4yli0ISIk4VHVNiOw7gHP4nNe1fBJ93w30xT1jaWP8AKRqyws1KLS6N/mTnmHq0cyjOptKCt6xUU/xO6rx/4n6o+i/FTwxqK7vJgtyZyO0TOVYn/vqvYK8y8X28F38VLC3vIllt5NFuRJG4yGGeldMtjx8bCU4KMXZtr8zy1bMDxV4B1NiX+2+IZXHPAIYrx9Rj8q+lNXg+06Te2+M+bA6Y+qkV80XmoxRXnwislPzjUvPb2DTkD+VfUR5FYYX+Gj6DOtcXLv8A5NpfhY+bfC9jb6r4S8DWd0ziIX8lnMY22kq6owGfQ9PoTXp/wdRYI/FFpGoRINYmVVHAUcYH6V4d4H1owxx6e5O6y1tR/utHIy/qjL/3zXufw0/d+J/HUHTGqeZj/eGajD6SlHsY55FSqYXEL7Sl+rt8m2j0GvFfifawt8Qbi6keaOW10RruCSFtrJIjnaQf0/Gvaq8g+KcDTeNmjjGXl8P3IA9dpLf0roqfA7HmShCpVpRqbOcb+lzE+HejR6V8dXgjHMOh5Y/7TGEt+pNX/wBpu3aKy8K6snH2TUvKZ/QSIQP1AqH4WaxFr/xl1u6h5VNNU5PYMyAD8kzXafHTQn8QfC7XLaBC1zBF9rhx13Rnfx74BH41nSinS5ejuexja0qeO9q/ii439Ulf8TzHT5LSXSnd7mdLu5giFjPcAAW1xC5cKG6FGY9e2cHjBr1jxxeNL8L7+7vrdre4mscNGQCY3dQuPzbGa8r+BOsnX9Hghg+zternzLa6XdDdKOG7HZIoPXupAINew+M9Bl1HwbLo+kRxR5MSojNtVUV1JH5A1FDn5XF9DLOKOGhVlXoxvzptq+kr3fqm720/Bpo8H8eQW3h/w1fw65bwS6u0jSSFQdrRm3GxV9BvfBx1K5rsf2RoynwyvSed+qSkH1xFEP6VwX7T+pxWmryaX50lxfXOyRmdNqwQAfLGnrk5JPc/SvWf2adPNh8IdJdwQ128t1+DOcfoBV0Y8t/UeOqKUacea9o+iV22kl2Ssl6HqNFFFbnnhRRRQBxPxDW7mdLcpqTadLYXQxYLKWa5+QRB/L+bbgydflJ+92rFgTVLee2juINTh0omzS6a1hkE2wWj8AxjfgShA23kd8DNeoVV1LTrHVLcW+p2dteQBgwjuIlkXI6HBBGeTQB5NLHqmueGrWZ01C5jaxhkaaONjI2y+VjhgMlhGudo5OOma2prrV28W2DWMerxW0d1BCRLDdOs9sYhmRicRJycEFTJlckjpXo8UaQxJFCixxooVUUYCgdAB2FOoA4Syh1Sz+EdlDZx3dvqkdpCgRIz5qHcoPykZzjPasvVU1+2vLqzik1T+xYtSZBNi4mlMZtYHTDRnzWTzWmGVJAICngEV6fRQB55Zaf4i1I3avrGpxTQ6Xb/AGWZofIiluSsoZ3QrnOQhKZGM8gcVRu7vxPqNtaajcQ6lp9je3D+baLFMZbZUjVYwyw/vMM4kYlfVAeM16jRQB5vpcutxeI9I+1TanqavHCkjm3uLRIh5R3SMpXym3NyQxV1JwOgFekUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABXyV+17/AMj9o/8A2Dv/AGoa+ta+Uf2tIhP8Q/D8ROBJY7SfYymk3ZXKhFykordlf4CaiulKNU1Z821lbTPboDlnLEIqgf3icge1e+/BWBoPhzphfH70ySgegLmuE8HeG9N0bxDbQy28cpj0Jb6Bm5Cy85YfQcV6X8LU2fD3QR62qn88n+tc+H1Te12zpziMljqcXK6jTST+av8AidTXi+vkT2njWISlDPrltAxU8qMJz+h/KvaK+bPFtxeWGo+I75FZ7C+1OVMgcRywEFSfqGI/CtK2sGcuHqezxuHf97/hvxNr9lKU3tn4w1BgQJ9RVVBOcBU4Ge/DV2n7Qtobz4PeI1Ay0UKzj/gDq39K5D9kKHZ8O9Rl7y6i/wCkaCvSPiynmfDLxQnrp03/AKAa0SS0Q5Sc5OUnds8L+Ht3Z6vfeFIJYkmiYSwyo4yrpIpIz+JNexfA/A8AQKBwtzOo/wC/hrwb9n2YanqPhy18oLLZTTbpf76bS6g/Qkj8a95+CP8AyIqjuLu4H/kQ1y4aHI5Lz/RHo57iPb18NU2vCTt5uWv3/kd9Xmvis4+K9gfTRLr+Zr0qvLPG13Ha/FvRVl6XOlz26n0Zt2P1GPxrplseLXai4N/zR/M+dtVu5Lfx54IiOdsL2twCT1LzD9AFA/OvtyviTxpA0XibwDd7T5c1vAm7sWjumBH1AK/nX23UUElTjbsetmcnLGVXL+Z/mfE9hI1l8T/FtgFyjX8jj/YZLjg/kxH419LeDcwfFHxpbn/lottcD8Y+a+fJ7ZYvir44uGQk/wBpeUjdlzKrsT+AA/GvavBeuLqvxj1a5gj22d1Y+XBJ2mWJwpce2d35VEWvayt5fqc+Y3hhcI5dZzt6WS/M9bryT4sQXTeL7S7068NpdWOk3Fzv2bg6hgChB7EMa9bryT4l30MXjr7FN1vdBntkbsrsxYZ+uzH41rU+F2OOooSnTjU2co3+9HA/swtIvxM8ZRz/AOtWBVPttkIxX0w6q6MrgFWGCD3FeD/B6wS3+LWp6pagiz1rRYrtRj7squElU+4YE/8AAq95ohblVtjsxXP7aftPiu7+t9T401241/4GfFC/XRcf2bdEzQwzAmK4gJyFPoynK5HI+hrt5v2ngdNYQ+GGXUNuAXugYg3rwuSPb9a9r+IngbR/HmiHTtZjYMhLwXMfEkD+qn+YPBr55v8A9mbxFHeFbDXNMmtc8STI6OB7qMj9asxPJbq41r4geMla5ka71jVZ1jBA4GeAAOyqPyAr758PaXDomhafpdsP3NnAkC+4UAZrzv4QfBzTfAMrajc3H9pa26lPtBTakKnqI17Z7k8/SvVKAYUUUUCCiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAr5S/a2la2+IHh24j2l47IuAwyCRLnmvq2vlD9sAH/hNNBOODp7/APoyga0Zc8Ka7qmuCz1TSIJLgWmnyx/ZT99YNzIyZ/iwW4PXAFe/fDVg3gHQSvI+yIPyFeD/ALNd0kFjezSMoMGmTlQTycSFjXsvwleW28ODSLp981gEKk945EEin/x5h/wGubDxUea3c7M3xDqYihzrXk373s/8zuK+cvEt7e3ngnVrG3tZEspNVuZLi7cYVnLNsRPX7uSe2BXuvivWk0LR5boIZrlvkt4B1lkI4H04JJ7AE187654kaX4f6bptujq8AuLu7d14aRw7AD1G1ifxFPEP3bGeVtSzCKSu4xk9em2v+R3X7J0Wz4UCT/nrfTt+oH9K9E+Isfm+AfEaeunz/wDoBrkf2abQ2nwb0LcMGbzZv++pGruvF6eb4T1pMfesph/5Daug5j5P/Z/OpxyW50O3E2oTCVImfhItwCmRvZRmvoX4Ghk8DtG7b3jvbhWb1Ifk15V+zPJbLqGjhCAX0p1HvIH+f8eDXq3wV48N6lH/AM89VuVx/wACB/rXPR3l6s6M2jbE4d3/AOXa/wAz0CvE/jPbyy+N7G4tiRNY6Y94uO/lyZI/LNe2V55rkUc3xm0aKdFeKXSZ0ZGGQwLcg1vLY8vHQ56aj3a/M8D8YWsR8KeFb1T/AMxVZE/2T5oVwPYjyz+FfX9fIvxImht9D0zT4Qqi38QSFVHRV3oAPpwfyr66rDC/w0j6LOk/rTk93q/69LHyxpMltqk3xSvo8GX7Y8qZ6hVnUE/ko/OvQtO1iOX4jeD2/s99NmFrLaS2+zCAMu5GQjhlPXivnLwdrrWPiHWYGeQf2g0qAryCSx3Bh6EZ/ECvf9Q1xH8P+Dp58xalod9brcRScExOMCRfVSAORWa92s0+osz5auURqxjdwkvlblv8mlr5v7/c68g+IenSav4i8S/ZzGs9jptrLG8jbQhErOTnt8oNev15ylra6h4o8cz36eZb2y2wKkkKTHEzYYdxlgcHiuqex4lSnGrOnTns3032exzPwmvEHjOw09QNw0Zrvd6B3jBH5rn8a9sr5r+Bd9Jd/GS6WRgRDofljHYeYhxX0pWeH/hRPXzZr67Vt3/4f8QooorY84KKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAK+bP2xtNJj8M6oo4VprVz6ZAYfyNfSdedfH/w0/ib4YapBboXu7QC9gUDktHyQPqu4UAj55+Euox6fpSG4ileCUujPEMvGcn5lB4YYyCp4YEivdtC8VWyazDqs8+nLZNZi3nlhlEYKq2UfynwwIBYYG7qMV4B8D9b08XFxo+sOyWc67lmT78BzlZV/3T19mNfT/gDQBYwXcl1HYXEczq8NzbNuinGD+8EfSNjnnbwetcMI1I1Wkz6XEywdbBU6lSN5RSW9ttHr3XbtZ2aZgeIvEkfiCG7ubGBLDTtPjeObVr9CGjWRRuEUXUsy4wTjr71498U5LfQfBL2cFpNbTzqEgWQhiYXAKsGHVmG4t6HA6CvoTxX4Nt9S0C6tLeRUnlleVri5YsF8xh5jY6ZCZVSegr5onkf4m/GrTNJtysml29zgmM7k8mLG4g+m1VUH3z3rVUpOSc9TzfrdOHPHDx5Y2t5tu633tZX6Wdklvf6l+HOl/wBi+AvD+nkYaCyiVh6NtBP6k1ra6nmaJqCf3reQf+Omro46VFdp5lrNH/eRl/MV0nmHxJ8FNTcavaaZ9pWyeO4E8F63IhJ4Kkd1J2/r619FfCzV4tF1jXPDutzw2+qyX7zqoyEkLgEhSfzA9DXyz8N7ldO8cwNJALlBIytA3SUBuV/EAivpjX7S30Q6N4x0+J9V0uKNbe/jmUNIEVv3bn/bQgLnr8o965bNVXy+p6OKqQWCo1aseZRbV+sb66Ptqrp9NrNM9krznxLcx2fxe0a5nYLFDpNzI7HoACSauP401STTBqNv4cMWnsgkW5vL6KJCp5B4ya8/1ZdR+ILza7c239maZp9pLG08chYXA5O1cgZye/SqnXitFv6ERyerXUZtpQUo3fMn16Wbu+yPEviJqDzatpEe3CTzm/ds/eZpSoHtgKf++q+5+or4c+NNounePYoAAixrGdo4CE7WI/MmvuGFg8SMDkFQc1VBWppFZrJzxc5X31Xo0rfcrI+FPhnoH9ufEpNPZzFi4kXcP4TuIz/OvdYtBm8T6D4YXy5Bc2FxNpk0nl7xGUy0Zcd0BAB+teHveXPg34z6mbVhHJb6pKoLDjBcsv8AMfnX2d4R1R9Y0OG9mtYraSXJZIpVkU/7QI9ffn1rKdNTq2b6f1+J20cU6GCTjFNXad7btNbdU4teV0XxcGy0sT6rNBEYog08i/LGCByRnoK8x1j7RdyahFpitp9nrZa6upJ8tO1uiANIF4EaEAAA5JLdq9SvLSC8iEV3Ck0W5X2OMjIOQcfUV5N8Q9Sg0TRta1PUvOsbS5LLsmkzdX7DIVB/zzhHoOT7Z5uve1uhz5bGlKpzyXvJ3V9l6L7329FdrjP2b7f7T8T/ABReoD5VtYxW4PuzZx+S19J14t+yzostr4JvdculKz61dtMuR/yzX5V/XdXtNa048kFHscWMre3rzqr7Tb+9hRRRVnOFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFBAYEEZB6g0UUAfF/xw+Hl/8AD/xU2s6MsseiXM3nW1xF/wAukhOTGT25zt7EcVt+D/2i9X0bTYbLVNEsr5IV2pJbt9mYj3UAr+QFfV97aW99aS2t7BFcW0q7ZIpVDKw9CDwa8s1P9n/wFfXTTJY3dnuOTHa3LKn4A5xQVzaWPCfiN8cPEXjOzbSrK3TStPn+R4bZjJNOD/AWwOD6KBmvaP2cfhpN4Q0ibWdbg8rWtQQKIW620PUIf9onk+mAPWuv8G/Czwh4QuFutI0pDer925uGMsi/Qt0/DFdxQIKKKKBH5769DL4c8fanC4KyWWoSqcegc/0NfXWjapZ+OvDulWNpf21vb3kMn9oQx7PNkfaOikHgnLbhXg/7UvhxtH+I39pxx4tdXhEoYDjzUAVx9cbT+Jq1+zff6fqGpz+H9Rvbmw1Fh5umXlvL5bj+/D6MDwwB9DWNSDbuj0cJiYQjyVNOqe9na233elkevWnhSKXxMdB8XX15dxJB/wAShWbbC8YGDkDrIvHHpzXZatYzLp+maTOQNKtollv7sgIrJFghAO24gE+gB9a6O1tRFb2yTObmaBQonlA3k4wTwOCfavL/ANo/xlbeGvAk+nq6tquqjybePPKrkFpCPQdvcj3pRoqKdv68mXVzGVWpDm2XbZPa8VpZ9bdz5i+KOsf8JP8AEG9uYOVln2IPq3A/kK+8bSMw2sMR6oir+Qr4Z+B3hyTxR8TtJgZDJbWsn266Y8gKhyM/Vto/OvuutYR5YpHFiKvtqjna1/wXRfJHxv8AtSeHn0n4knUlQi11aBZQw6eYgCuPrgKfxrZ+DXxq0vwzZtYeJdNdWYKp1GzTc0gHA81PUf3h17jvXv8A8UvAlj4/8Mvpl4/kXMbeba3IXJhkx1x3B6EdxXyjq3wP8fafdtCmjLeoDhZrWdCrD1wSCPxFNpPUzjOSTino9/M9/wBW/aF8DWdm0tncXmoT4+WCG3ZST7lsAV4XPeeIPjx8SbaAxC1s1ADJFylpbg8sx/iY5wD3J44rQ8K/s8eLtUuEOttbaNafxM0gmlx/sqvGfqRX058P/BGjeBdFGnaHARuIae4kOZZ2/vMf5DoKYk7bG7pWn22laZa6fYRiK1tYlhiQfwqowBVqiigkKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigDhfjJ4Fj8feDZtPjKJqUB8+ylbosgH3SfRhwfz7V8N3dtfaNqsltdRz2Wo2cuGQ5SSJweue3sRX6PVx3jr4b+GPG4V9d08NdqNqXcDeXMo9Nw6j2ORQNM+ZNI/aD8b6fpotJX0++dV2rc3MJ8wfXaQGP4VwlzceI/iH4r3SfadX1u6IUKi/dXsABwiD8AK+n7T9nDwVDOJJrjWrlAf9VLcoFP/AHwin9a9N8L+FNC8K2htvD+l21jGfvGJPmf/AHmPJ/E0Bc5T4KfDeH4feHnS4ZJ9avMPdzr0GOka/wCyM/icmvRqKKBBRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFAH/9k=);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The path of palmar arteries (red) and nerves (green) to the fingers is shown. Each digit is innervated by four digital nerves; the dorsal arteries and nerves are not shown in this figure. In order to achieve a complete anesthetic effect, it is necessary to block all four nerves.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Dorsal hand anatomy",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 433px; height: 443px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The path of dorsal arteries (red) and nerves (green) to the fingers is shown. Each digit is innervated by four digital nerves; the palmar arteries and nerves are not shown in this figure. In order to achieve a complete anesthetic effect, it is necessary to block all four nerves.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f22_0_22537=[""].join("\n");
var outline_f22_0_22537=null;
var title_f22_0_22538="Anemia in the older adult";
var content_f22_0_22538=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"5\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Anemia in the older adult",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?22/0/22538/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?22/0/22538/contributors\">",
"     Elizabeth A Price, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?22/0/22538/contributors\">",
"     Stanley L Schrier, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?22/0/22538/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?22/0/22538/contributors\">",
"     William C Mentzer, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?22/0/22538/contributors\">",
"     Kenneth E Schmader, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?22/0/22538/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?22/0/22538/contributors\">",
"     Stephen A Landaw, MD, PhD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?22/0/22538/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Mar 19, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Anemia is common in the older adult population. While the anemia is typically mild, it has been associated with substantial morbidity and mortality. Anemia in the older adult will be discussed here [",
"    <a class=\"abstract\" href=\"UTD.htm?22/0/22538/abstract/1-4\">",
"     1-4",
"    </a>",
"    ]. The overall approach to the anemic adult patient is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/46/29418?source=see_link\">",
"     \"Approach to the adult patient with anemia\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     DEFINING ANEMIA IN THE OLDER ADULT",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     WHO criteria for anemia",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although average hemoglobin values differ from laboratory to laboratory, a working definition of anemia in the adult is a level less than the normal mean minus two standard deviations. For the values shown in the table this would be a hemoglobin &lt;14.0",
"    <span class=\"nowrap\">",
"     g/dL",
"    </span>",
"    (&lt;140",
"    <span class=\"nowrap\">",
"     g/L)",
"    </span>",
"    in men and &lt;12.3",
"    <span class=\"nowrap\">",
"     g/dL",
"    </span>",
"    (&lt;123",
"    <span class=\"nowrap\">",
"     g/L)",
"    </span>",
"    in women (",
"    <a class=\"graphic graphic_table graphicRef64238 \" href=\"UTD.htm?41/52/42827\">",
"     table 1",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    Alternatively, the 1968 World Health Organization (WHO) criteria of a hemoglobin (HGB) &lt;13",
"    <span class=\"nowrap\">",
"     g/dL",
"    </span>",
"    (&lt;130",
"    <span class=\"nowrap\">",
"     g/L)",
"    </span>",
"    in men and &lt;12",
"    <span class=\"nowrap\">",
"     g/dL",
"    </span>",
"    (&lt;120",
"    <span class=\"nowrap\">",
"     g/L)",
"    </span>",
"    in women have been used to define anemia [",
"    <a class=\"abstract\" href=\"UTD.htm?22/0/22538/abstract/5\">",
"     5",
"    </a>",
"    ]. However, these criteria were based upon data in populations that did not include individuals &gt;65 years of age [",
"    <a class=\"abstract\" href=\"UTD.htm?22/0/22538/abstract/6-9\">",
"     6-9",
"    </a>",
"    ], and may or may not be applicable to the older individual [",
"    <a class=\"abstract\" href=\"UTD.htm?22/0/22538/abstract/10,11\">",
"     10,11",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/46/29418?source=see_link&amp;anchor=H3#H3\">",
"     \"Approach to the adult patient with anemia\", section on 'Normal range'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Racial and ethnic considerations",
"    </span>",
"    &nbsp;&mdash;&nbsp;There is additional debate as to whether modifications in the definition of anemia should be made for different racial and ethnic groups. As an example, up to 30 percent of African-Americans carry the 3.7 kb deletion in the alpha thalassemia gene. In the heterozygous state (ie, silent carrier of alpha thalassemia, thalassemia minima) this leads to low-normal and occasionally mildly low hemoglobin and mean corpuscular volume values, whereas homozygotes (ie, alpha thalassemia trait) have a mild, microcytic anemia [",
"    <a class=\"abstract\" href=\"UTD.htm?22/0/22538/abstract/12\">",
"     12",
"    </a>",
"    ]. Thus, the presence of thalassemia may contribute to lowering of the average hemoglobin level in racial or ethnic groups having a high incidence of these mutations. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/13/38106?source=see_link\">",
"     \"Clinical manifestations and diagnosis of the thalassemias\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    There may be additional underlying factors that contribute to lowering of average hemoglobin levels in certain ethnic populations. As an example, when subjects with the alpha thalassemia -3.7 kb allele, iron deficiency, renal insufficiency, and sickle cell trait were removed from consideration, African-Americans still had significantly lower hemoglobin values when compared with a corresponding white population [",
"    <a class=\"abstract\" href=\"UTD.htm?22/0/22538/abstract/12\">",
"     12",
"    </a>",
"    ]. Additional data bolstering this hypothesis is that the prevalence of anemia, using WHO criteria, is three-fold higher in elderly African-Americans relative to elderly Caucasians [",
"    <a class=\"abstract\" href=\"UTD.htm?22/0/22538/abstract/13\">",
"     13",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Normal values for a population with a high incidence of chronic disease may be skewed toward anemic levels. Thus, anemia may be difficult to define in countries in which malnutrition, infection (eg, tuberculosis, malaria),",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    congenital hematologic disorders are common. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?40/51/41783?source=see_link&amp;anchor=H1#H1\">",
"     \"Community public health issues and the thalassemic syndromes: Lessons from other countries\", section on 'Introduction'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Proposed definitions",
"    </span>",
"    &nbsp;&mdash;&nbsp;Values for hemoglobin and hematocrit in apparently healthy older adults are generally lower than those in younger adults, and differences between males and females that are seen in younger adults are lessened with aging [",
"    <a class=\"abstract\" href=\"UTD.htm?22/0/22538/abstract/14-16\">",
"     14-16",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In an attempt to more accurately determine normal hemoglobin ranges in elderly adults, two large databases, the third US National Health and Nutrition Examination Survey (NHANES III), a nationally representative sampling of community-dwellers, and the Scripps-Kaiser database, collected in the San Diego area between 1998 and 2002 were evaluated [",
"    <a class=\"abstract\" href=\"UTD.htm?22/0/22538/abstract/10\">",
"     10",
"    </a>",
"    ]. Older subjects (&ge;59 years in men and &ge;49 years in women) with laboratory-based evidence of increased inflammation or renal insufficiency were excluded from consideration, which led to the elimination from the analysis of up to 50 percent of older black men and 40 percent of black women from the NHANES database.",
"   </p>",
"   <p>",
"    Using the fifth percentile value of hemoglobin concentration, new lower limits of normal were proposed for older patients (",
"    <a class=\"graphic graphic_table graphicRef79757 \" href=\"UTD.htm?37/22/38251\">",
"     table 2",
"    </a>",
"    ). Compared with current WHO criteria, these values were slightly higher for older white men and women (13.2 and 12.2",
"    <span class=\"nowrap\">",
"     g/dL,",
"    </span>",
"    respectively) and slightly lower for older black men and women (12.7 and 11.5, respectively).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Significance of these definitions",
"    </span>",
"    &nbsp;&mdash;&nbsp;While further data are needed to confirm or refute the necessity for more precise age-, race-, and ethnicity-based definitions of anemia in the older adult, setting a lower limit of normal for hemoglobin does not imply that such levels are \"optimal\" in terms of morbidity and mortality. As an example, one study has suggested that the lower limits of an optimal hemoglobin level, as assessed by all-cause mortality data, are 14.0 and 13.0",
"    <span class=\"nowrap\">",
"     g/dL",
"    </span>",
"    for elderly men and women, respectively [",
"    <a class=\"abstract\" href=\"UTD.htm?22/0/22538/abstract/17\">",
"     17",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    However, alternative criteria for anemia in the older adult might be required for different ethnic groups (",
"    <a class=\"graphic graphic_table graphicRef79757 \" href=\"UTD.htm?37/22/38251\">",
"     table 2",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?22/0/22538/abstract/10\">",
"     10",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A study in community dwelling older adults (age 71 to 82 years) confirmed the adverse effect of anemia, as defined by the WHO criteria, on mortality and mobility disability in white men and women [",
"      <a class=\"abstract\" href=\"UTD.htm?22/0/22538/abstract/18\">",
"       18",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      However, in the same study, older black subjects classified as anemic by WHO criteria did not appear to be at risk for adverse events such as mortality and mobility disability.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Further, it has been suggested that older adults should NOT be presumed to have a lower \"normal\" range for hemoglobin, for fear of missing an underlying, treatable disorder [",
"    <a class=\"abstract\" href=\"UTD.htm?22/0/22538/abstract/13,19-24\">",
"     13,19-24",
"    </a>",
"    ]. In any event, studies in older adults with hemoglobin levels in the \"low normal\" range according to WHO criteria have linked these levels to declines in performance as well as increased morbidity and mortality. (See",
"    <a class=\"local\" href=\"#H7\">",
"     'Prevalence and clinical importance'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h1\">",
"     PREVALENCE AND CLINICAL IMPORTANCE",
"    </span>",
"    &nbsp;&mdash;&nbsp;Given the absence of a uniform definition of anemia, it is not surprising that the reported prevalence of anemia in the older adult has wide variability in the literature. In a systematic literature review, prevalence rates of anemia in older adults were found to vary between 2.9 and 51 percent in men and 3.3 and 41 percent in women [",
"    <a class=\"abstract\" href=\"UTD.htm?22/0/22538/abstract/13,25\">",
"     13,25",
"    </a>",
"    ]. While nursing home residents were found to be at high risk for anemia [",
"    <a class=\"abstract\" href=\"UTD.htm?22/0/22538/abstract/15,16\">",
"     15,16",
"    </a>",
"    ], the highest prevalence rates were noted in hospitalized older adults [",
"    <a class=\"abstract\" href=\"UTD.htm?22/0/22538/abstract/13,14\">",
"     13,14",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Anemia is also very prevalent in non-institutionalized older adults.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In large studies of community-dwelling older adults from the United States and Europe, prevalence rates for anemia ranged from 8 to 25 percent [",
"      <a class=\"abstract\" href=\"UTD.htm?22/0/22538/abstract/16\">",
"       16",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      In the community-dwelling NHANES III population, 10.2 percent of women and 11 percent of men &ge;65 were anemic [",
"      <a class=\"abstract\" href=\"UTD.htm?22/0/22538/abstract/13\">",
"       13",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      In the NHANES III population, the prevalence of anemia also increased with increasing age, such that 26 percent of men and 20 percent of women aged &ge;85 were anemic [",
"      <a class=\"abstract\" href=\"UTD.htm?22/0/22538/abstract/13\">",
"       13",
"      </a>",
"      ], a pattern also seen in other studies [",
"      <a class=\"abstract\" href=\"UTD.htm?22/0/22538/abstract/25-29\">",
"       25-29",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The public health importance of this finding is particularly relevant in light of the aging global population. In 2008, the estimated world population was 6.7 billion with 98 million people &ge;80 years of age [",
"    <a class=\"abstract\" href=\"UTD.htm?22/0/22538/abstract/16,30\">",
"     16,30",
"    </a>",
"    ]. By 2030 this is estimated to grow to 8.4 billion total population, with 216 million &ge;80 years of age [",
"    <a class=\"abstract\" href=\"UTD.htm?22/0/22538/abstract/30\">",
"     30",
"    </a>",
"    ], leading to an estimated 49 million anemic elderly adults in this age bracket alone, extrapolating from data obtained in the industrialized world.",
"   </p>",
"   <p>",
"    This number is likely to be substantially increased, however, if one takes into account the much higher prevalence rates of anemia found in areas of the developing world [",
"    <a class=\"abstract\" href=\"UTD.htm?22/0/22538/abstract/31\">",
"     31",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Degree of severity",
"    </span>",
"    &nbsp;&mdash;&nbsp;The anemia reported in studies of the older adult tends to be mild, with hemoglobin values generally &gt;10",
"    <span class=\"nowrap\">",
"     g/dL.",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In",
"      NHANES III, less than 10 percent of anemic men and women &ge;65 had hemoglobin levels &lt;10",
"      <span class=\"nowrap\">",
"       g/dL",
"      </span>",
"      [",
"      <a class=\"abstract\" href=\"UTD.htm?22/0/22538/abstract/13\">",
"       13",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      In a population study of 85-year-old residents of Leiden, in which the overall prevalence of anemia was 27 percent according to the WHO criteria, 15 percent of the anemic subjects had \"severe\" anemia (ie, hemoglobin &lt;10",
"      <span class=\"nowrap\">",
"       g/dL",
"      </span>",
"      in women and &lt;11",
"      <span class=\"nowrap\">",
"       g/dL",
"      </span>",
"      in men) [",
"      <a class=\"abstract\" href=\"UTD.htm?22/0/22538/abstract/29\">",
"       29",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In institutionalized elderly subjects, 11 to 19 percent had hemoglobin levels &lt;10",
"    <span class=\"nowrap\">",
"     g/dL",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?22/0/22538/abstract/15,21\">",
"     15,21",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Functional outcomes",
"    </span>",
"    &nbsp;&mdash;&nbsp;Many of the studies showing an association between anemia and morbidity",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    mortality replicate a reversed J-shaped curve, with worse outcomes at both the lower (Hgb &lt; 12",
"    <span class=\"nowrap\">",
"     g/dL)",
"    </span>",
"    and upper (Hgb &gt;15",
"    <span class=\"nowrap\">",
"     g/dL)",
"    </span>",
"    extremes of hemoglobin [",
"    <a class=\"abstract\" href=\"UTD.htm?22/0/22538/abstract/11,17,29,32-35\">",
"     11,17,29,32-35",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Importantly, available studies investigating anemia in the older adult and poor outcomes have not been designed to establish causality. Accordingly, it is unknown whether anemia itself leads to increased morbidity",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    mortality or whether it is the underlying etiology of the anemia or associated co-morbidities which do so. Nonetheless, it is plausible to suggest that anemia, potentially leading to increased cardiac output",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    local tissue hypoxia, could aggravate functional decline in the older adult population.",
"   </p>",
"   <p>",
"    Decreased functioning, if present, can radically affect an older person's life and ultimately lead to loss of independent living in the community [",
"    <a class=\"abstract\" href=\"UTD.htm?22/0/22538/abstract/36\">",
"     36",
"    </a>",
"    ]. Accordingly, measures of physical function are important both in assessing current status and in predicting more severe disability, such as decreased mobility leading to subsequent nursing home admission [",
"    <a class=\"abstract\" href=\"UTD.htm?22/0/22538/abstract/36,37\">",
"     36,37",
"    </a>",
"    ]. The following observations are important in this regard:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A number of studies have highlighted the association between mild anemia, and even low-normal hemoglobin values, and impaired performance-based mobility function [",
"      <a class=\"abstract\" href=\"UTD.htm?22/0/22538/abstract/19,29,38-40\">",
"       19,29,38-40",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Anemia in the older adult has been found to be associated with other markers of impaired physical function, including increased frailty [",
"      <a class=\"abstract\" href=\"UTD.htm?22/0/22538/abstract/32\">",
"       32",
"      </a>",
"      ], muscle weakness [",
"      <a class=\"abstract\" href=\"UTD.htm?22/0/22538/abstract/39,40\">",
"       39,40",
"      </a>",
"      ], and falls [",
"      <a class=\"abstract\" href=\"UTD.htm?22/0/22538/abstract/41\">",
"       41",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Anemia in the elderly is also associated with impaired cognitive performance, depressive symptoms, and reduced quality of life [",
"    <a class=\"abstract\" href=\"UTD.htm?22/0/22538/abstract/40,42-45\">",
"     40,42-45",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In the Women's Health and Aging Study (WHAS II) of 364 women age 70 to 80 with a hemoglobin &ge; 10",
"      <span class=\"nowrap\">",
"       g/dL,",
"      </span>",
"      the presence of mild anemia (Hgb 10 to 12",
"      <span class=\"nowrap\">",
"       g/dL)",
"      </span>",
"      was associated with significantly poorer performance on the Trail Making Test, Parts B and A, concerning tests of executive function [",
"      <a class=\"abstract\" href=\"UTD.htm?22/0/22538/abstract/43\">",
"       43",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In community-dwelling adults age 65 to 84, the presence of mild anemia (Hgb 10 to 11.9",
"    <span class=\"nowrap\">",
"     g/dL)",
"    </span>",
"    was associated with significantly worse results in measures of selective attention [",
"    <a class=\"abstract\" href=\"UTD.htm?22/0/22538/abstract/42\">",
"     42",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Increased mortality",
"    </span>",
"    &nbsp;&mdash;&nbsp;Multiple studies have shown an association between anemia and increased mortality [",
"    <a class=\"abstract\" href=\"UTD.htm?22/0/22538/abstract/11,20,29,33,46-48\">",
"     11,20,29,33,46-48",
"    </a>",
"    ]. As examples:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In 686 community-dwelling women &ge;65 years of age with self-reported disabilities, hemoglobin (HGB) levels progressively lower than 11.0",
"      <span class=\"nowrap\">",
"       g/dL",
"      </span>",
"      were associated with increasingly higher risks for all-cause mortality than levels of 12.0",
"      <span class=\"nowrap\">",
"       g/dL,",
"      </span>",
"      whereas HGB levels of 13.0 and 14.0",
"      <span class=\"nowrap\">",
"       g/dL",
"      </span>",
"      were associated with a lower risk of death [",
"      <a class=\"abstract\" href=\"UTD.htm?22/0/22538/abstract/33\">",
"       33",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      A Dutch study of 755 community-dwelling subjects &gt;85 years of age showed that a HGB &lt;13.0",
"      <span class=\"nowrap\">",
"       g/dL",
"      </span>",
"      in males and &lt;12.0",
"      <span class=\"nowrap\">",
"       g/dL",
"      </span>",
"      in females was associated with an increased relative risk of mortality of 1.6 in males (95% CI 1.2-2.1) and 2.3 in females (95% CI 1.6-3.3) [",
"      <a class=\"abstract\" href=\"UTD.htm?22/0/22538/abstract/20\">",
"       20",
"      </a>",
"      ]. Disorders such as malignancy, peptic ulcer, and infection were more common in the anemic patients. However, the mortality risk in elderly anemic patients without obvious clinical disease was also increased to more than twice that of nonanemic patients.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h3\">",
"     Effect of race",
"    </span>",
"    &nbsp;&mdash;&nbsp;The impact of anemia on morbidity",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    mortality may also be influenced by race, although data are conflicting.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In the 1988-1994 NHANES III survey of 4089 participants &gt;65 years of age, the hemoglobin level below which the risk of death increased significantly was 0.4 and 0.2",
"      <span class=\"nowrap\">",
"       g/dL",
"      </span>",
"      higher than the WHO cutoff point for defining anemia in non-Hispanic whites and Mexican-Americans, respectively [",
"      <a class=\"abstract\" href=\"UTD.htm?22/0/22538/abstract/49\">",
"       49",
"      </a>",
"      ]. In non-Hispanic blacks this threshold level was 0.7",
"      <span class=\"nowrap\">",
"       g/dL",
"      </span>",
"      lower than the WHO cutoff point for defining anemia.",
"     </li>",
"     <li>",
"      In the Health, Aging, and Body Composition (Health ABC) Study, which included 3075 community-dwelling adults aged 70 to 79, anemia, as defined by WHO criteria, in Caucasians but not African-Americans was significantly associated with increased mortality over six years of follow-up [",
"      <a class=\"abstract\" href=\"UTD.htm?22/0/22538/abstract/18\">",
"       18",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      In a prospective cohort study including 1744 men and women aged &ge;71 from North Carolina, anemia was significantly associated with mortality, when adjusted for demographic and other variables, in African-Americans but not Caucasians over eight subsequent years of follow-up [",
"      <a class=\"abstract\" href=\"UTD.htm?22/0/22538/abstract/45\">",
"       45",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      In the Chicago Health and Aging Project (CHAP) study, which included 1806 elderly men and women, anemia was associated with increased mortality in both African-Americans and Caucasians after 3.5 years of follow-up [",
"      <a class=\"abstract\" href=\"UTD.htm?22/0/22538/abstract/50\">",
"       50",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    These discrepant results may be due to different sampling strategies [",
"    <a class=\"abstract\" href=\"UTD.htm?22/0/22538/abstract/51\">",
"     51",
"    </a>",
"    ] or disproportionately missing follow-up data among the different races [",
"    <a class=\"abstract\" href=\"UTD.htm?22/0/22538/abstract/18\">",
"     18",
"    </a>",
"    ]. However, these studies further the debate regarding the validity of using race-specific normal values, and the potential disparate impact of anemia within different racial and ethnic groups.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h3\">",
"     Other factors",
"    </span>",
"    &nbsp;&mdash;&nbsp;The risk of mortality may be related to the etiology of the anemia; in one study, elderly female subjects with anemia due to renal insufficiency or the anemia of chronic inflammation had an increased risk of death compared with non-anemic controls, whereas those with anemia due to nutrient deficiencies or unexplained anemia did not [",
"    <a class=\"abstract\" href=\"UTD.htm?22/0/22538/abstract/52\">",
"     52",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h1\">",
"     ETIOLOGY",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24163702\">",
"    <span class=\"h2\">",
"     NAHANES III Study",
"    </span>",
"    &nbsp;&mdash;&nbsp;The causes of anemia in the older adult were evaluated in a study of the noninstitutionalized United States population in the third National Health and Nutrition Examination Survey (NHANES III) [",
"    <a class=\"abstract\" href=\"UTD.htm?22/0/22538/abstract/13\">",
"     13",
"    </a>",
"    ]. Overall, 10 to 11 percent of men and women &ge;65 years of age were anemic, with a higher rate (28 percent) in non-Hispanic blacks. The anemia was generally mild, with only 2 to 3 percent of men and women having a hemoglobin level &lt;11.0",
"    <span class=\"nowrap\">",
"     g/dL.",
"    </span>",
"    The causes for anemia were estimated as follows:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      One-third were related to presence of a nutritional deficiency (eg, iron, folate, B12). Iron deficiency, alone or in combination with folate or B12 deficiency, constituted more than one-half of this group.",
"     </li>",
"     <li>",
"      One-third were related to chronic kidney disease",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      other chronic disorders (eg, arthritis, diabetes, increased serum C-reactive protein, or a positive rheumatoid factor). (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?9/13/9434?source=see_link\">",
"       \"Anemia of chronic disease (anemia of chronic inflammation)\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Anemia in the remaining one-third was unexplained, although 17 percent of these patients (6 percent of the entire patient population) satisfied one or more criteria for the diagnosis of the myelodysplastic syndrome (eg, macrocytosis, thrombocytopenia, neutropenia). (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?40/57/41882?source=see_link&amp;anchor=H37#H37\">",
"       \"Clinical manifestations and diagnosis of the myelodysplastic syndromes\", section on 'Diagnosis'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    These determinations concerning etiology were based upon laboratory data alone. However, reliance on biochemical data alone, without an accompanying clinical evaluation, may lead to the faulty presumption that a subclinical biochemical abnormality has caused the anemia. This is particularly important for the \"nutrient\" deficiency category. Two examples are described below:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In the NHANES study, anemia was attributed to cobalamin deficiency when the cobalamin level was &lt;200",
"      <span class=\"nowrap\">",
"       pg/mL,",
"      </span>",
"      which occurred in 11.3 percent of anemic patients, either as the sole abnormality or in combination with other findings [",
"      <a class=\"abstract\" href=\"UTD.htm?22/0/22538/abstract/13\">",
"       13",
"      </a>",
"      ]. This is consistent with other studies, in which low cobalamin levels have been found to occur in 10 to 20 percent of older adults [",
"      <a class=\"abstract\" href=\"UTD.htm?22/0/22538/abstract/53,54\">",
"       53,54",
"      </a>",
"      ]. While low cobalamin levels are frequently found in older adults, for the most part the deficiency tends to be subclinical, without hematologic or neurologic manifestations [",
"      <a class=\"abstract\" href=\"UTD.htm?22/0/22538/abstract/54-56\">",
"       54-56",
"      </a>",
"      ]. Thus, the NHANES III data are likely to overestimate the prevalence of anemia due to cobalamin deficiency. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?11/32/11786?source=see_link&amp;anchor=H11#H11\">",
"       \"Etiology and clinical manifestations of vitamin B12 and folate deficiency\", section on 'Older adult subjects'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Although the Third NHANES study of persons &ge;60 years of age found a prevalence of vitamin D deficiency of 33 percent in the nonanemic population as well as in those with unexplained anemia [",
"      <a class=\"abstract\" href=\"UTD.htm?22/0/22538/abstract/57\">",
"       57",
"      </a>",
"      ], there is no evidence that vitamin D deficiency is causally implicated in anemia of the elderly.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21668749\">",
"    <span class=\"h2\">",
"     Stanford study",
"    </span>",
"    &nbsp;&mdash;&nbsp;Our own study of subjects &ge;65 years of age was comprised of non-anemic community-living control subjects and 190 community-living subjects with anemia according to the WHO criteria, referred to us from outpatient hematology clinics. All anemic participants underwent a clinical hematologic evaluation, including history and physical examination, complete blood count with red cell indices, iron indices (serum iron, transferrin, ferritin), levels of B12 and folate, and a review of the peripheral blood smear. Laboratory data in these older anemic outpatients were as follows (mean values, ranges in parentheses) [",
"    <a class=\"abstract\" href=\"UTD.htm?22/0/22538/abstract/2\">",
"     2",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Absolute neutrophil count: 5.6 x",
"      <span class=\"nowrap\">",
"       10",
"       <sup>",
"        3",
"       </sup>",
"       /microL",
"      </span>",
"      (range: 1.4 to 18.6)",
"     </li>",
"     <li>",
"      Platelets: 219 x",
"      <span class=\"nowrap\">",
"       10",
"       <sup>",
"        3",
"       </sup>",
"       /microL",
"      </span>",
"      (43 to 608)",
"     </li>",
"     <li>",
"      Hemoglobin: 11.2",
"      <span class=\"nowrap\">",
"       g/dL",
"      </span>",
"      (6.4 to 12.9)",
"     </li>",
"     <li>",
"      Mean corpuscular volume: 93 fL (73 to 118)",
"     </li>",
"     <li>",
"      Red cell distribution width: 14.4 percent (12.1 to 26.5)",
"     </li>",
"     <li>",
"      Absolute reticulocyte count: 50.2 x",
"      <span class=\"nowrap\">",
"       10",
"       <sup>",
"        3",
"       </sup>",
"       /microL",
"      </span>",
"      (7.2 to 157)",
"     </li>",
"     <li>",
"      Reticulocyte production index: 0.7 (0.1 to 2.0)",
"     </li>",
"     <li>",
"      Serum erythropoietin concentration: 18.5",
"      <span class=\"nowrap\">",
"       mU/mL",
"      </span>",
"      (3.8 to 700)",
"     </li>",
"     <li>",
"      Creatinine: 1.3",
"      <span class=\"nowrap\">",
"       mg/dL",
"      </span>",
"      (0.7 to 3.2)",
"     </li>",
"     <li>",
"      Estimated glomerular filtration rate: 60.8",
"      <span class=\"nowrap\">",
"       mL/min/1.73",
"      </span>",
"      m",
"      <sup>",
"       2",
"      </sup>",
"      (20 to 113)",
"     </li>",
"     <li>",
"      Serum albumin: 3.7",
"      <span class=\"nowrap\">",
"       g/dL",
"      </span>",
"      (2.3 to 4.5)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The etiology of anemia in these subjects was as follows:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Unexplained anemia: 35 percent",
"     </li>",
"     <li>",
"      Hematologic malignancy (including myelodysplastic syndrome (MDS) or suspicion of same): 22 percent",
"     </li>",
"     <li>",
"      Iron deficiency anemia: 12 percent",
"     </li>",
"     <li>",
"      Treatment for non-hematologic malignancy: 11 percent",
"     </li>",
"     <li>",
"      Anemia of inflammation: 6 percent",
"     </li>",
"     <li>",
"      Renal insufficiency: 4 percent",
"     </li>",
"     <li>",
"      Other or incomplete data: 10 percent",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Of interest were the following observations in this group of subjects:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      No subject was found to be anemic on the basis of thyroid dysfunction.",
"     </li>",
"     <li>",
"      As unexplained anemia worsened, erythropoietin (Epo) levels remained relatively low compared to those participants who were suspicious for having MDS. This observation, which has been made by others [",
"      <a class=\"abstract\" href=\"UTD.htm?22/0/22538/abstract/21\">",
"       21",
"      </a>",
"      ], suggests that the pathology underlying this relative decrease in Epo may reflect defects in hypoxia sensing or response.",
"     </li>",
"     <li>",
"      Only four of the 23 subjects with iron deficiency had a mean corpuscular volume (MCV) &lt;80 fL and only six had hypochromia seen on examination of the peripheral blood smear. Of the 16 subjects with iron deficiency and a trial of iron supplementation, only eight showed a rise in hemoglobin into the normal range, despite improved iron indices and a ferritin level of at least 50",
"      <span class=\"nowrap\">",
"       ng/mL.",
"      </span>",
"     </li>",
"     <li>",
"      A self-selected subpopulation of those with unexplained anemia agreed to have additional laboratory studies performed. When compared with non-anemic older control subjects, this subpopulation had significantly higher erythrocyte sedimentation rates, serum ferritin, and serum hepcidin levels.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h1\">",
"     DIAGNOSTIC EVALUATION",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Initial approach",
"    </span>",
"    &nbsp;&mdash;&nbsp;In general, diagnostic algorithms for determining the cause of anemia in older adults are similar to those for anemia found in any adult patient (",
"    <a class=\"graphic graphic_algorithm graphicRef54266 \" href=\"UTD.htm?6/61/7123\">",
"     algorithm 1",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/46/29418?source=see_link\">",
"     \"Approach to the adult patient with anemia\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The following additional pieces of evidence are especially important when evaluating anemia in an older adult:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In addition to a complete history and physical examination, the evaluation should, when such information is available, take into account the rate of fall of hemoglobin as well as any accompanying changes in red cell indices and other cell counts.",
"     </li>",
"     <li>",
"      The absolute reticulocyte count",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      reticulocyte production index is crucial in determining if the anemia is hypo- or hyper-proliferative [",
"      <a class=\"abstract\" href=\"UTD.htm?22/0/22538/abstract/58\">",
"       58",
"      </a>",
"      ]. Determination of the mean corpuscular volume (MCV) will allow for further narrowing of diagnostic possibilities [",
"      <a class=\"abstract\" href=\"UTD.htm?22/0/22538/abstract/53\">",
"       53",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?34/45/35543?source=see_link\">",
"       \"Mean corpuscular volume\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?28/46/29418?source=see_link&amp;anchor=H20#H20\">",
"       \"Approach to the adult patient with anemia\", section on 'Morphologic approach'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Particular attention should be paid to abnormalities that warrant more aggressive diagnostic maneuvers, including the findings of leukopenia or leukocytosis, thrombocytopenia, macrocytosis without an attributable cause, or dysplasia or the presence of early white cell precursors on the peripheral smear, suggestive of an underlying myelodysplastic syndrome or other hematologic disorder [",
"      <a class=\"abstract\" href=\"UTD.htm?22/0/22538/abstract/59\">",
"       59",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?40/57/41882?source=see_link&amp;anchor=H10#H10\">",
"       \"Clinical manifestations and diagnosis of the myelodysplastic syndromes\", section on 'Pathologic features'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      While the incidence of monoclonal gammopathy of undetermined significance is increased in older adults, the presence of a monoclonal protein in the serum or urine in addition to anemia raises the possibility of a clonal plasmacytic proliferative disorder (eg, multiple myeloma, amyloidosis, Waldenstrom macroglobulinemia). (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?14/59/15290?source=see_link&amp;anchor=H14#H14\">",
"       \"Diagnosis of monoclonal gammopathy of undetermined significance\", section on 'Differential diagnosis'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Evaluation of the patient's nutritional status plays an important part in the diagnostic approach to anemia in the older adult. Thus, such issues as adequacy of dietary",
"      <a class=\"drug drug_general\" href=\"UTD.htm?8/61/9174?source=see_link\">",
"       folic acid",
"      </a>",
"      , use of alcohol, and reduction of cobalamin absorption secondary to atrophic gastritis, Helicobacter pylori infection, and use of agents which suppress gastric acid production need to be assessed in some depth [",
"      <a class=\"abstract\" href=\"UTD.htm?22/0/22538/abstract/53\">",
"       53",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?11/32/11786?source=see_link&amp;anchor=H5#H5\">",
"       \"Etiology and clinical manifestations of vitamin B12 and folate deficiency\", section on 'Causes of vitamin B12 deficiency'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Older adult patients can have multiple causes for their anemia. As an example, underlying renal insufficiency, myelodysplasia, or a nutritional deficiency may blunt the ability of the patient's bone marrow to respond to hemolysis or blood loss. Accordingly, full evaluation of the anemic elderly patient may take several visits, including, for example, monitoring for response to nutrient supplementation or hormone replacement. Bone marrow examination may be indicated at a subsequent visit if initial studies are unrewarding. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/46/29418?source=see_link&amp;anchor=H50#H50\">",
"     \"Approach to the adult patient with anemia\", section on 'Multiple causes of anemia'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The following disorders are common in the older adult population and warrant particular attention:",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Iron deficiency anemia",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h3\">",
"     Making the diagnosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;While iron deficiency anemia is typically associated with the presence of microcytic, hypochromic red cells, iron deficiency anemia may be normocytic in its early stages [",
"    <a class=\"abstract\" href=\"UTD.htm?22/0/22538/abstract/60\">",
"     60",
"    </a>",
"    ] or when iron deficiency is found in combination with other disorders [",
"    <a class=\"abstract\" href=\"UTD.htm?22/0/22538/abstract/21,61\">",
"     21,61",
"    </a>",
"    ]. While this subject is discussed in depth separately, several issues are of importance in determining the presence or absence of anemia in the older adult. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?25/39/26234?source=see_link&amp;anchor=H23#H23\">",
"     \"Causes and diagnosis of anemia due to iron deficiency\", section on 'Estimation of iron stores'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The serum ferritin is perhaps the most frequently used peripheral blood measurement to assess iron deficiency anemia. Iron stores are reliably depleted when ferritin is &lt;12",
"    <span class=\"nowrap\">",
"     microg/L",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?22/0/22538/abstract/53,62\">",
"     53,62",
"    </a>",
"    ]. Whereas a low serum ferritin dependably indicates iron deficiency irrespective of patient age [",
"    <a class=\"abstract\" href=\"UTD.htm?22/0/22538/abstract/60\">",
"     60",
"    </a>",
"    ], a normal ferritin level in an elderly patient does not necessarily rule out iron deficiency, as serum ferritin rises with aging [",
"    <a class=\"abstract\" href=\"UTD.htm?22/0/22538/abstract/63\">",
"     63",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Accordingly, a higher serum ferritin cutoff may more accurately diagnose iron deficiency in the older adult. This was shown in a study in hospitalized older adult patients, in which the optimal cutoff point for serum ferritin in predicting an iron-deficiency state was 50 [",
"    <a class=\"abstract\" href=\"UTD.htm?22/0/22538/abstract/64\">",
"     64",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Iron indices may also be influenced by the presence of inflammation or malignancy (eg, the anemia of chronic inflammation, ACD), in which condition the transferrin level is normal or low, and the ferritin is normal or elevated [",
"    <a class=\"abstract\" href=\"UTD.htm?22/0/22538/abstract/65,66\">",
"     65,66",
"    </a>",
"    ]. The serum soluble transferrin receptor (sTfR) divided by the log of the ferritin can be particularly useful to diagnose iron deficiency anemia in the setting of concomitant inflammation [",
"    <a class=\"abstract\" href=\"UTD.htm?22/0/22538/abstract/67,68\">",
"     67,68",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?25/39/26234?source=see_link&amp;anchor=H32#H32\">",
"     \"Causes and diagnosis of anemia due to iron deficiency\", section on 'TfR-ferritin index'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?9/13/9434?source=see_link&amp;anchor=H13#H13\">",
"     \"Anemia of chronic disease (anemia of chronic inflammation)\", section on 'ACD with coexisting iron deficiency'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    As an example, in one study in the older adult, the",
"    <span class=\"nowrap\">",
"     sTfR/log",
"    </span>",
"    ferritin was found to be more sensitive than standard iron indices in diagnosing iron deficiency anemia (88 versus 16 percent, respectively) [",
"    <a class=\"abstract\" href=\"UTD.htm?22/0/22538/abstract/67\">",
"     67",
"    </a>",
"    ]. The authors suggested that while the serum ferritin is the most cost-effective measurement for diagnosing iron deficiency, the",
"    <span class=\"nowrap\">",
"     sTfR/log",
"    </span>",
"    ferritin may be useful in more complex settings [",
"    <a class=\"abstract\" href=\"UTD.htm?22/0/22538/abstract/69\">",
"     69",
"    </a>",
"    ]. However, the lack of standardized reagents for the sTfR assay [",
"    <a class=\"abstract\" href=\"UTD.htm?22/0/22538/abstract/70,71\">",
"     70,71",
"    </a>",
"    ] complicates interpretation of the",
"    <span class=\"nowrap\">",
"     sTfR/ferritin",
"    </span>",
"    ratio.",
"   </p>",
"   <p>",
"    Accordingly, a carefully monitored trial of iron supplementation may be needed to confirm the diagnosis of iron deficiency when complicated by the anemia of chronic inflammation. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?9/13/9434?source=see_link&amp;anchor=H13#H13\">",
"     \"Anemia of chronic disease (anemia of chronic inflammation)\", section on 'ACD with coexisting iron deficiency'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h3\">",
"     Treatment",
"    </span>",
"    &nbsp;&mdash;&nbsp;Treatment of iron deficiency is discussed separately. However, constipation can be a major side effect for elderly patients on oral iron supplementation and may require initiation of low oral doses with slow dose escalation over several weeks, or, rarely, the use of parenteral iron. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/62/25578?source=see_link&amp;anchor=H10#H10\">",
"     \"Treatment of anemia due to iron deficiency\", section on 'Side effects'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h3\">",
"     Determining the cause",
"    </span>",
"    &nbsp;&mdash;&nbsp;The diagnosis of iron deficiency anemia requires, in addition to iron repletion, a search for the source(s) of blood loss. In the industrialized world where iron deficiency is less likely due to decreased available iron in the diet, this generally leads to evaluation of the gastrointestinal tract due to the high frequency of occult upper and lower gastrointestinal lesions found in these patients [",
"    <a class=\"abstract\" href=\"UTD.htm?22/0/22538/abstract/72,73\">",
"     72,73",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In one study in 111 hospitalized patients &ge;75 years of age who were found to have iron deficiency anemia, 92 percent of whom underwent endoscopy and 82 percent of whom underwent colonoscopy, 68 percent were found to have a bleeding source, and 11 percent had synchronous lesions [",
"    <a class=\"abstract\" href=\"UTD.htm?22/0/22538/abstract/74\">",
"     74",
"    </a>",
"    ]. Of the 43 patients found to have a colorectal source of bleeding, 31 (72 percent) had colon cancer; of the 44 patient found to have an upper gastrointestinal source of bleeding, 6 (14 percent) had a malignancy.",
"   </p>",
"   <p>",
"    The importance of making an accurate and timely diagnosis in these patients was shown in follow-up studies of these patients [",
"    <a class=\"abstract\" href=\"UTD.htm?22/0/22538/abstract/75\">",
"     75",
"    </a>",
"    ]. At two years, those with cancer treated curatively",
"    <span class=\"nowrap\">",
"     (28/102)",
"    </span>",
"    had a survival rate (68 percent) similar to those with benign lesions (80 percent) or those in whom no cause of the anemia was found (66 percent). In contrast, none of the 10 patients with cancer treated palliatively were still alive.",
"   </p>",
"   <p>",
"    Even iron deficiency in the absence of anemia may require an evaluation for a bleeding source. In one instructive study, 151 elderly hospitalized patients with serum ferritin levels &lt;50",
"    <span class=\"nowrap\">",
"     microg/L",
"    </span>",
"    on two occasions underwent upper endoscopy and either",
"    <a class=\"drug drug_general\" href=\"UTD.htm?12/17/12564?source=see_link\">",
"     barium",
"    </a>",
"    enema or colonoscopy, regardless of their hemoglobin level [",
"    <a class=\"abstract\" href=\"UTD.htm?22/0/22538/abstract/76\">",
"     76",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A potential upper GI lesion was found in approximately half of both anemic and non-anemic patients. A lower GI lesion was found in 32 and 16 percent of anemic and non-anemic patients, respectively.",
"     </li>",
"     <li>",
"      Six percent of the non-anemic patients were found to have cancer in the upper gastrointestinal tract and 9 percent of the non-anemic patients were found to have colon cancer.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The absence of iron deficiency as defined by a serum ferritin of &ge;50",
"    <span class=\"nowrap\">",
"     microg/L",
"    </span>",
"    does not exclude the presence of a gastrointestinal malignancy. In one retrospective study of elderly patients undergoing colonoscopy for either anemia or symptoms, the prevalence of colorectal carcinoma was 16 percent, 20 percent, and 13 percent for those with a serum ferritin &lt;50",
"    <span class=\"nowrap\">",
"     microg/L,",
"    </span>",
"    between 50 and 100",
"    <span class=\"nowrap\">",
"     microg/L,",
"    </span>",
"    and &gt;100",
"    <span class=\"nowrap\">",
"     microg/L,",
"    </span>",
"    respectively [",
"    <a class=\"abstract\" href=\"UTD.htm?22/0/22538/abstract/77\">",
"     77",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h2\">",
"     Renal disease/hypoxia-sensing abnormalities",
"    </span>",
"    &nbsp;&mdash;&nbsp;In adults, erythropoietin (EPO) is produced primarily by the peritubular interstitial cells in the kidney. The normal response to decreased oxygen tension in the blood is a logarithmic increase in erythropoietin levels corresponding to the severity of the anemia (",
"    <a class=\"graphic graphic_figure graphicRef53916 \" href=\"UTD.htm?34/53/35677\">",
"     figure 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?22/0/22538/abstract/78\">",
"     78",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?20/10/20650?source=see_link&amp;anchor=H12#H12\">",
"     \"Regulation of erythropoiesis\", section on 'Erythropoietin'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The EPO response is blunted in patients with renal disease, and worsening renal excretory function corresponds with lower erythropoietin levels [",
"    <a class=\"abstract\" href=\"UTD.htm?22/0/22538/abstract/79,80\">",
"     79,80",
"    </a>",
"    ]. This is of particular importance in the older adult, given the known decline in renal excretory function that occurs with aging [",
"    <a class=\"abstract\" href=\"UTD.htm?22/0/22538/abstract/81,82\">",
"     81,82",
"    </a>",
"    ]. However, the degree of renal impairment necessary and sufficient to cause anemia in the older adult, and how to measure it, is a matter of ongoing debate.",
"   </p>",
"   <p>",
"    Varying degrees of impairment in renal excretory function have been found to correlate with anemia in the older adult [",
"    <a class=\"abstract\" href=\"UTD.htm?22/0/22538/abstract/83,84\">",
"     83,84",
"    </a>",
"    ]. In a study of 1005 community-dwelling men and women &ge;65 living in Italy, a creatinine clearance, calculated from a 24 hour urine collection, of &le;30",
"    <span class=\"nowrap\">",
"     mL/min",
"    </span>",
"    was associated with a significantly increased risk of anemia, and significantly decreased age- and hemoglobin-adjusted serum erythropoietin levels [",
"    <a class=\"abstract\" href=\"UTD.htm?22/0/22538/abstract/85\">",
"     85",
"    </a>",
"    ], suggesting that this might be the inflection point below which anemia is most likely to be due to renal disease in older adult patients.",
"   </p>",
"   <p>",
"    The measurement of serum erythropoietin is not generally useful in this regard for two reasons:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      EPO levels do not rise dramatically until the anemia is more severe than is typically seen in the elderly anemic patient [",
"      <a class=\"abstract\" href=\"UTD.htm?22/0/22538/abstract/78\">",
"       78",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      There is substantial overlap of EPO levels in those with and without chronic kidney disease [",
"      <a class=\"abstract\" href=\"UTD.htm?22/0/22538/abstract/80\">",
"       80",
"      </a>",
"      ]",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Although there are data to the contrary [",
"    <a class=\"abstract\" href=\"UTD.htm?22/0/22538/abstract/86,87\">",
"     86,87",
"    </a>",
"    ], several studies have shown a rise in serum EPO levels with increasing age [",
"    <a class=\"abstract\" href=\"UTD.htm?22/0/22538/abstract/88,89\">",
"     88,89",
"    </a>",
"    ]. This finding suggests the need for relatively more EPO in order to maintain physiologic erythropoiesis in the older adult, possibly secondary to a relative resistance to EPO. Alternatively, elevated EPO levels might reflect decreased utilization by a hypoplastic marrow, increased local hypoxia, or a perturbation in the hypoxia-sensing pathway.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h2\">",
"     Unexplained anemia",
"    </span>",
"    &nbsp;&mdash;&nbsp;Unexplained anemia (also called \"idiopathic anemia of aging\") occurs in approximately 20 to 30 percent of community-dwelling elderly anemic subjects in cross-sectional epidemiologic studies [",
"    <a class=\"abstract\" href=\"UTD.htm?22/0/22538/abstract/13,14,90,91\">",
"     13,14,90,91",
"    </a>",
"    ], and in up to one-half of anemic nursing home residents [",
"    <a class=\"abstract\" href=\"UTD.htm?22/0/22538/abstract/21,92\">",
"     21,92",
"    </a>",
"    ]. Even after a thorough clinical and laboratory evaluation, 17 percent of elderly hospitalized patients with a hemoglobin &lt;11.5",
"    <span class=\"nowrap\">",
"     g/dL",
"    </span>",
"    had unexplained anemia [",
"    <a class=\"abstract\" href=\"UTD.htm?22/0/22538/abstract/93\">",
"     93",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Interest has focused on the importance of this group and potential mechanisms underlying the anemia [",
"    <a class=\"abstract\" href=\"UTD.htm?22/0/22538/abstract/13,94,95\">",
"     13,94,95",
"    </a>",
"    ]. These include hypogonadism [",
"    <a class=\"abstract\" href=\"UTD.htm?22/0/22538/abstract/96\">",
"     96",
"    </a>",
"    ], alterations in hematopoietic stem and erythroid progenitor cell number",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    function [",
"    <a class=\"abstract\" href=\"UTD.htm?22/0/22538/abstract/97,98\">",
"     97,98",
"    </a>",
"    ], age-related decline in renal function",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    erythropoietin secretion [",
"    <a class=\"abstract\" href=\"UTD.htm?22/0/22538/abstract/82,85,90\">",
"     82,85,90",
"    </a>",
"    ], and the presence of \"early\" or overt myelodysplastic syndrome [",
"    <a class=\"abstract\" href=\"UTD.htm?22/0/22538/abstract/99,100\">",
"     99,100",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Results from two studies indicate that EPO levels are significantly lower in this group compared with those in whom the etiology of the anemia is found [",
"    <a class=\"abstract\" href=\"UTD.htm?22/0/22538/abstract/101,102\">",
"     101,102",
"    </a>",
"    ]. If these reports are confirmed, this would suggest impairment in hypoxia sensing, erythropoietin production,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    bone marrow response to erythropoietin.",
"   </p>",
"   <p>",
"    In kinetic terms, the anemia is invariably hypoproliferative, with low absolute reticulocyte counts and a low reticulocyte index. It is customarily assumed that the bone marrow can achieve a compensatory increase in erythropoiesis of about eightfold in children and about fivefold in adults in response to hemolytic anemia. However, there is little information on this point for the older adult. In any case, most of the potential compensatory increases in erythropoiesis appear to be lost in unexplained anemia of the older adult.",
"   </p>",
"   <p>",
"    Increased inflammation, or a &ldquo;proinflammatory state&rdquo; leading to otherwise unexplained anemia in the older adult is an attractive hypothesis, given the increase in interleukin-6 (IL-6) and C-reactive protein seen with advancing age [",
"    <a class=\"abstract\" href=\"UTD.htm?22/0/22538/abstract/103,104\">",
"     103,104",
"    </a>",
"    ], together with the known effects of the",
"    <span class=\"nowrap\">",
"     IL-6/hepcidin",
"    </span>",
"    axis on erythropoiesis [",
"    <a class=\"abstract\" href=\"UTD.htm?22/0/22538/abstract/105\">",
"     105",
"    </a>",
"    ]. However, available studies are conflicting, as shown below.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In two studies, elderly patients with unexplained anemia were found to have no elevation in inflammatory markers (IL-6, tumor necrosis factor alpha, C-reactive protein, hepcidin) compared with non-anemic elderly controls [",
"      <a class=\"abstract\" href=\"UTD.htm?22/0/22538/abstract/90,102\">",
"       90,102",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      In the third study, 18 patients with unexplained anemia were compared with age- and sex-matched controls, as well as a control group with the anemia of chronic inflammation (ACD); there were no significant differences in hepcidin levels between the groups. In this study, plasma hepcidin levels were measured using a newly-described immunoassay which had not been validated in large numbers of older adults [",
"      <a class=\"abstract\" href=\"UTD.htm?22/0/22538/abstract/106\">",
"       106",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      The Leiden 85-Plus Study employed time of flight mass spectrometry to measure plasma hepcidin levels in 490 participants who had reached 85 years of age [",
"      <a class=\"abstract\" href=\"UTD.htm?22/0/22538/abstract/107\">",
"       107",
"      </a>",
"      ]. When compared with the 376 subjects without anemia, mean plasma hepcidin levels were significantly higher in the eight subjects with reduced creatinine clearance, 23 with the anemia of inflammation, and 29 with unexplained anemia.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Although differences in methodology may explain these discordant results, results of the Leiden study suggest that inflammatory processes may contribute to the anemia seen in many older patients, including those with unexplained anemia. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?9/13/9434?source=see_link&amp;anchor=H2#H2\">",
"     \"Anemia of chronic disease (anemia of chronic inflammation)\", section on 'Pathogenesis'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h2\">",
"     Myelodysplastic syndrome",
"    </span>",
"    &nbsp;&mdash;&nbsp;A percentage of older adults with otherwise unexplained anemia are likely to have myelodysplastic syndrome (MDS), a disease of the older adult with a median age at the time of diagnosis of &ge;65 years [",
"    <a class=\"abstract\" href=\"UTD.htm?22/0/22538/abstract/91,108\">",
"     91,108",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?40/57/41882?source=see_link&amp;anchor=H2#H2\">",
"     \"Clinical manifestations and diagnosis of the myelodysplastic syndromes\", section on 'Epidemiology'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Several small studies have investigated the prevalence of MDS in elderly patients with otherwise unexplained anemia.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In the first study, 124 patients &gt;75 years of age underwent evaluation for macrocytosis (mean corpuscular volume &gt; 95 fL). A diagnosis was established in 60 percent by non-invasive techniques; the remaining 49 patients underwent bone marrow examination. Six of 124 (5 percent) were diagnosed with MDS; an additional 19 (15 percent) had some dysplastic features but did not fit diagnostic criteria for MDS by the French-American-British (FAB) classification and were felt to have \"pre-MDS\"; the remaining 24 had no morphological abnormalities [",
"      <a class=\"abstract\" href=\"UTD.htm?22/0/22538/abstract/99\">",
"       99",
"      </a>",
"      ]. There was no follow-up information regarding evolution of the \"pre-MDS\" group to frank MDS or leukemia.",
"     </li>",
"     <li>",
"      In a second study, 37 of 245 (15 percent) hospitalized geriatric patients who underwent evaluation for unexplained hematologic abnormalities were diagnosed with MDS, also using the FAB classification [",
"      <a class=\"abstract\" href=\"UTD.htm?22/0/22538/abstract/100\">",
"       100",
"      </a>",
"      ]. Thirty-four patients had refractory anemia, two had refractory anemia with ringed sideroblasts, and one had refractory anemia with excess blasts. Seven additional patients had dysplastic features in only one cell line, and were considered to have \"early MDS\"; five of these seven had only dysmegakaryopoiesis [",
"      <a class=\"abstract\" href=\"UTD.htm?22/0/22538/abstract/100\">",
"       100",
"      </a>",
"      ]. Follow-up ranged from 1 to 70 months, and there was no survival difference between those with MDS and those with \"early MDS\".",
"     </li>",
"     <li>",
"      In a third study, 178 of 732 (24 percent) patients admitted to an acute geriatric ward (age range: 65 to 81 years) were found to be anemic [",
"      <a class=\"abstract\" href=\"UTD.htm?22/0/22538/abstract/93\">",
"       93",
"      </a>",
"      ]. One hundred nine underwent bone marrow evaluation, and 9 patients of the 178 (5 percent) were diagnosed with MDS by FAB criteria.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Thus, approximately 5 to 15 percent of older adult patients with unexplained anemia are likely to have MDS using FAB criteria, and an additional minority may have abnormalities which are suspicious for, but not confirmatory of, MDS. This \"pre-MDS\" category is particularly intriguing; more data are needed to better categorize these patients and better understand their long-term prognosis. Emerging molecular techniques to detect clonal hematopoiesis will likely play an important role in this area [",
"    <a class=\"abstract\" href=\"UTD.htm?22/0/22538/abstract/109\">",
"     109",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h1\">",
"     MANAGEMENT",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h2\">",
"     Search for treatable disorders",
"    </span>",
"    &nbsp;&mdash;&nbsp;Effective management of anemia in the older adult requires detection and correction of any treatable underlying etiology [",
"    <a class=\"abstract\" href=\"UTD.htm?22/0/22538/abstract/95\">",
"     95",
"    </a>",
"    ]. The following is a partial list of conditions that should be considered in this regard (",
"    <a class=\"graphic graphic_table graphicRef53867 \" href=\"UTD.htm?28/27/29116\">",
"     table 3",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/46/29418?source=see_link\">",
"     \"Approach to the adult patient with anemia\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Deficiencies of iron, vitamin B12, or",
"      <a class=\"drug drug_general\" href=\"UTD.htm?8/61/9174?source=see_link\">",
"       folic acid",
"      </a>",
"     </li>",
"     <li>",
"      Underlying infection, inflammation, or malignancy",
"     </li>",
"     <li>",
"      Myelodysplastic syndrome",
"     </li>",
"     <li>",
"      Renal disease",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Other disorders that should be considered include, but not be limited to, the following:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Bleeding disorder",
"     </li>",
"     <li>",
"      Hypothyroidism",
"     </li>",
"     <li>",
"      Alcohol abuse",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25\">",
"    <span class=\"h2\">",
"     Symptomatic anemia",
"    </span>",
"    &nbsp;&mdash;&nbsp;In the individual with unexplained anemia, treatment requires individual management, and depends upon a multiplicity of factors, including functional status, co-morbidities, and patient wishes. There is no single threshold at which therapy should be initiated. In some patients, a hemoglobin &lt;10",
"    <span class=\"nowrap\">",
"     g/dL",
"    </span>",
"    may be well tolerated, whereas in others, particularly those with underlying cardio-pulmonary or renal disease, intervening to maintain a hemoglobin &gt;10",
"    <span class=\"nowrap\">",
"     g/dL",
"    </span>",
"    may be of benefit. Given the generally mild nature of anemia in this population, the majority of patients will not require therapy. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?5/52/5961?source=see_link\">",
"     \"Indications for red cell transfusion in the adult\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Current therapeutic interventions for the treatment of symptomatic anemia in the older patient are limited to the use of packed red cell transfusions or erythropoiesis stimulating agents (ESAs) [",
"    <a class=\"abstract\" href=\"UTD.htm?22/0/22538/abstract/110\">",
"     110",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26\">",
"    <span class=\"h3\">",
"     Red cell transfusion",
"    </span>",
"    &nbsp;&mdash;&nbsp;Risks of red blood cell transfusion include the more common and less serious febrile or cutaneous reactions, as well as the more rare and more serious risks such as infection, anaphylaxis, volume overload, transfusion-related acute lung injury and fatal hemolytic reactions [",
"    <a class=\"abstract\" href=\"UTD.htm?22/0/22538/abstract/111\">",
"     111",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In addition, given the transient beneficial effects of red cell transfusion, committing those with chronic anemia to a chronic transfusion program brings with it the attendant risks of iron overload. Although transfusional iron overload in thalassemia major leads to severe cardiac and hepatic iron overload [",
"    <a class=\"abstract\" href=\"UTD.htm?22/0/22538/abstract/44\">",
"     44",
"    </a>",
"    ], there is debate about whether iron overload leads to the same degree of organ toxicity in other settings, including MDS [",
"    <a class=\"abstract\" href=\"UTD.htm?22/0/22538/abstract/112\">",
"     112",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    However, current guidelines recommend consideration of iron chelation therapy in patients with lower-risk MDS in whom 20 to 30 units of packed red blood cells have been transfused and who have ongoing transfusion requirements and a serum ferritin &gt;2500",
"    <span class=\"nowrap\">",
"     ng/mL.",
"    </span>",
"    (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/54/25450?source=see_link&amp;anchor=H2104230#H2104230\">",
"     \"Management of the complications of the myelodysplastic syndromes\", section on 'Iron overload'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    It is unknown if similar recommendations are warranted in elderly patients with unexplained anemia who are receiving chronic transfusion therapy.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H27\">",
"    <span class=\"h3\">",
"     Erythropoietin and darbepoetin",
"    </span>",
"    &nbsp;&mdash;&nbsp;The currently available alternative to packed red blood cell transfusion is the use of an erythropoiesis-stimulating agent (ESA). Three ESAs are currently in use:",
"    <a class=\"drug drug_general\" href=\"UTD.htm?2/48/2825?source=see_link\">",
"     epoetin alfa",
"    </a>",
"    , epoetin beta, and darbepoetin. All are recombinant human erythropoietins and bind to the erythropoietin receptor [",
"    <a class=\"abstract\" href=\"UTD.htm?22/0/22538/abstract/110,113\">",
"     110,113",
"    </a>",
"    ]. Most data related to the use of ESAs exist in patients with renal disease (both dialysis-dependent and non-dialysis dependent), myelodysplastic syndrome, and other malignancies. Data from patients with renal disease are most likely to be relevant to elderly patients with unexplained anemia, given the decline in renal function with aging and low erythropoietin levels seen in these patients.",
"   </p>",
"   <p>",
"    A number of trials suggest that ESAs can be harmful in those with renal disease, particularly when the anemia is aggressively corrected. Based in part on these data, the United States Food and Drug Administration has issued a black box warning related to the use of ESAs in renal disease, and the package inserts recommend maintaining hemoglobin levels between 10 and 12",
"    <span class=\"nowrap\">",
"     g/dL.",
"    </span>",
"    (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?40/18/41257?source=see_link&amp;anchor=H17#H17\">",
"     \"Anemia of chronic kidney disease: Target hemoglobin/hematocrit for patients treated with erythropoietic agents\", section on 'Summary and recommendations'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Similar warnings have been given concerning the aggressive use of ESAs in cancer patients. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/15/38138?source=see_link&amp;anchor=H23#H23\">",
"     \"Role of erythropoiesis-stimulating agents in the treatment of anemia in patients with cancer\", section on 'Regulatory and fiscal policies'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The value of erythropoietin for the treatment of chronic unexplained (undiagnosed) anemia in the elderly patient is unclear [",
"    <a class=\"abstract\" href=\"UTD.htm?22/0/22538/abstract/110\">",
"     110",
"    </a>",
"    ]. In one randomized, blinded, placebo-controlled crossover trial in elderly predominately African-American women with unexplained anemia or anemia of inflammation (defined by iron indices), increasing the hemoglobin by 2",
"    <span class=\"nowrap\">",
"     g/dL",
"    </span>",
"    led to improvements in quality of life as measured by the Functional Assessment of Chronic Illness Therapy (FACIT) measurement system [",
"    <a class=\"abstract\" href=\"UTD.htm?22/0/22538/abstract/114\">",
"     114",
"    </a>",
"    ]. Importantly, the target hemoglobin in this study was 13.0 to 13.9",
"    <span class=\"nowrap\">",
"     g/dL,",
"    </span>",
"    a target higher than that suggested in current guidelines and which has been associated with an increased incidence of adverse side effects.",
"   </p>",
"   <p>",
"    No serious adverse events were felt to be treatment related in this study. The one reported thrombotic event was a pulmonary embolism occurring during",
"    <a class=\"drug drug_general\" href=\"UTD.htm?2/48/2825?source=see_link\">",
"     epoetin alfa",
"    </a>",
"    administration with a last study hemoglobin of 14.3",
"    <span class=\"nowrap\">",
"     g/dL.",
"    </span>",
"    (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?5/31/5626?source=see_link&amp;anchor=H16#H16\">",
"     \"Erythropoietin for the anemia of chronic kidney disease in hemodialysis patients\", section on 'Adverse cardiovascular effects with high hemoglobin levels'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/15/38138?source=see_link&amp;anchor=H264001313#H264001313\">",
"     \"Role of erythropoiesis-stimulating agents in the treatment of anemia in patients with cancer\", section on 'Thromboembolic risk'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Additional data are needed to determine whether correction of mild anemia in the elderly patient with unexplained anemia will lead to improvements in functional outcomes without accompanying toxicity, as well as to determine the optimal therapeutic target.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topics (see",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?18/53/19281?source=see_link\">",
"       \"Patient information: Anemia caused by low iron (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Beyond the Basics topics (see",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?29/49/30484?source=see_link\">",
"       \"Patient information: Anemia caused by low iron (Beyond the Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H28\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H29\">",
"    <span class=\"h2\">",
"     Who should be considered anemic",
"    </span>",
"    &nbsp;&mdash;&nbsp;At present, there is not a uniformly accepted definition of anemia for the older adult, with proposed definitions differing by sex, age, race, and ethnicity (",
"    <a class=\"graphic graphic_table graphicRef64238 \" href=\"UTD.htm?41/52/42827\">",
"     table 1",
"    </a>",
"    and",
"    <a class=\"graphic graphic_table graphicRef79757 \" href=\"UTD.htm?37/22/38251\">",
"     table 2",
"    </a>",
"    ). (See",
"    <a class=\"local\" href=\"#H2\">",
"     'Defining anemia in the older adult'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    Until such definitions become available, anemia should be considered when the hemoglobin is &lt;13.0",
"    <span class=\"nowrap\">",
"     g/dL",
"    </span>",
"    in elderly men and &lt;12.0",
"    <span class=\"nowrap\">",
"     g/dL",
"    </span>",
"    in elderly women. (See",
"    <a class=\"local\" href=\"#H3\">",
"     'WHO criteria for anemia'",
"    </a>",
"    above and",
"    <a class=\"local\" href=\"#H5\">",
"     'Proposed definitions'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H30\">",
"    <span class=\"h2\">",
"     Establishing the diagnosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Elderly anemic patients should undergo a standard evaluation for anemia. (See",
"    <a class=\"local\" href=\"#H24\">",
"     'Search for treatable disorders'",
"    </a>",
"    above and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/46/29418?source=see_link&amp;anchor=H52#H52\">",
"     \"Approach to the adult patient with anemia\", section on 'Summary and recommendations'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Testing should include, as a minimum:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Complete blood count with red cell indices, reticulocyte count, platelet count, white blood cell differential and a review of the peripheral smear",
"     </li>",
"     <li>",
"      BUN, creatinine, and urinalysis",
"     </li>",
"     <li>",
"      Stool examination for occult blood if a component of iron deficiency is suspected",
"     </li>",
"     <li>",
"      Serum iron, total iron binding capacity (transferrin) and ferritin",
"     </li>",
"     <li>",
"      Serum B12 and folate",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H31\">",
"    <span class=\"h2\">",
"     Treatment",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Any treatable cause for the anemia, if found (eg, iron deficiency, myelodysplastic syndrome, nutritional anemia), should be corrected.",
"     </li>",
"     <li>",
"      For those with unexplained, mild, asymptomatic anemia, treatment is not indicated.",
"     </li>",
"     <li>",
"      For those with unexplained, symptomatic anemia, options include red cell transfusions or erythropoiesis-stimulating agents (ESAs, eg, erythropoietin, darbepoetin). Available data are insufficient to help in choosing one of these alternatives over another. However, ESAs are not FDA approved for this indication and their use in this setting may not be reimbursed. (See",
"      <a class=\"local\" href=\"#H25\">",
"       'Symptomatic anemia'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      While neither the optimal threshold for initiating therapy nor the optimal therapeutic target have been established for SYMPTOMATIC anemia in the older adult, we suggest a target hemoglobin level in the range of 10 to 12",
"      <span class=\"nowrap\">",
"       g/dL",
"      </span>",
"      (",
"      <a class=\"grade\" href=\"._grade_5?title=Grade 2B\">",
"       Grade 2B",
"      </a>",
"      ).",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/0/22538/abstract/1\">",
"      Price EA, Schrier SL. Anemia in the elderly: introduction. Semin Hematol 2008; 45:207.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/0/22538/abstract/2\">",
"      Price EA, Mehra R, Holmes TH, Schrier SL. Anemia in older persons: etiology and evaluation. Blood Cells Mol Dis 2011; 46:159.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/0/22538/abstract/3\">",
"      Pang WW, Schrier SL. Anemia in the elderly. Curr Opin Hematol 2012; 19:133.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/0/22538/abstract/4\">",
"      Merchant AA, Roy CN. Not so benign haematology: anaemia of the elderly. Br J Haematol 2012; 156:173.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/0/22538/abstract/5\">",
"      Nutritional anaemias. Report of a WHO scientific group. World Health Organ Tech Rep Ser 1968; 405:5.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/0/22538/abstract/6\">",
"      KILPATRICK GS, HARDISTY RM. The prevalence of anaemia in the community. A survey of a random sample of the population. Br Med J 1961; 1:778.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/0/22538/abstract/7\">",
"      De Leeuw NK, Lowenstein L, Hsieh YS. Iron deficiency and hydremia in normal pregnancy. Medicine (Baltimore) 1966; 45:291.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/0/22538/abstract/8\">",
"      STURGEON P. Studies of iron requirements in infants. III. Influence of supplemental iron during normal pregnancy on mother and infant. A The mother. Br J Haematol 1959; 5:31.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/0/22538/abstract/9\">",
"      Natvig K. Studies on hemoglobin values in Norway. V. Hemoglobin concentration and hematocrit in men aged 15-21 years. Acta Med Scand 1966; 180:613.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/0/22538/abstract/10\">",
"      Beutler E, Waalen J. The definition of anemia: what is the lower limit of normal of the blood hemoglobin concentration? Blood 2006; 107:1747.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/0/22538/abstract/11\">",
"      Mindell J, Moody A, Ali A, Hirani V. Using longitudinal data from the Health Survey for England to resolve discrepancies in thresholds for haemoglobin in older adults. Br J Haematol 2013; 160:368.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/0/22538/abstract/12\">",
"      Beutler E, West C. Hematologic differences between African-Americans and whites: the roles of iron deficiency and alpha-thalassemia on hemoglobin levels and mean corpuscular volume. Blood 2005; 106:740.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/0/22538/abstract/13\">",
"      Guralnik JM, Eisenstaedt RS, Ferrucci L, et al. Prevalence of anemia in persons 65 years and older in the United States: evidence for a high rate of unexplained anemia. Blood 2004; 104:2263.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/0/22538/abstract/14\">",
"      Nilsson-Ehle H, Jagenburg R, Landahl S, et al. Haematological abnormalities and reference intervals in the elderly. A cross-sectional comparative study of three urban Swedish population samples aged 70, 75 and 81 years. Acta Med Scand 1988; 224:595.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/0/22538/abstract/15\">",
"      Nilsson-Ehle H, Jagenburg R, Landahl S, et al. Decline of blood haemoglobin in the aged: a longitudinal study of an urban Swedish population from age 70 to 81. Br J Haematol 1989; 71:437.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/0/22538/abstract/16\">",
"      Patel KV. Epidemiology of anemia in older adults. Semin Hematol 2008; 45:210.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/0/22538/abstract/17\">",
"      Culleton BF, Manns BJ, Zhang J, et al. Impact of anemia on hospitalization and mortality in older adults. Blood 2006; 107:3841.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/0/22538/abstract/18\">",
"      Patel KV, Harris TB, Faulhaber M, et al. Racial variation in the relationship of anemia with mortality and mobility disability among older adults. Blood 2007; 109:4663.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/0/22538/abstract/19\">",
"      Penninx BW, Guralnik JM, Onder G, et al. Anemia and decline in physical performance among older persons. Am J Med 2003; 115:104.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/0/22538/abstract/20\">",
"      Izaks GJ, Westendorp RG, Knook DL. The definition of anemia in older persons. JAMA 1999; 281:1714.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/0/22538/abstract/21\">",
"      Artz AS, Fergusson D, Drinka PJ, et al. Mechanisms of unexplained anemia in the nursing home. J Am Geriatr Soc 2004; 52:423.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/0/22538/abstract/22\">",
"      Baldwin JG Jr. Hematopoietic function in the elderly. Arch Intern Med 1988; 148:2544.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/0/22538/abstract/23\">",
"      Balducci L. Epidemiology of anemia in the elderly: information on diagnostic evaluation. J Am Geriatr Soc 2003; 51:S2.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/0/22538/abstract/24\">",
"      Nissenson AR, Goodnough LT, Dubois RW. Anemia: not just an innocent bystander? Arch Intern Med 2003; 163:1400.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/0/22538/abstract/25\">",
"      Begh&eacute; C, Wilson A, Ershler WB. Prevalence and outcomes of anemia in geriatrics: a systematic review of the literature. Am J Med 2004; 116 Suppl 7A:3S.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/0/22538/abstract/26\">",
"      Salive ME, Cornoni-Huntley J, Guralnik JM, et al. Anemia and hemoglobin levels in older persons: relationship with age, gender, and health status. J Am Geriatr Soc 1992; 40:489.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/0/22538/abstract/27\">",
"      An&iacute;a BJ, Suman VJ, Fairbanks VF, Melton LJ 3rd. Prevalence of anemia in medical practice: community versus referral patients. Mayo Clin Proc 1994; 69:730.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/0/22538/abstract/28\">",
"      den Elzen WP, Westendorp RG, Fr&ouml;lich M, et al. Vitamin B12 and folate and the risk of anemia in old age: the Leiden 85-Plus Study. Arch Intern Med 2008; 168:2238.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/0/22538/abstract/29\">",
"      den Elzen WP, Willems JM, Westendorp RG, et al. Effect of anemia and comorbidity on functional status and mortality in old age: results from the Leiden 85-plus Study. CMAJ 2009; 181:151.",
"     </a>",
"    </li>",
"    <li>",
"     Older Americans update 2008: Key indicators of well-being. Federal Interagency Forum on Aging-related Statistics, US Government Printing Office, Washington, DC 2008.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/0/22538/abstract/31\">",
"      Singh PM, Anita P, Vedpal D. Prevalence of anemia in an elderly rural population of northern India. J Am Geriatr Soc 2009; 57:355.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/0/22538/abstract/32\">",
"      Chaves PH, Semba RD, Leng SX, et al. Impact of anemia and cardiovascular disease on frailty status of community-dwelling older women: the Women's Health and Aging Studies I and II. J Gerontol A Biol Sci Med Sci 2005; 60:729.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/0/22538/abstract/33\">",
"      Chaves PH, Xue QL, Guralnik JM, et al. What constitutes normal hemoglobin concentration in community-dwelling disabled older women? J Am Geriatr Soc 2004; 52:1811.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/0/22538/abstract/34\">",
"      Chaves PH. Functional outcomes of anemia in older adults. Semin Hematol 2008; 45:255.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/0/22538/abstract/35\">",
"      Artz AS. Anemia and the frail elderly. Semin Hematol 2008; 45:261.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/0/22538/abstract/36\">",
"      Fried LP, Guralnik JM. Disability in older adults: evidence regarding significance, etiology, and risk. J Am Geriatr Soc 1997; 45:92.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/0/22538/abstract/37\">",
"      Harris T, Kovar MG, Suzman R, et al. Longitudinal study of physical ability in the oldest-old. Am J Public Health 1989; 79:698.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/0/22538/abstract/38\">",
"      Chaves PH, Ashar B, Guralnik JM, Fried LP. Looking at the relationship between hemoglobin concentration and prevalent mobility difficulty in older women. Should the criteria currently used to define anemia in older people be reevaluated? J Am Geriatr Soc 2002; 50:1257.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/0/22538/abstract/39\">",
"      Penninx BW, Pahor M, Cesari M, et al. Anemia is associated with disability and decreased physical performance and muscle strength in the elderly. J Am Geriatr Soc 2004; 52:719.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/0/22538/abstract/40\">",
"      Thein M, Ershler WB, Artz AS, et al. Diminished quality of life and physical function in community-dwelling elderly with anemia. Medicine (Baltimore) 2009; 88:107.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/0/22538/abstract/41\">",
"      Penninx BW, Pluijm SM, Lips P, et al. Late-life anemia is associated with increased risk of recurrent falls. J Am Geriatr Soc 2005; 53:2106.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/0/22538/abstract/42\">",
"      Lucca U, Tettamanti M, Mosconi P, et al. Association of mild anemia with cognitive, functional, mood and quality of life outcomes in the elderly: the \"Health and Anemia\" study. PLoS One 2008; 3:e1920.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/0/22538/abstract/43\">",
"      Chaves PH, Carlson MC, Ferrucci L, et al. Association between mild anemia and executive function impairment in community-dwelling older women: The Women's Health and Aging Study II. J Am Geriatr Soc 2006; 54:1429.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/0/22538/abstract/44\">",
"      Zurlo MG, De Stefano P, Borgna-Pignatti C, et al. Survival and causes of death in thalassaemia major. Lancet 1989; 2:27.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/0/22538/abstract/45\">",
"      Denny SD, Kuchibhatla MN, Cohen HJ. Impact of anemia on mortality, cognition, and function in community-dwelling elderly. Am J Med 2006; 119:327.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/0/22538/abstract/46\">",
"      Kikuchi M, Inagaki T, Shinagawa N. Five-year survival of older people with anemia: variation with hemoglobin concentration. J Am Geriatr Soc 2001; 49:1226.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/0/22538/abstract/47\">",
"      Gagnon DR, Zhang TJ, Brand FN, Kannel WB. Hematocrit and the risk of cardiovascular disease--the Framingham study: a 34-year follow-up. Am Heart J 1994; 127:674.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/0/22538/abstract/48\">",
"      Zakai NA, French B, Arnold AM, et al. Hemoglobin decline, function, and mortality in the elderly: the cardiovascular health study. Am J Hematol 2013; 88:5.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/0/22538/abstract/49\">",
"      Patel KV, Longo DL, Ershler WB, et al. Haemoglobin concentration and the risk of death in older adults: differences by race/ethnicity in the NHANES III follow-up. Br J Haematol 2009; 145:514.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/0/22538/abstract/50\">",
"      Dong X, Mendes de Leon C, Artz A, et al. A population-based study of hemoglobin, race, and mortality in elderly persons. J Gerontol A Biol Sci Med Sci 2008; 63:873.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/0/22538/abstract/51\">",
"      Artz A, Dong X. Defining anemia by race using epidemiologic data. Blood 2008; 111:2941; author reply 2941.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/0/22538/abstract/52\">",
"      Semba RD, Ricks MO, Ferrucci L, et al. Types of anemia and mortality among older disabled women living in the community: the Women's Health and Aging Study I. Aging Clin Exp Res 2007; 19:259.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/0/22538/abstract/53\">",
"      Carmel R. Nutritional anemias and the elderly. Semin Hematol 2008; 45:225.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/0/22538/abstract/54\">",
"      Carmel R, Green R, Rosenblatt DS, Watkins D. Update on cobalamin, folate, and homocysteine. Hematology Am Soc Hematol Educ Program 2003; :62.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/0/22538/abstract/55\">",
"      Carmel R. How I treat cobalamin (vitamin B12) deficiency. Blood 2008; 112:2214.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/0/22538/abstract/56\">",
"      Pennypacker LC, Allen RH, Kelly JP, et al. High prevalence of cobalamin deficiency in elderly outpatients. J Am Geriatr Soc 1992; 40:1197.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/0/22538/abstract/57\">",
"      Perlstein TS, Pande R, Berliner N, Vanasse GJ. Prevalence of 25-hydroxyvitamin D deficiency in subgroups of elderly persons with anemia: association with anemia of inflammation. Blood 2011; 117:2800.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/0/22538/abstract/58\">",
"      Sawada K, Fujishima N, Hirokawa M. Acquired pure red cell aplasia: updated review of treatment. Br J Haematol 2008; 142:505.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/0/22538/abstract/59\">",
"      Vardiman JW, Harris NL, Brunning RD. The World Health Organization (WHO) classification of the myeloid neoplasms. Blood 2002; 100:2292.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/0/22538/abstract/60\">",
"      Schultz BM, Freedman ML. Iron deficiency in the elderly. Baillieres Clin Haematol 1987; 1:291.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/0/22538/abstract/61\">",
"      Punnonen K, Irjala K, Rajam&auml;ki A. Serum transferrin receptor and its ratio to serum ferritin in the diagnosis of iron deficiency. Blood 1997; 89:1052.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/0/22538/abstract/62\">",
"      Lipschitz DA, Cook JD, Finch CA. A clinical evaluation of serum ferritin as an index of iron stores. N Engl J Med 1974; 290:1213.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/0/22538/abstract/63\">",
"      Casale G, Bonora C, Migliavacca A, et al. Serum ferritin and ageing. Age Ageing 1981; 10:119.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/0/22538/abstract/64\">",
"      Joosten E, Hiele M, Ghoos Y, et al. Diagnosis of iron-deficiency anemia in a hospitalized geriatric population. Am J Med 1991; 90:653.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/0/22538/abstract/65\">",
"      Weiss G, Goodnough LT. Anemia of chronic disease. N Engl J Med 2005; 352:1011.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/0/22538/abstract/66\">",
"      Ferrucci L, Balducci L. Anemia of aging: the role of chronic inflammation and cancer. Semin Hematol 2008; 45:242.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/0/22538/abstract/67\">",
"      Rimon E, Levy S, Sapir A, et al. Diagnosis of iron deficiency anemia in the elderly by transferrin receptor-ferritin index. Arch Intern Med 2002; 162:445.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/0/22538/abstract/68\">",
"      Karlsson T. Comparative evaluation of the reticulocyte hemoglobin content assay when screening for iron deficiency in elderly anemic patients. Anemia 2011; 2011:925907.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/0/22538/abstract/69\">",
"      Ruivard M, Gerbaud L, Doz M, Philippe P. Ferritin is more cost-effective than transferrin receptor-ferritin index for the diagnosis of iron deficiency. Arch Intern Med 2002; 162:1783.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/0/22538/abstract/70\">",
"      Pfeiffer CM, Cook JD, Mei Z, et al. Evaluation of an automated soluble transferrin receptor (sTfR) assay on the Roche Hitachi analyzer and its comparison to two ELISA assays. Clin Chim Acta 2007; 382:112.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/0/22538/abstract/71\">",
"      Worwood M. Soluble transferrin receptor and iron homeostasis. Haematologica 2005; 90:2.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/0/22538/abstract/72\">",
"      Rockey DC, Cello JP. Evaluation of the gastrointestinal tract in patients with iron-deficiency anemia. N Engl J Med 1993; 329:1691.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/0/22538/abstract/73\">",
"      Rockey DC. Gastrointestinal tract evaluation in patients with iron deficiency anemia. Semin Gastrointest Dis 1999; 10:53.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/0/22538/abstract/74\">",
"      Nahon S, Lahmek P, Aras N, et al. Management and predictors of early mortality in elderly patients with iron deficiency anemia: a prospective study of 111 patients. Gastroenterol Clin Biol 2007; 31:169.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/0/22538/abstract/75\">",
"      Nahon S, Lahmek P, Barclay F, et al. Long-term follow-up and predictive factors of recurrence of anemia in a cohort of 102 very elderly patients explored for iron-deficiency anemia. J Clin Gastroenterol 2008; 42:984.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/0/22538/abstract/76\">",
"      Joosten E, Ghesquiere B, Linthoudt H, et al. Upper and lower gastrointestinal evaluation of elderly inpatients who are iron deficient. Am J Med 1999; 107:24.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/0/22538/abstract/77\">",
"      Joosten E, Meeuwissen J, Vandewinckele H, Hiele M. Iron status and colorectal cancer in symptomatic elderly patients. Am J Med 2008; 121:1072.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/0/22538/abstract/78\">",
"      Erslev AJ, Caro J, Miller O, Silver R. Plasma erythropoietin in health and disease. Ann Clin Lab Sci 1980; 10:250.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/0/22538/abstract/79\">",
"      Radtke HW, Claussner A, Erbes PM, et al. Serum erythropoietin concentration in chronic renal failure: relationship to degree of anemia and excretory renal function. Blood 1979; 54:877.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/0/22538/abstract/80\">",
"      Artunc F, Risler T. Serum erythropoietin concentrations and responses to anaemia in patients with or without chronic kidney disease. Nephrol Dial Transplant 2007; 22:2900.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/0/22538/abstract/81\">",
"      Rowe JW, Andres R, Tobin JD, et al. The effect of age on creatinine clearance in men: a cross-sectional and longitudinal study. J Gerontol 1976; 31:155.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/0/22538/abstract/82\">",
"      Adamson JW. Renal disease and anemia in the elderly. Semin Hematol 2008; 45:235.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/0/22538/abstract/83\">",
"      Cumming RG, Mitchell P, Craig JC, Knight JF. Renal impairment and anaemia in a population-based study of older people. Intern Med J 2004; 34:20.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/0/22538/abstract/84\">",
"      Hsu CY, McCulloch CE, Curhan GC. Epidemiology of anemia associated with chronic renal insufficiency among adults in the United States: results from the Third National Health and Nutrition Examination Survey. J Am Soc Nephrol 2002; 13:504.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/0/22538/abstract/85\">",
"      Ble A, Fink JC, Woodman RC, et al. Renal function, erythropoietin, and anemia of older persons: the InCHIANTI study. Arch Intern Med 2005; 165:2222.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/0/22538/abstract/86\">",
"      Mori M, Murai Y, Hirai M, et al. Serum erythropoietin titers in the aged. Mech Ageing Dev 1988; 46:105.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/0/22538/abstract/87\">",
"      Musso CG, Musso CA, Joseph H, et al. Plasma erythropoietin levels in the oldest old. Int Urol Nephrol 2004; 36:259.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/0/22538/abstract/88\">",
"      Ershler WB, Sheng S, McKelvey J, et al. Serum erythropoietin and aging: a longitudinal analysis. J Am Geriatr Soc 2005; 53:1360.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/0/22538/abstract/89\">",
"      Kario K, Matsuo T, Nakao K. Serum erythropoietin levels in the elderly. Gerontology 1991; 37:345.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/0/22538/abstract/90\">",
"      Ferrucci L, Guralnik JM, Bandinelli S, et al. Unexplained anaemia in older persons is characterised by low erythropoietin and low levels of pro-inflammatory markers. Br J Haematol 2007; 136:849.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/0/22538/abstract/91\">",
"      Tettamanti M, Lucca U, Gandini F, et al. Prevalence, incidence and types of mild anemia in the elderly: the \"Health and Anemia\" population-based study. Haematologica 2010; 95:1849.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/0/22538/abstract/92\">",
"      Artz AS, Fergusson D, Drinka PJ, et al. Prevalence of anemia in skilled-nursing home residents. Arch Gerontol Geriatr 2004; 39:201.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/0/22538/abstract/93\">",
"      Joosten E, Pelemans W, Hiele M, et al. Prevalence and causes of anaemia in a geriatric hospitalized population. Gerontology 1992; 38:111.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/0/22538/abstract/94\">",
"      Makipour S, Kanapuru B, Ershler WB. Unexplained anemia in the elderly. Semin Hematol 2008; 45:250.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/0/22538/abstract/95\">",
"      Steensma DP, Tefferi A. Anemia in the elderly: how should we define it, when does it matter, and what can be done? Mayo Clin Proc 2007; 82:958.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/0/22538/abstract/96\">",
"      Ferrucci L, Maggio M, Bandinelli S, et al. Low testosterone levels and the risk of anemia in older men and women. Arch Intern Med 2006; 166:1380.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/0/22538/abstract/97\">",
"      Gazit R, Weissman IL, Rossi DJ. Hematopoietic stem cells and the aging hematopoietic system. Semin Hematol 2008; 45:218.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/0/22538/abstract/98\">",
"      Pang WW, Price EA, Weissman IL, Schrier SL. Hematopoiesis in the elderly: Age-associated effects in frequency, function, and gene expression of human hematopoietic stem cells (abstract). Blood 2009; 114:604.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/0/22538/abstract/99\">",
"      Mahmoud MY, Lugon M, Anderson CC. Unexplained macrocytosis in elderly patients. Age Ageing 1996; 25:310.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/0/22538/abstract/100\">",
"      Beloosesky Y, Cohen AM, Grosman B, Grinblat J. Prevalence and survival of myelodysplastic syndrome of the refractory anemia type in hospitalized cognitively different geriatric patients. Gerontology 2000; 46:323.",
"     </a>",
"    </li>",
"    <li>",
"     Price EA, Schrier SL. A large proportion of elderly patients with anemia seen in the outpatient setting have unexplained anemia, which is characterized as a hypoproliferative, normocytic anemia. American Society of Hematology Annual Meeting; 2007; Atlanta, Georgia. ASH Annual Meeting Poster 3667.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/0/22538/abstract/102\">",
"      Waalen J, von L&ouml;hneysen K, Lee P, et al. Erythropoietin, GDF15, IL6, hepcidin and testosterone levels in a large cohort of elderly individuals with anaemia of known and unknown cause. Eur J Haematol 2011; 87:107.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/0/22538/abstract/103\">",
"      Ershler WB, Sun WH, Binkley N, et al. Interleukin-6 and aging: blood levels and mononuclear cell production increase with advancing age and in vitro production is modifiable by dietary restriction. Lymphokine Cytokine Res 1993; 12:225.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/0/22538/abstract/104\">",
"      Ferrucci L, Semba RD, Guralnik JM, et al. Proinflammatory state, hepcidin, and anemia in older persons. Blood 2010; 115:3810.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/0/22538/abstract/105\">",
"      Ganz T. Hepcidin and its role in regulating systemic iron metabolism. Hematology Am Soc Hematol Educ Program 2006; :29.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/0/22538/abstract/106\">",
"      Ganz T, Olbina G, Girelli D, et al. Immunoassay for human serum hepcidin. Blood 2008; 112:4292.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/0/22538/abstract/107\">",
"      den Elzen WP, de Craen AJ, Wiegerinck ET, et al. Plasma hepcidin levels and anemia in old age. The Leiden 85-Plus Study. Haematologica 2013; 98:448.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/0/22538/abstract/108\">",
"      Ma X, Does M, Raza A, Mayne ST. Myelodysplastic syndromes: incidence and survival in the United States. Cancer 2007; 109:1536.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/0/22538/abstract/109\">",
"      Swierczek SI, Agarwal N, Nussenzveig RH, et al. Hematopoiesis is not clonal in healthy elderly women. Blood 2008; 112:3186.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/0/22538/abstract/110\">",
"      Agarwal N, Prchal JT. Erythropoietic agents and the elderly. Semin Hematol 2008; 45:267.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/0/22538/abstract/111\">",
"      Klein HG, Spahn DR, Carson JL. Red blood cell transfusion in clinical practice. Lancet 2007; 370:415.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/0/22538/abstract/112\">",
"      Konen E, Ghoti H, Goitein O, et al. No evidence for myocardial iron overload in multitransfused patients with myelodysplastic syndrome using cardiac magnetic resonance T2 technique. Am J Hematol 2007; 82:1013.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/0/22538/abstract/113\">",
"      Koury MJ, Bondurant MC. Erythropoietin retards DNA breakdown and prevents programmed death in erythroid progenitor cells. Science 1990; 248:378.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/0/22538/abstract/114\">",
"      Agnihotri P, Telfer M, Butt Z, et al. Chronic anemia and fatigue in elderly patients: results of a randomized, double-blind, placebo-controlled, crossover exploratory study with epoetin alfa. J Am Geriatr Soc 2007; 55:1557.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 7130 Version 20.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1005-83.177.194.223-B60670ABF6-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f22_0_22538=[""].join("\n");
var outline_f22_0_22538=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H28\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      DEFINING ANEMIA IN THE OLDER ADULT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      WHO criteria for anemia",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Racial and ethnic considerations",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Proposed definitions",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Significance of these definitions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      PREVALENCE AND CLINICAL IMPORTANCE",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Degree of severity",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Functional outcomes",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Increased mortality",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      - Effect of race",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      - Other factors",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      ETIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H24163702\">",
"      NAHANES III Study",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H21668749\">",
"      Stanford study",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      DIAGNOSTIC EVALUATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Initial approach",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Iron deficiency anemia",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      - Making the diagnosis",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      - Treatment",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      - Determining the cause",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      Renal disease/hypoxia-sensing abnormalities",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      Unexplained anemia",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      Myelodysplastic syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      MANAGEMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      Search for treatable disorders",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H25\">",
"      Symptomatic anemia",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H26\">",
"      - Red cell transfusion",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H27\">",
"      - Erythropoietin and darbepoetin",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H28\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H29\">",
"      Who should be considered anemic",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H30\">",
"      Establishing the diagnosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H31\">",
"      Treatment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"HEME/7130\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"HEME/7130|ALG\">",
"      <a href=\"#\" title=\"ALGORITHMS\">",
"       ALGORITHMS",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_algorithm\" href=\"UTD.htm?6/61/7123\" title=\"algorithm 1\">",
"      Evaluation of anemia in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"HEME/7130|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?34/53/35677\" title=\"figure 1\">",
"      Serum EPO and anemia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"HEME/7130|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?41/52/42827\" title=\"table 1\">",
"      Normal red cell values",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?37/22/38251\" title=\"table 2\">",
"      Anemia in elderly adults",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?28/27/29116\" title=\"table 3\">",
"      Causes of anemia",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?9/13/9434?source=related_link\">",
"      Anemia of chronic disease (anemia of chronic inflammation)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?40/18/41257?source=related_link\">",
"      Anemia of chronic kidney disease: Target hemoglobin/hematocrit for patients treated with erythropoietic agents",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?28/46/29418?source=related_link\">",
"      Approach to the adult patient with anemia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?25/39/26234?source=related_link\">",
"      Causes and diagnosis of anemia due to iron deficiency",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?40/57/41882?source=related_link\">",
"      Clinical manifestations and diagnosis of the myelodysplastic syndromes",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?37/13/38106?source=related_link\">",
"      Clinical manifestations and diagnosis of the thalassemias",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?40/51/41783?source=related_link\">",
"      Community public health issues and the thalassemic syndromes: Lessons from other countries",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?14/59/15290?source=related_link\">",
"      Diagnosis of monoclonal gammopathy of undetermined significance",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?5/31/5626?source=related_link\">",
"      Erythropoietin for the anemia of chronic kidney disease in hemodialysis patients",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?11/32/11786?source=related_link\">",
"      Etiology and clinical manifestations of vitamin B12 and folate deficiency",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?5/52/5961?source=related_link\">",
"      Indications for red cell transfusion in the adult",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?24/54/25450?source=related_link\">",
"      Management of the complications of the myelodysplastic syndromes",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?34/45/35543?source=related_link\">",
"      Mean corpuscular volume",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?29/49/30484?source=related_link\">",
"      Patient information: Anemia caused by low iron (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?18/53/19281?source=related_link\">",
"      Patient information: Anemia caused by low iron (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?20/10/20650?source=related_link\">",
"      Regulation of erythropoiesis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?37/15/38138?source=related_link\">",
"      Role of erythropoiesis-stimulating agents in the treatment of anemia in patients with cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?24/62/25578?source=related_link\">",
"      Treatment of anemia due to iron deficiency",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f22_0_22539="Effects of sedative drugs";
var content_f22_0_22539=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F51282&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=8\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F51282&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=8\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Effects of sedative drugs",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tr>",
"      <td class=\"subtitle1\">",
"       Drug",
"      </td>",
"      <td class=\"subtitle1\">",
"       Anxiolysis",
"      </td>",
"      <td class=\"subtitle1\">",
"       Hypnosis",
"      </td>",
"      <td class=\"subtitle1\">",
"       Amnesia",
"      </td>",
"      <td class=\"subtitle1\">",
"       Analgesia",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Benzodiazepines",
"      </td>",
"      <td>",
"       +",
"      </td>",
"      <td>",
"       +",
"      </td>",
"      <td>",
"       +",
"      </td>",
"      <td>",
"       -",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Dexmedetomidine",
"      </td>",
"      <td>",
"       +",
"      </td>",
"      <td>",
"       -",
"      </td>",
"      <td>",
"       -",
"      </td>",
"      <td>",
"       +",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Haloperidol",
"      </td>",
"      <td>",
"       +",
"      </td>",
"      <td>",
"       +*",
"      </td>",
"      <td>",
"       +*",
"      </td>",
"      <td>",
"       -",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Opioid analgesics",
"      </td>",
"      <td>",
"       -",
"      </td>",
"      <td>",
"       -",
"      </td>",
"      <td>",
"       -",
"      </td>",
"      <td>",
"       +",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Propofol",
"      </td>",
"      <td>",
"       +&bull;",
"      </td>",
"      <td>",
"       +",
"      </td>",
"      <td>",
"       +*",
"      </td>",
"      <td>",
"       -",
"      </td>",
"     </tr>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     * Minimal effect.",
"     <br>",
"      &bull; Only at low doses.",
"     </br>",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f22_0_22539=[""].join("\n");
var outline_f22_0_22539=null;
var title_f22_0_22540="Nutritional deficiency IBD";
var content_f22_0_22540=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F72725&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=7\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F72725&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=7\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Laboratory evidence of nutritional deficiences reported in adults with inflammatory bowel disease",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        &nbsp;",
"       </td>",
"       <td class=\"subtitle1\">",
"        Percent",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Hypoalbuminemia",
"       </td>",
"       <td>",
"        25&nbsp;to 80",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Anemia",
"       </td>",
"       <td>",
"        60&nbsp;to 80",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Iron deficiency",
"       </td>",
"       <td>",
"        39&nbsp;to 81",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Vitamin B12 deficiency",
"        <sup>",
"         &bull;",
"        </sup>",
"       </td>",
"       <td>",
"        20&nbsp;to 60",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Folic acid deficiency",
"       </td>",
"       <td>",
"        36&nbsp;to 54",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Calcium deficiency",
"       </td>",
"       <td>",
"        13",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Magnesium deficiency",
"       </td>",
"       <td>",
"        14&nbsp;to 33",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Potassium deficiency",
"       </td>",
"       <td>",
"        6&nbsp;to 20",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Vitamin A deficiency",
"       </td>",
"       <td>",
"        11",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Vitamin&nbsp;D deficiency",
"       </td>",
"       <td>",
"        75",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Vitamin&nbsp;E deficiency",
"       </td>",
"       <td>",
"        *",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Vitamin K deficiency",
"       </td>",
"       <td>",
"        *",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Zinc deficiency",
"       </td>",
"       <td>",
"        40&nbsp;to 50",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Copper deficiency",
"       </td>",
"       <td>",
"        *",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Vitamin C deficiency&nbsp;",
"       </td>",
"       <td>",
"        *&nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Vitamin B1 (thiamine) deficiency",
"        <sup>",
"         [1]",
"        </sup>",
"       </td>",
"       <td>",
"        32&nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Niacin deficiency",
"       </td>",
"       <td>",
"        *",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     * Cases reported but prevalence not described.",
"     <br>",
"      &bull; Frequency of vitamin B12 deficiency depends on extent of ileal involvement or ileal resection.",
"     </br>",
"    </div>",
"    <div class=\"reference\">",
"     Adapted from: Perkal MF, Seashore JH.&nbsp;Nutrition and inflammatory bowel disease. Gastroenterol Clin N Am 1989; 18(3):567.",
"     <ol>",
"      <li>",
"       Hwang C, Ross V, Mahadevan U. Micronutrient deficiencies in inflammatory bowel disease: from A to zinc. Inflamm Bowel Dis 2012; 18:1961.",
"      </li>",
"     </ol>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f22_0_22540=[""].join("\n");
var outline_f22_0_22540=null;
var title_f22_0_22541="Summary ACIP recs I";
var content_f22_0_22541=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ALLRG%2F72390&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=13\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ALLRG%2F72390&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=13\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Summary of ACIP recommendations on immunization of immunocompromised infants and children",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Vaccine",
"       </td>",
"       <td class=\"subtitle1\">",
"        Routine",
"        <br/>",
"        (not immunocompromised)",
"       </td>",
"       <td class=\"subtitle1\">",
"        HIV infection/ AIDS",
"       </td>",
"       <td class=\"subtitle1\">",
"        Severely immunocompromised",
"        <br/>",
"        (non- HIV-related)*",
"       </td>",
"       <td class=\"subtitle1\">",
"        Asplenia",
"       </td>",
"       <td class=\"subtitle1\">",
"        Renal failure",
"       </td>",
"       <td class=\"subtitle1\">",
"        Diabetes",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"7\">",
"        Routine infant immunizations",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        DTP(DT/T/Td)",
"        <sup>",
"         &bull;",
"        </sup>",
"       </td>",
"       <td>",
"        Recommended",
"       </td>",
"       <td>",
"        Recommended",
"       </td>",
"       <td>",
"        Recommended",
"       </td>",
"       <td>",
"        Recommended",
"       </td>",
"       <td>",
"        Recommended",
"       </td>",
"       <td>",
"        Recommended",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        OPV",
"       </td>",
"       <td>",
"        Use if indicated",
"       </td>",
"       <td>",
"        Use if indicated",
"       </td>",
"       <td>",
"        Contraindicated",
"       </td>",
"       <td>",
"        Use if indicated",
"       </td>",
"       <td>",
"        Use if indicated",
"       </td>",
"       <td>",
"        Use if indicated",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        eIPV",
"       </td>",
"       <td>",
"        Recommended",
"       </td>",
"       <td>",
"        Recommended",
"       </td>",
"       <td>",
"        Recommended",
"       </td>",
"       <td>",
"        Recommended",
"       </td>",
"       <td>",
"        Recommended",
"       </td>",
"       <td>",
"        Recommended",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        MMR(MR/M/R)",
"       </td>",
"       <td>",
"        Recommended",
"       </td>",
"       <td>",
"        Recommended/ considered",
"       </td>",
"       <td>",
"        Contraindicated",
"       </td>",
"       <td>",
"        Recommended",
"       </td>",
"       <td>",
"        Recommended",
"       </td>",
"       <td>",
"        Recommended",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Varicella",
"       </td>",
"       <td>",
"        Recommended",
"       </td>",
"       <td>",
"        Recommended/ considered",
"       </td>",
"       <td>",
"        Contraindicated",
"       </td>",
"       <td>",
"        Recommended",
"       </td>",
"       <td>",
"        Recommended",
"       </td>",
"       <td>",
"        Recommended",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Hib",
"       </td>",
"       <td>",
"        Recommended",
"       </td>",
"       <td>",
"        Recommended",
"       </td>",
"       <td>",
"        Recommended",
"       </td>",
"       <td>",
"        Recommended",
"       </td>",
"       <td>",
"        Recommended",
"       </td>",
"       <td>",
"        Recommended",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Hepatitis B",
"       </td>",
"       <td>",
"        Recommended",
"       </td>",
"       <td>",
"        Recommended",
"       </td>",
"       <td>",
"        Recommended",
"       </td>",
"       <td>",
"        Recommended",
"       </td>",
"       <td>",
"        Recommended",
"       </td>",
"       <td>",
"        Recommended",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Pneumoccocal&sect;&nbsp;",
"       </td>",
"       <td>",
"        Recommended",
"       </td>",
"       <td>",
"        Recommended",
"       </td>",
"       <td>",
"        Recommended",
"       </td>",
"       <td>",
"        Recommended",
"       </td>",
"       <td>",
"        Recommended",
"       </td>",
"       <td>",
"        Recommended",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Influenza",
"        <sup>",
"         &Delta;&loz;",
"        </sup>",
"       </td>",
"       <td>",
"        Recommended",
"       </td>",
"       <td>",
"        Recommended",
"       </td>",
"       <td>",
"        Recommended",
"       </td>",
"       <td>",
"        Recommended",
"       </td>",
"       <td>",
"        Recommended",
"       </td>",
"       <td>",
"        Recommended",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     * Severe immunosuppression can be the result of congenital immunodeficiency, HIV infection, leukemia, lymphoma, aplastic anemia, generalized malignancy, or therapy with alkylating agents, antimetabolites, radiation or large amounts of corticosteroids.",
"     <br>",
"      <font class=\"bullet\">",
"       &bull;",
"      </font>",
"      Including DTaP (diphtheria, tetanus, acellular pertussis).",
"      <br>",
"       &Delta; Routinely recommended for children between 6 and 59 months of age.",
"       <br>",
"        <font class=\"lozenge\">",
"         &loz;",
"        </font>",
"        Inactivated vaccine.",
"        <br>",
"         &sect; In 2012, the ACIP recommended the use of the 13-valent pneumococcal conjugate vaccine in children and adults with immunocompromising conditions or functional or anatomic asplenia, in addition to the pneumococcal polysaccharide vaccine (PPSV23). Patients who have not been previously immunized with the unconjugated vaccine should receive 13-valent conjugate vaccine first, followed 8 weeks later by PPSV23. Patients who have previously received PPSV23 should receive the 13-valent conjugate vaccine after an interval of at least one year.",
"        </br>",
"       </br>",
"      </br>",
"     </br>",
"    </div>",
"    <div class=\"reference\">",
"     Adapted from: CDC. Recommendations of the advisory committee on immunization practices (ACIP): use of vaccines and immune globulins for persons with altered immune competence. MMWR 2006; 55RR-15:1 and the American Academy of Pediatrics Red Book: 2006 Report of the Committee on Infectious Diseases.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f22_0_22541=[""].join("\n");
var outline_f22_0_22541=null;
var title_f22_0_22542="Acute urticaria child";
var content_f22_0_22542=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ALLRG%2F81168&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ALLRG%2F81168&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Urticaria",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 206px; height: 175px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Fleisher GR, Ludwig S, Baskin MN. Atlas of Pediatric Emergency Medicine. Philadelphia: Lippincott Williams &amp; Wilkins, 2004. Copyright &copy; 2004 Lippincott Williams &amp; Wilkins.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f22_0_22542=[""].join("\n");
var outline_f22_0_22542=null;
var title_f22_0_22543="Dx incomplete KD";
var content_f22_0_22543=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F79349&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F79349&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 541px\">",
"   <div class=\"ttl\">",
"    Evaluation of suspected incomplete Kawasaki disease (KD)*",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 521px; height: 524px; background-image: url(data:image/gif;base64,R0lGODlhCQIMAsQAAP///wAAAIiIiERERLu7uyIiIpmZmWZmZt3d3TMzMxEREe7u7szMzFVVVXd3d6qqqj8/P8/Pz5+fn9/f319fXw8PD+/v739/f7+/vwAAAAAAAAAAAAAAAAAAAAAAAAAAACH5BAAAAAAALAAAAAAJAgwCAAX/ICCOZGmeaKqubOu+cCzPdG3feK7vfO//wKBwSCwaj8ikcslsOp/QqHRKrVqv2Kx2y+16v+CweEwum8/otHrNbrvf8Lh8Tq/b7/i8fs/v+/+AgYKDhIWGh0QBiouMjY6PkJGSk5SVlpeYkYibnF0BnYmgoqNRn6Q/pqeqq0OprDmur7KzNbG0M7a3ursnubwtvr/CtMHDKMXGyaTIyiPMzdCHz83T0daB1U0CA0UE2Trf1+J6vo1CBowEJ9vdsQ6KBQwyCwqKCQjH4/rSxwY9BwP8kTBQYAU7It5KNJDXoIGNBA7y7ZsoqJxAAAgSKDoAoIAAAPQeECigyN+AbQUH/zZQcGCBCHSKPpIQsIjbgUUGEARQ523BO0XyRpAMEA9AAI0B/I1chMKBQxIDFA1wmbQAxxILClwsEY6i1zblFglowBGBAgYCCqYFoMDfAwUABtxLUXJggKAAGOwEcFDEgQQADnAUbPSBigIRA3xcq+BjQhMEFOAbkXbBggQfAzwtcZObxK+g81gUysgAPQIJcjZCcPKEgZUtTex9mZKdgHpEAUTWiS9tgNgiFtzcaFQdQd66bRHE6/eqAI6zT5D9HLo6ndEippM4UECBy7ZQZW4PqNCfAe8j9DIcoNOwg5RyN4sA/zKAywTQjRdszDeWXJclVJZVZuqoJEIC8pHQlf91DIKBHUZIBYCPTjItlVtrnDXiD00B0DfCcAlwExVRKT2wFz32AAghPPkBQJCL9riiEyOTiTDiVMWVwABSc/XS4I9vLChFX2QICeSRVhj5hFmGmaEkklBC8SQxUVY5xpSzYGnllkVouQKGNkRHxGUBeAaEl1ymiYoRrYk5Aph0FbhCQkSi8FiAizS5ppp8JsmmeLXI2UKdMHAYgJ4+oNnnomEGYSgDbRLgjUZnxbXYIgwMVZSYFgqwDU3ozPhbRsR9mtQnMP0GkkZm7snoq00oKoJeckbqjToDcHQSrSYgluMI/ImQFk+fHDSdWWgVQKxdKrYC67NLyOpiSjYS+Bj/YSe9GNxwqkaHnLCe0enZUCUdlJABEdboLLTsGiEtr9UWd62uAsCLzn0tAiueucUCBoB24IqQkK8mqiuEtO0m7IyjmNpqCraXAoWUVb8KjJun4X7CQD0HkKoIAvz2R5SE7ipssqsUIXwyuyqL0vLKsL7cicwwL0rzJjfXrGbO/Ojssww8GxL0z1EOTYjRRB+ZydJMN+3001Cbk/TUcSBN9dWcWI311oVozfXXgHgN9th7iE322XaYjfbabUwQgQimRDAB23TTYkEAEEgQgAQQBGBB3YC/QkEjFARuuCoRNPL24YyL0rciEDQueSd6KyLB5JgjUkEAFWTueSEXBHDB/+ekBzJBAHOXrnofGKzu+uuwxy776lHXbrvtsweutpS5A777E7/3Xl3wsQpPN/FMIG98yoMov/w+zicR/fPiTH+E9dRHg32X2ZO9fSjdg12NiVctcRCh67S6wvfhD1PNAAOgZ776LKBPXftXT6NTpv4sMCJcP7mLhfwRQAacJyZQQQpHUtWxRRyAHQOMiwJFVT4VsA9/vJiGAAADQfs4Q0/geUth3hQREwzAIeoZwb3Ox40QwgV+yQEZ/eiCwZVN4G80bAG5SPYO/vjmAHqh0Q8XgJoyMQdDSUHXImQILlF9rDW8sZ+PUmCB1NVQTYmjwOJk04Ke2KiEeSHZfM6zFf9gXQRglgJAwQgmoQ0GzENpjKK/gIGCCAxui1dM0+PyxkUWHGAz5/HGRlB0FCJqipAJ8B88jigWkZEEARv7DQQ1FUcJRbKCOSQB3yCXxz5VThEVuIAV1QYnJaRiAhfY3CIud8XbufKVsIxl7VpnlCmUUnoiwIAsd8nLC7rBl374JOdEubA5oAOTUwQAKlVpubKFBph92CMrFUQHucgvkyPYJN6cCRpo7iGLeKSmC+70Bd7AMZklsGMAwlkHb6rBnXm4oQVfQE4bSJEy9GMhCxzADQfM8X4lqCI5nqmwatSzBvdUQUJJQA9/6ERQfTwaQRNWDI81YFIdkoem5FEVweD/RDdDMdQBIniSAXikn5hy4CRjckDFnOdNyBSnRLtZUBU0wEy3iksFfaUZzgAmWHzxjAsl2BtuHAqfbxTPAMA4okVcM6LNm2i7iqGVEcxLOA781W3g8a2gYmQ1GLINSVrCwq4WcQDMoWPXpMoym+L0YQe4FwDwk6P2AOA9bNmXv+AY1la1xY1eBeoI0KjWmX4FnoY9gUXn5TGKzWZEBShIZGJySQsVpK+IXMAlIXgxyKaVBYjtQWidVNOKCI2t0BotDlQLDtQ+i7WNWitNKRpV2R62tNg47WynWtvEMo+2prWtV2Drh14aF5a6ve3siPtO17qOuWmA7hekOxHqkna3/7Gzbhm0uwXuVg9K3s1CeK0xXgc5l3bgPa/qyjtd9ZaOvV6ALxXkmwz6dte9XDqufmMp3N/GDBH2hap/XxVggP6hwMBLLYD7W10F96y3w3VwcoOr3P8+mMIRhsZ+e5moDeuXCwh2QoiDAE9FsXZ6I06e9tBgYrCAGL+6KHGiXHxf7NaXxTNmA4phfAsZi5bGWkhxtFZ8hhbr+MU2NoaPeXBiJFdYGUveQZNr/OQbFznHa9hxkt23AoLYA6LAALObUnBLrmC5BCMqIw4OetA4YRMLQjYlkVFgIoE8EBxgRkGZZSplMgNKCG0+Rp7h5uQMU8OmYBSBxyKSFpIkckeKcP/ITiCtGW6BbJEYPUuq1FxMJvs5OZSSx6MmCx65EIfSF0XVxSjZgBRlmgGWRieceUwlMpexIXlRAAHSgoCGAhZuu/7nXjYmD6fkNFdpnOeP9eyYveQKXnl1kXdg6A2QzTEhS7WqKTZ4HwEcO1+yvkKccalhm2KyqnExwEG0goBWp6Y47T6KP/aSKqLMK9lvhsWn56Wtr05GQlCUULxTk5CzMuBajBgpXCsmYHHTOksqMJFMHohrWq37ImuJTsYNQ2xtNycuiQ73avcNV2j7cNof6eqwXEEWL3Lb44GBDqLMTGVDQ9kguBkAARbt1Y6o+6M7MZQ/hnPpjdwbJpwm9LL/TViSe4+6HqVOeRtxgu1FkqkgrW76woku8iqMGwlf7/OVl97cmg/Yytf19JHN3uByj13tWS702ZWMY7JHV+5tPzQqBn3m1jpqhgfDO/TmbINIAVuxJPOGAJwY8sKKPQfiCtgJCENUbiWA7+sTvD7C7nc8H94EvNGLQxOPoBgYmQf6nDxHGpDImPvlLrjQ/Dg4r+8XiDA99jmJpY9SlxG0hz7f0kuzQNt3F2CGBA1wQLVVGtlCbkcwrXd9dhrv+FlvWRjZWMBdjjOWNM5GMXyh1leP4nsxMpz4dneBU3TKloMXyzO8buh2FKEnyvfc9LL/rttfgJnU/PEjhpcj/fZV/+hyFcHnQS9wejDwFuqWACIUeT2Hbn6RGpUiff9CfegXZA8nC99wGxyhAJXSJk1Cb+LHG1kREciBGjGlbHAXAyAIMgrgEHTiLxf3fHwhGdJ3EwbjAlpWZXQHA7yCV2lEdCRIAsiBAFbhRH9WfbUnAzcFEkmRHLkmSeOyFZSXFrC2CAnwWTyYf9dAeyP3do9Xdhp4fb8QZZ1HhuK1ga+Ahk2ohtbng1wmhml4d2w3ePu3XcVHhw5nhhlUdy1oh2Uoh9gHiGMoiGvoh7vgYbvUYYzIYXe4eRLGYAfGhkqzYL6VdwSGiRA2d30ybikGhutiYROWW4oIJW6jdHIDCKlYS/8AsIphY4nWcTd5szd9g0N+QIt6s0m4WFyyaB2DwwiFEwjBuAjDGIunCCWJwwjsxAfLuAjNyE2EyCWPs02DUI2Rg2GemCafNE2B0I0O8oiuBAqimAWb0zmFcI5h4E20V45YEDqjAzqis45phzPPcjpWNAj4SI96ODPQQkuGAJDt1Y9Z00kXJgbt2GPiuJCa0GP1yIkcaIq4wJBQs4cDWZC1Vok0AEwKiJDk6JDIGHtXYpHOAA+YZ0JLuGcmsFAJmZG+uJFFQpJwsyFwcQMqGSCAx2cQ2YYSCTQxmX5c4Q96EW+FdCuK8T+WokgdsmkkNUFZlW+lyAoFJiQcKZNGMXT/HtF6mKF4yaEiJ+FF8cIWbvFC3FBtLPmRLtkHVFkEYBJokseChygbi8Qtv3EnPQSAH3GXlUQjAcdEmeePackHa1kC2nIbBGB5J3kCDqNQOdlpLyBPUKkgGBd9UkgCQwkml1lCfCV11paB9hiY0uiThKkWlUJ5N8GFKtCWxXCWMQBOBiaZyEd1piBIqvKVWYV0llVJkMQxcLmTUikEGrGDfgKTo3keQWF/yTceIqAVr+Z9kqIxHuExHLEND9WVNBcD0tRw5gWYEAcEkXF8kciEMAFG9kckALGcBvBtzukNmaIOx3IW7EAY9ueYLyBMoTRKD3mQvwkEf6QtBdRSH5F1/4+GFAtBoGdSCyZwHgz4cdOnnD53bw6jACW0Q+pWlpJhfiVpO7TEjmjZnT4QEqcxQl9EGVrpKXP0awdKnANREHphGKaJoWsRGem5cA4TGQFaQQcRH123AvZJTEr3kxjpoT1Qb9M5VkTEKlnoQAOXE+6WdGEokisqMElheWmFhEfRFhBqLRrDEh7TRp5hInnWFdl5nTQgSImJMr65CtKSbdY5RoP1QJRJGdSyFmgKA85jP+HgmjtqfEt4PR0akT6wP0KxVYXkWf+CE0IndCkKpVbAJK+pApD5qC6ga8XDnYCqkYy6nYEYA8NRANLZER8REiSFErEVpJf6kpl6kXFpev/uWRbwqRb7MZZEdQMtKaRqiaAjCZR2qg4Uehqp4UQA16f4Z6k8GZKi6ZG6moCtyhnd8R1bcZNdSKz7eQJttlD8mKrxZZWgpQ5dOiHgB1LwgG+4aqrFSq25YK3mak+NCXPROpEU6TTaOoifaaskUK3rmgJuOSj3WpntSq+aOq+nWgLnklVpUQ+tdyNEtBOnkiKUhLBGeR4u8WsU9KkAqikAGpmqwKHSqqb46gorVACW4RECspXfqmiH8hgj623fWlUS2HPvCSlg9Bhs2pvlmqvkOq2QgSrpkqOC4RwKNytNNaMM+hx3sg0PIH4RWBoG9xgGh7GnoLE3y7F28glsxET/ZqFuIDsg1wIY2jejEZu1HnEn9ACeJJodMdVyCGi2TrsM+RmVUpuuHPJIhvIUDjub9UASpqERlyUVCUsCDvBUU9gx6eJZV2eoksq2BAmwNUsF0LqpOIusUZuxV2Aiwxd4CvmuT/OniyuYBqmqmxuanSuvnztQoeuFLtOTpRuHAcu5qSu6Uom5mNu6rvuJsruxfOKOnYu7fVi7aXq7vKu4NvO7vbszwquftFu8lOi7yJuJx7u82hi8zvu8IAa71Fu91nu9vJQmF6S7PsO9Knat0cs9+QW54Qs+W7K95Vsy4wu+6Uti2ksX2Bu/UvNa8lu/mHCrhzu8xHtzrLunwAu9/2hHuv6rv+/Lv6Crk6PgvV6ndwdMnwncVgYswNqpuYyiwEx4B8HAvRY8BRv8lw38o08LwQEsGmurBuSxqs2bByNhvhJMpizgZUexa1rYG4uQIAJLwwhkhEjhpC1gFguQKh7BoHYqwjSwAFkXAInRSEZhkiyASAbDIXEqA3dGLg3grcJ5rC2MwClQZ37hKSkBEeGHEUGcoAnQIyJAucjnEGhMA88xLcLCH/PZr5v4EK2HGlepRh4UhbdhhCxRuQeSaCkExkWMg1XFGiDbVaWaxQ6cAsk5EwUxIGH8L5i0QTq3kkirACMoKCPzG/aQHUqsLG4sLIARxxecwjIgfEF5g/8zGUbqIhwFcMIjkBVbAVhE4htHgRSGYSGmYABVCCwPgMjjqsgg/CVlJFLCwqJwdBNqNiMQ9X1bAX7cgQAPdRv40BoP4C/9lhCk7JlzXKZIu8QxvMrcgQI0QS2dgZPH7MjSDM0tFBGP4YDo+SaLh6HBTML5+6YBUhB/ISxPORMhAmZDSQKY/HmHdxA7QXmt0QAy0W9utM0eTIozENCSuTEjuEhYwR2wjM9le389txfUmXhbKhQXgcnArKLC7IotIHFdTKd0RacpgC5zUckmwgDViWtrXNCeEXRgKwDaByCFCR4OTbMATANljA92HIVvwVGcZhbA8RJPUXrnGciJZtD/6sAOPvQJDgBGhWxS/vaG9jzAM5Fzu5YSSOjFXYTD4FedHlNGHp3TBEAmROEpgLQI6EaXZ4rSED0DrKEIEnrH4acTS90ILMoj+HCeIhOnVO1VMEES7UcakeYSTrSvJVw1ky0GsgzP8Wol3pUW1+yn/TvB2yUVlvtadMAhlAp2+AvWbmvKhfjZLvzAkziHH4zXMZCvYLDCY6baVSIkd7LCc4DbZypfGVwD9bRDkMQj86bEKQAoUWExRIGaUkwgpay8M3And+YCxk1p78YIwqpndvvcOnBnuQ3a11HZ6UoCLSvIbYzUactQNyEewzEfeflPNUAP+DDerz3UtW0K9v0C/+ldQuvtFu3N1JUb39HmTznQ3/itxWnzZqLSerwXhbpcAumtPnpck0Z4AH09Av5EE2HkEvW0ySCSHCQRg4pQQrwMNztsKVzN4NTt2Juy4hPuIvBnD0pNMSJNAiGSynt80a98ER2uMR4U4kMx4t5Q4lmH4jm94iWFtMIdmXYFfozRbBROI0mKVuB8eSWgE0jLa+hQmdWmIB8RzQ+VU68MIwcygotxWWa8yKwtFImx5tH2zhwHe+fZU1W+RFfOUV+23Lnh5Z/AtBgKzZ5a5ntx5l8+V2oexnKxg09+P5ACdPqRgrHQstsBGElB0aCn4VrdCKgc4lXt1jJL5RvjDPohrv9u/uIgwS0tchwgnWu0ITAFMWaW/iGYbgCa7uMnvEN3MeSx0NbANupSWOqH9yJl9uiyts9dK4D7cSkUvhXvFhhGNZZciFWAkuj8geAKEurBbgqtkRBZbepufOxEDCP4wuzR5uHhHkbrcX4+p+N2Nu1qVIGK1seuYQrZTt/ALi/eTuXrju7k7to6OVl4i+4woRF5/jEBNBdR+NfLbRfOXRTb3tHPGS8JQe9FGPCkrcMsYvAx0tj8fBQcBWbGvfD3LRC8Vn6MIH6JTvBpte87IewXjxcZ36fITt500NlY3M00oPNy4PNDLPCpHrmq3tqzrcHlbvQnjfSxrfRfjfMEvL7/I4wHw/22ee30VG/ezPvmfyj0cGO/8ssyYD/2kpDantu+dZpe7Iv2mT085Mv2bf+LIgb37iv1Z0/3dVg0b989ZF+/negJNWTBIYY9rRg3+fg8gv/3WKCLtug34ZP40osFxagIx5g9kI+6WvCMihCNwnP5xsoF2Ig/no+pXQCO7TP6qOoF6ij6/ur1WQCPGIT6Zt8F+8j6qzv7XSCQj9/6s433cb/ave/7jou4mH8w1oskfV+9GZr870pu6isFHbyosE3bFDyK4gv9yC+5w1z9o339pZD9Ibz9tlv3z//9lxj+1D/+0s/CvHP+xI+7PJMzuxP9aR+k8O/83t/+QHL//+IPAoA4kqV5oqm6sq0LBK+sxrNN1re+5rv/A4NCVG9oxBGOKcGAOCoqjYFk1MR0VrHZElRGiF2B3S25bH4KCQjAIBBQUIdT4xcVNuXGu/Y7LpwP1Z3ccZ2hGeqJuC2a1BHuJBpKTvpEthgkJKyNOCQcAaaNPR7C7BwMGKB0fvoBCVo1nVh+SkYGpKI4xv7MUvr+0vgIJAy0AjQckCzwKQAUCAAgBCAIFCgEJCx8JQQUMMAkNbhlfxW8iQc4ABCY37JxByS3FxgsJo8qkt4YNCgcLJRApoyZM2jSqFnDpg1bt29z0JHrds6NOnZuUg2AJ88NPXsA8JWqJZIGrmjwKv+CaULgmgIDCwJ8G6HgQTBgNm+26HXigLsS9QpsEvEFoIhn0aZVW7Dg2ZdvDRqAGwYwgYAvSQo0qQegJYAHzQaonPZKRL0FIPMEuUi2W9B1AYgWPIpQKVOYx6BOkQqAqlVnWWNw9comLIKxAMqenaQzLY9FAp4CYABH11ZoBhQsoIqAnmQeOD+DLrRjWDErBUo4eAPN6MEwAw4IqgaOpz1BA6B9kbZo2m25gjAtorZLdEgd/PzBFSGbRGoFqw0ijfU69ukptN3ArtE7927e0AvXAO5GuJYzi8XwKElPBCpdBxUhcIDswTOoNUPjv3n+BCZNCDQB4EAzJjDA2z3RRdP/kiAJJJNXNiPYhhtgJbHx3VDOqPMAgrLoM8MpFP63hoAnFIjAax8hiICCNTAY1YNCaSfhVhT2dtCFBWS4IR6KjZRCT3dFNgVlzn2EmWSn9QPNffkxScl+uSCwADoF+PEFdm4xRM0iUFmJzRoPLWJAhG6tM0+FcmXWjQAc6UjckyJcd5GUHFXpkZXcaOkGl4sACOZFY9ZhUTdnHpTmM2ySx2GPZthS0n8UkXnFSm/gQqSGbSnapKaIgEaIYaCh9Zmnb5JBqg6m2oAqLZuyWoaqQozaZKg4xcrkqzLc6kKujLXaaxW7+rrCZjFpAWywKQy7JKOL4mTssa06+6wyBRyg/wCxO+YjbRZLVXstceYxq5+2494wRm94GENuCZnhBlSxKJzLRbrqjsBumZh26Gq4LICkyLwsREsvqPAqKa8O8RpxBcJ2DMfJLgd4kqm5BSNxMMVDKHzxIA2L4MDDEWPLqcgy4NMbKDMELHCzBMvy7woLHwHzC/ayg2+2xZUg88kyyDxEzy3Q7G6m4I78Qr/gnKqy0kOT0Ns8DsGTyqRc3TYAtWHW8ydLGDFRgFELzETCmm4wUPUzqIQpKNdWX3EdLtxa62O+7K3GEdRqTb321RdlfUveFVr9ddgjjA2T2Uz0LWY7ercdpghwe4sDj0WvUHgTbp9pnXTq5LS053OfOf8CjjBAI0AzRF62DIAjQBw66phltIYBp81OQoFxxP5RE+cG9hWAhLQuwn+RS35zzhSPHkDpp1sG++pwesJ786rLTvtpI9w+Qu4Zi9D7O2sAD/LwyupLeQrZh5+5GtO81/nnnk+8wHUNJsHdJt4pd82gNU4D37lgEyABFKqd9pTEPd0E51xXMB1HcAW628jPI3Own/8MqL/T8O9+JlISAAVIAgLSTTm7g85uNijCIjXwBSljWqlcQMAFXlB9FXJAMnT1PvgRrCx7oV+ATkMk0y0DOjRxAAY590PYFWwYA8IeKBS4OyPSyIADkMYQr2dD4zVNADps0RyIWJkiBfEoVWT/gxGXF0blJGCJIsheCHVHxu5FUYRU7KED95WFXhTIKVMMwBhNVj9rEK88N6TXxB7VjQbRaR1bCx0fvHYYrVEqdAB4icYKVzYpPtJvZnIiGzhiRffhLIuGpBYMEvm3czWSdpCkWsEoaYVFXPKEWVNcAzmZyjqabws6oQ0xOtkNDEIDEL1U4SCVtsIbrCQ5+JlVaJKpqWN+q3xRACAui6kuaM4gAZyTFehsos1NYbObUQjYKqppzXGFc2nMPKccJke0gbGTXOk0pjjjWS53Lis087TnH/jZTiz6ExL4lOZn9hnQShwUPQBNKMoG2kJ9MtRXBiVkPSNKvoe+s6AWhdZG/++50I56xo6/6g5JS2rSk6LUpCB9Zkpb6tKXwjSmMo3pE2Zq05viNKcvdWivJrpSi/qUnj8NatJ+alSCHvWKKyWqR5Pq1FU9FZQgZWqqompVXl31ohGlakOz6tWqflWQG+WqOcNqVrGelawrk5Zaz0pRtxZvqdpqK1zRWdeK+pOuALsrX0PpVr3+QlU6HSxhXdpXdfYVsL4QLDsVe9iyptWojD2nYx+r1LpWVqTEpKxlBZZZVn02o0W1Zmg7i1azlhapTS1mak0bzb9KVgcTiEC2IjABz822trd1batyGxLbhtW3NQDuWHVggQBAQAIBkAAEAmABzx03uctt7nN5y/+q6CqXuc4NK3anu93i6oAC3aHA+8S7G/Jat1XmXQR6w7peN7QXqDuIQHdo+zn67sa+6d0Ufheh36/21w3/3aoPmusGCAzSwMjdb68UjGC3OliuO1CuGyQwSAovl8GtwrCF3cphCe+gAgGogDVFTGINt8rEd1UxiHVwgQBcwJovjjGKWTXju964xTeYQAB2O0ge+7jGTQLyXYms4xtggJ1JFjKrlnxXJ0+VyVKeMmapbOUr87OwWt5ySvHA5S/vBsuKAPNJ9UnmM2v5VwmFQmhb+75wktXNWIVqXkPGUTHDGaJrVvNB2RwsOeNQtDYBNC/4HFA/S1TMfr2jnvts6Dr/v/aZis4zPB09zj1Hmpt4RuZ+4lxMBsDjkx9V6KHtDNpJoyBOFCJTVzU6yAPYh4X9tHRc74zlMRyghif41F4rfZOjoUsF7GBQ5KJFaIFm2lao3omuTaKnbbzhG3+TdWC50B2XHW80HKOBy3IdoLcku9A52w22oyAIXou71roKs6CnjOvd8GMXfTnR65Q5aidtzAY/49e2feSyjGijAMo0tglOBAx0z1rdOVl1Pm+d6mavB0ZwOkD7+mfqQecbBrODzeIA4LbEjQCBEeFG3CwXkHEABB3NYIg7pi0f5V084dprNkTkZ58BOMCQ97iNxcvkBgEYUh3VMEc25uEIrylE/yseT4baluEGNQK0047SSFzA9gC1AU7UvXY4s0nQAHnXwNtHtPeiqw0LRdjHe6yLnsaEx8d5HwB9w9ELVaoRFJjLpt4j0FDM58yeRdzmQXyZRokEoiIGVKMVRBIBZCRDALuDTUw1OHqUWqJ0safCKxdiYacdY3hrySbvmfedzULKdROo2pANEIS3p933xWZ8DggcDwP3d7GypS3sB3jhcOKU62bPYXYVzxNXwo3QnOna9zPcSJge0T5n4AIVYaDHuVNSFANcnuLdiY9qLi510cG7gwaYPf7AenrVAqMLYQBE8cVIR5yXoHUvkfzE83iMub/oI0JDWu3Gbno6s4eu6f/FCFwGHBxDs43C4gHJ7Uyf5AEEZUBfbvxHMrQfE2EKouFKSQgECRyANQBEBe6b3Gxau5ldCawfFQgKBnlSJpXEpJgD/S2dx41Dw6CDOxBE8J2G64mgEkCBwTGe4/iF8MBDmwiF/gDdSbgR9BkKBK5HGyhAi6RglzRb1KXK1AXHUShJCkoSZEkZpbkarQGgPWGgrV2ZF64VGEoBpimcpI1gw51hqV0aGpadsrUh+pUgHPKgGuLVF5ZhLt0hpOXhwQRAv91ACMrcvfkAwq2WlaFZSZlZI0LiTT2aDHgF2Z2A0ykEy6hWtCii+SkaF34ixt0AsJGAidBF220hoxnfDnT/YquF4mW94hu+AAIZwNgkgENs3AlQxcn9nDPYTep8xC3CQ6y5IiKajc59G9kEHZkIztV1XGqQjVbFIrVNI76NYhPY3ynAADGKDcgoh7sgzOisBz0MQ7rVU+58XoHQBONBheMdnf7NSFes3Dr+XzXuoD2mnw5cAQGxA9KgXv5NHN1E0JUwAX1Egzh40CLOYRu1w0VUQzwsRfTRn/iRH0JApDTiIyJmJEbNwBXY39f5Y8i1iGmc4hYlA9jsIuFoHSwuZOhsYAm0ROMJSdh5YDyaQAW+3kYeW3q9SRjYokO0Qt8MSr2Q3DOMUg0JCEAUDsOxZCSciyHBhP5kwzIKgjRk/+E8gA3KYWRG7qR1fZYhbtYaatpGUiNZcqSmaIglKmSbmWVZtuUkimFOLpOGRWJdnplldaUnaqSveeVV5aUsxuUq8iVv/SVcVpkcsiWDFWYcHtZiNuWf0aVf4qVdUmZLeVll4lRkWpVjviUo0iVmOuIygeZOdSZkMiJgistYliYZdiFqiiIdriZrMhlTtRVgceayURlt5odtxmZP9WFqNpokeMz1uWVvuiaK6eZcUgIAgZBgGmc+nmYhoqJeHqcKgKUKdM283GYdtuYJzJ7WXefWDeZRLAJ4TicRtMVSEOJ2nl93msDzFdx5eibsvWfPxSfKBEXh/IhYPicfumcJwP+nJWXElSzjfFojgNqngFJdgeIBpvwMe3rVaGbmZqLAd7LRYLgFAjSeAYLffvLnH7pdeV4oWGTohvpBnAxiAd1jfyJbolGod/Zcc2ZQxKGCgfLU88nod9AoU9qneLLoaPnmi9ZnUIzod8hkuX0ofSIokTaRkbbjzsCHjf7oVipnVI3Bd6II2WQQg7IkcJbibpyGgH4Hl+JA6Z3WlHYpG1ppdSrpbqJpiwbpmnqpfwbnm0opnR5VctbpntqpVMlmnrLpgbqpcUqoSuFAoUqiZwUqT+HpW3paksLmNS2qZr1mbD7qHvIpWyGqG+zmppYZodZpa0Fomg5Vn8LpnIpqlAn/qakWY6W2ZKQS2KqyaljKYqp21Kia46ySqqC+6qCCl5zqKq2i6q8RYnHGE64eX7Du6hIEgH0YBantJZx0R7EmIXZSq3NyVlIJlwgQl7KuqAuYDlc8a652GpKC67VC6rE6VXdpV3V565li5zNghlH85CKWa9XNxIDGgxsJihZ5BCmma2M91XsFQHy9q1zagcD5wzNkI7qa2r3WTu0MwJMiXhMoIAG+BcBiKmk9VYAFwIAdbMCaYJj+HD+upI/eq/iFzi0wAY4OYaIs62J5aiQ22CI8WMgaq2kUhfJ8pMNG070G44D0xqVcgQKODtH6bK8y6pv1yofhbM6O7FqUzjgE/1I9Aq0r+RLeqYQRjo05wKyfNirT9gqLPS3CUo6pOFMqMmamim2r5FjZYitSmco3tZEuwSpr+YqRwa3Iyi1b3e0ghRaU7W20uqHSsi10Cuzg2lUQhKcg5QqUsoCoTRGV8ireKu5cCYEfAanhAgwBtKIIUAW1JIN8aJM3xi3AzCynjlTqNsbM/uitNC7TPK65sg7MrUWx7sqlBmLYEu5Z9qa5LCjVYZ0fQVvJAZ7j5gJDeEOWLm/XAuXREV3KOcZemI63kW7wQC3YIu7usilXISvHnsDEBgkDpKP3EO8cvIY6VuvPJq9TNIBkfIN8wG+A4IXnggFQRJ7prEG8SK6Zcv+uj7pqGo4n39oti06MIswOvG3f+U4c7yHvrtVANQhlR5QnODChAXib2gprrgbwP/Hu/6pifx7wpbykTYbQTNafXYCk7CYv6MZd3KwRDPvLBSfFUsgn5W7w9oahDpstEEwuDuskvEwvVBbGJgWT/QYkbWDFAzcCn4DPv0oQEjdgmqjJqXIwD3tw95rBD3+rpWriEZSwuo3B59pARFpxsk6qQmIxAetbCXXxah6wz4xD6RXBGAPL8Z5xHovNbtywHkOrHfBxCMOrz/gvCFej7hpyB/vxNxauAMdrIydbQ/aiC6CSGw9yWyKyrR7iIHyS814GGh0DylmFh/awGkct4fz/4oCUY82NMlMmaSSQcRY1TSF/r+X6pyb73SDsxvzKR+TNCN1Vhe3WoyMzKyzFTS9zRUsA8xf0sS2sgCDcArVg3ccBIRdfsllmst9mccJibAUX5Gn4HhkHjCUsRyY10DfLYG30gjMLWw00KxzJIweyXat6MV/i8h9zMvbI8FHQa/6JsyBzcwxfizT0M1z881ZCcxJUZO0BEz3Dcahq8ybrLCpficdhxg/+yToDdD5T9L5aNFHUIAwCsPElNDy7XR9tU8xic+rWMUuTpkSD6DYrcj2VtM/tzwrOUg7DbWkl5gej8ZyWsu/uLU+bpk8vMqV67+VuLFCraRpT5xov9UYP//Wx9LRTO3TGGSYbZ3XZErWLwgrHAOw4G02xxrJbJrVSJ3KbnhoZhLVUM0w7//RleqribisAdCt+1PVd3y20Na/daBy1QCNMXEFgFwh2XMYkazWp9s09JMRU8slSNFDNgZqevDFa4we7UleTYPZ3NTWMuC8v44V98BHhNMFon9AbXfPm8kfGCpwNh9zbRbDgCUA5DrNlMwnBGix+4LZsUscE++ND/sMCmUNwx0IADWKxufVhvKxrxB0f+E3Y7QbFIaQrp7Vtn4HHgmxoYDdvs8gLX8vOKPNwKLPphnF113ZR5Ah5qAgGe8L8XcgAis3Jmrd1l0GEsYp9rzUJdMnvRP/xJEmlWQxAViqEZMRDIyH3VnctUmyJIkmES3ADkjQfEGYvfVOC026KhYNTE6s1MTM1hYcG2bIKiGd4CZS1TJt4THs4aLytjcGYV1v1ndphiuOE3rIKjY+4Uas2VMv4TQhukxX1i+v0hu94sCIyh8/0kJtqkZ+4kCO5j7h0To0ZokIyiueyjjf56Y44UUGTksM0k195UK+1ljMKS98RmX/5SC+umP84+J55jGuzmrs4m7d5AauMO3e4asr5nG/1C7QBx2juQ0WLiiRBc2K5lSOWntM5KjvreVZi+B5x+QTMFUTchB95oCE6XIZrKowrVmcb5K7Km3Qi2GhjZf/tDdX/cmdCQTUAEb1S7Ws7ZKtrLh8EuHx0IwfGAvUp74HrgSRjSiuuictUVl4HmdII+6WHYVIsrAA0rNhgo11oox/VMFUIhjY2AMWMOq67L7bsOnV3IpiS+mdstrsuTbgbu5GHXsleTz+S9mGke0NbRw0JwD/wEc5dxrVcOwyW8yFseykOY/F+Q72y2rd/xm7fEMGX+yYvhzkouwrPXbPrkfrUsFH0gwFIBtTJxkrA4EgWz66X0Aq7RRKkr7MXNzuzynbfkMkffC4vRz1MLTZci0/C+qPLulJetMYLD9GtyBxrewpMOvRBiO6ZbJDjB37fENGn/BU3iSLaOQr0vMezXtwx/7zQhwaGvw/VH/1Rg4bSjxqvq97TZ+ktSv2Hjxg7ifjVY72Lwrnbtvg5rbjZn32Qpn2N9xg72bjbmzLmzjfSN0mPDxLf2/1Vv/md/70IH3rcD/6UPjmUl5KUo27iS6i1Ob7qHr5iAmpik+Dkd9apo2x+Y35fxpblT3nnP5bmWy3ni75pkb6yOFbqn75Qyxfou3nrH2apwr7ry/5dEVrsbv6N3/7oc1oiucJ56H7p837vJxaniYjp6kCJD7/q+8ALwcF1JADtprbxZ9WT5AaQIGM1XMOD1JzIQfZQCkXHKSiBIqG9Pn+Yxk0G80TVaq/1w5YNdMnkpmPEz7Zsv/bVQf9B74woCAwAESBNAzAKAbTuC78BPMf2bRSGwrTH4Wo4bkRa8YhMKpfMpvMJjUqn1Kr1Gq01SYgdAlAIiAMGgQgw+I0DB8ZgbCDBEGty4TUQAOgIXWtg8KTVMuhkIDbkA9RiJlWIBRkpOUlZaXmJSfWYxAXgkLDQsMgogqBQBupykACwQEayAHPqwhDA8qfHd5JiK2gUtfMwC/ATlAi1mam8zNzs/Ay9lHzUiTaAkDCGIDCGAtAAR6AQEGawkH3nQhBGDsAt5pZbgo2I/AuVw/tAvHhQ4hgtoMCBBAsaPDJtSqODSAolRJJvBBl/YhL0AMgwo8aNHDsqeRhloUcZ9zL/ghyJMqXKlVdOssxSkqHLlzRr2mQ58+bHmAdz6vwJNOgzn056oXTIkajQpUybWlHKxJYcGMXQJEBAMUCCW5KmxoTqwqi7MzdEJgHrNK3atTbQniXgVRWQBqmq+rsYKW5Ynk2kzjAbAzBCtoQLG24YA1wABe4q9hiQjQ2AHWIEHFIEwBa7dIpWxeJn7MU6MQb6DPm0ALIYIPQkm3knhjMhvlG5Cn5xm4jbw7x7qywkoMAXXj0OiBgggsuAY5dB+41BcR9mUi9mCdujoIFwNChqMRCFnUFwFnpnkyRivIUOEtl4ZIb7V0QOAq2BmNkRSwAr3b77+2daSFWTpbMOGvIg/0BANgMw0Fwxz1GVwA4XCSiEC3Ss8cUh0uVBSA5rlHFGeZnR5sMZ6/WSxnty3HfVN6zx0IgffvD3X4020gTcdsR9c9yBQRzABTZA+PWZXO4o8IVd/7gwTAumaPcFhw+UAJ4LC8ESA1LomRhHDQ7Cd2QA0rFDWiNmPCBbWzeuyaZHj7yxWGNaPXYgnAU8tlgCQxJwTjtGunNnVhbBMBo5fehBV2pj5BJZCQv1maaWZd0hTpeYPaffISxUSd0CCiSgRxG7tUlqqS0FxSFGexHRh1anTPXlivKR0ZqjZzigQJE3jGpqr772hWqoMJ3XTKqi/opsspTwCpSky0yp667KTnZLrSZtOitTtdpuK821JA7ELLfi2hiuTtj2NG666pZ707kGsatuvITBW5O7BdErb75N1cFvv/7+C3DAAg9McL80FIxwwgHry3DDDj8MccQST0xxxRZfjHHGGm/McccefwxyyCKPTHLJJp+Mcsoqr8xyyy6/jHEIADs=);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     * In the absence of gold standard for diagnosis, this algorithm cannot be evidence based but rather represents the informed opinion of the expert committee. Consultation with an expert should be sought anytime assistance is needed.",
"     <br/>",
"     <span class=\"bullet\">",
"      &bull;",
"     </span>",
"     Infants &le;6 months old on day &ge;7 of fever without other explanation should undergo laboratory testing and, if evidence of systemic inflammation is found, an echocardiogram, even if the infants have no clinical criteria.",
"     <br/>",
"     &Delta; Patient characteristics suggesting disease other than Kawasaki disease include exudative conjunctivitis, exudative pharyngitis, discrete intraoral lesions, bullous or vesicular rash, or generalized adenopathy. Consider alternative diagnoses.",
"     <br/>",
"     <span class=\"lozenge\">",
"      &loz;",
"     </span>",
"     Supplemental laboratory criteria include albumin &le;3.0 g/dL, anemia for age, elevation of alanine aminotransferase, platelets after 7 days &ge; 450,000/mm",
"     <sup>",
"      3",
"     </sup>",
"     , white blood cell count &ge;15,000/mm",
"     <sup>",
"      3",
"     </sup>",
"     , and urine &ge;10 white blood cells/high-power field.",
"     <br/>",
"     &sect; Can treat before performing echocardiogram.",
"     <br/>",
"     &yen; Echocardiogram is considered positive for purposes of this algorithm if any of 3 conditions are met: z score of LAD or RCA &ge;2.5, coronary arteries meet Japanese Ministry of Health criteria for aneurysms, or &ge;3 other suggestive features exist, including perivascular brightness, lack of tapering, decreased LV function, mitral regurgitation, pericardial effusion, or z scores in LAD or RCA of 2-2.5.",
"     <br/>",
"     &Dagger; If the echocardiogram is positive, treatment should be given to children within 10 days of fever onset and those beyond day 10 with clinical and laboratory signs (CRP, ESR) of ongoing inflammation.",
"     <br/>",
"     ** Typical peeling begins under nail bed of fingers and then toes.",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Newburger JW, Takahashi M, Gerber MA, et al. Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Statement for Health Professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young. American Heart Association. Pediatrics 2004; 114:1708. Copyright &copy; 2004 American Academy of Pediatrics.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f22_0_22543=[""].join("\n");
var outline_f22_0_22543=null;
